id	sid	tid	token	lemma	pos
iajs-3367	1	1	9	9	NUM
iajs-3367	1	2	this	this	DET
iajs-3367	1	3	work	work	NOUN
iajs-3367	1	4	is	be	AUX
iajs-3367	1	5	licensed	license	VERB
iajs-3367	1	6	under	under	ADP
iajs-3367	1	7	a	a	DET
iajs-3367	1	8	creative	creative	ADJ
iajs-3367	1	9	commons	common	NOUN
iajs-3367	1	10	attribution	attribution	NOUN
iajs-3367	1	11	4.0	4.0	NUM
iajs-3367	1	12	international	international	ADJ
iajs-3367	1	13	license	license	NOUN
iajs-3367	1	14	ihjpas	ihjpa	NOUN
iajs-3367	1	15	.	.	PUNCT
iajs-3367	2	1	37	37	NUM
iajs-3367	2	2	(	(	PUNCT
iajs-3367	2	3	1	1	NUM
iajs-3367	2	4	)	)	PUNCT
iajs-3367	2	5	2024	2024	NUM
iajs-3367	2	6	ibn	ibn	PROPN
iajs-3367	2	7	al	al	PROPN
iajs-3367	2	8	-	-	PUNCT
iajs-3367	2	9	haitham	haitham	PROPN
iajs-3367	2	10	journal	journal	PROPN
iajs-3367	2	11	for	for	ADP
iajs-3367	2	12	pure	pure	ADJ
iajs-3367	2	13	and	and	CCONJ
iajs-3367	2	14	applied	applied	ADJ
iajs-3367	2	15	sciences	sciences	PROPN
iajs-3367	2	16	journal	journal	PROPN
iajs-3367	2	17	homepage	homepage	NOUN
iajs-3367	2	18	:	:	PUNCT
iajs-3367	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3367	2	20	pissn	pissn	ADJ
iajs-3367	2	21	:	:	PUNCT
iajs-3367	2	22	1609	1609	NUM
iajs-3367	2	23	-	-	SYM
iajs-3367	2	24	4042	4042	NUM
iajs-3367	2	25	,	,	PUNCT
iajs-3367	2	26	eissn	eissn	NOUN
iajs-3367	2	27	:	:	PUNCT
iajs-3367	2	28	2521	2521	NUM
iajs-3367	2	29	-	-	SYM
iajs-3367	2	30	3407	3407	NUM
iajs-3367	2	31	1anwar	1anwar	NUM
iajs-3367	2	32	khalil	khalil	PROPN
iajs-3367	2	33	ismael	ismael	PROPN
iajs-3367	2	34	*	*	PROPN
iajs-3367	2	35	2	2	NUM
iajs-3367	2	36	hazima	hazima	PROPN
iajs-3367	2	37	mossa	mossa	PROPN
iajs-3367	2	38	alabassi	alabassi	PROPN
iajs-3367	2	39	*	*	PUNCT
iajs-3367	2	40	corresponding	correspond	VERB
iajs-3367	2	41	author	author	NOUN
iajs-3367	2	42	:	:	PUNCT
iajs-3367	2	43	anwaarkhalil9@gmail.com	anwaarkhalil9@gmail.com	X
iajs-3367	3	1	abstract	abstract	ADJ
iajs-3367	3	2	systemic	systemic	ADJ
iajs-3367	3	3	lupus	lupus	PROPN
iajs-3367	3	4	erythematosus	erythematosus	NOUN
iajs-3367	3	5	(	(	PUNCT
iajs-3367	3	6	sle	sle	PROPN
iajs-3367	3	7	)	)	PUNCT
iajs-3367	3	8	is	be	AUX
iajs-3367	3	9	a	a	DET
iajs-3367	3	10	chronic	chronic	NOUN
iajs-3367	3	11	,	,	PUNCT
iajs-3367	3	12	autoimmune	autoimmune	ADJ
iajs-3367	3	13	disease	disease	NOUN
iajs-3367	3	14	,	,	PUNCT
iajs-3367	3	15	with	with	ADP
iajs-3367	3	16	a	a	DET
iajs-3367	3	17	wide	wide	ADJ
iajs-3367	3	18	range	range	NOUN
iajs-3367	3	19	of	of	ADP
iajs-3367	3	20	clinical	clinical	ADJ
iajs-3367	3	21	symptoms	symptom	NOUN
iajs-3367	3	22	.	.	PUNCT
iajs-3367	4	1	some	some	DET
iajs-3367	4	2	studies	study	NOUN
iajs-3367	4	3	have	have	AUX
iajs-3367	4	4	indicated	indicate	VERB
iajs-3367	4	5	the	the	DET
iajs-3367	4	6	association	association	NOUN
iajs-3367	4	7	between	between	ADP
iajs-3367	4	8	rankl	rankl	PROPN
iajs-3367	4	9	,	,	PUNCT
iajs-3367	4	10	sclerostin	sclerostin	ADJ
iajs-3367	4	11	,	,	PUNCT
iajs-3367	4	12	pd1	pd1	NOUN
iajs-3367	4	13	,	,	PUNCT
iajs-3367	4	14	and	and	CCONJ
iajs-3367	4	15	vitamin	vitamin	NOUN
iajs-3367	4	16	d	d	NOUN
iajs-3367	4	17	concentrations	concentration	NOUN
iajs-3367	4	18	and	and	CCONJ
iajs-3367	4	19	the	the	DET
iajs-3367	4	20	pathogenesis	pathogenesis	NOUN
iajs-3367	4	21	of	of	ADP
iajs-3367	4	22	sle	sle	PROPN
iajs-3367	4	23	.	.	PUNCT
iajs-3367	5	1	the	the	DET
iajs-3367	5	2	current	current	ADJ
iajs-3367	5	3	study	study	NOUN
iajs-3367	5	4	aimed	aim	VERB
iajs-3367	5	5	to	to	PART
iajs-3367	5	6	evaluate	evaluate	VERB
iajs-3367	5	7	the	the	DET
iajs-3367	5	8	role	role	NOUN
iajs-3367	5	9	of	of	ADP
iajs-3367	5	10	rankl	rankl	NOUN
iajs-3367	5	11	,	,	PUNCT
iajs-3367	5	12	sclerostin	sclerostin	ADJ
iajs-3367	5	13	,	,	PUNCT
iajs-3367	5	14	pd-1	pd-1	ADJ
iajs-3367	5	15	and	and	CCONJ
iajs-3367	5	16	vitamin	vitamin	NOUN
iajs-3367	5	17	d	d	NOUN
iajs-3367	5	18	in	in	ADP
iajs-3367	5	19	the	the	DET
iajs-3367	5	20	pathogenesis	pathogenesis	NOUN
iajs-3367	5	21	of	of	ADP
iajs-3367	5	22	sle	sle	PROPN
iajs-3367	5	23	.	.	PUNCT
iajs-3367	6	1	the	the	DET
iajs-3367	6	2	study	study	NOUN
iajs-3367	6	3	included	include	VERB
iajs-3367	6	4	180	180	NUM
iajs-3367	6	5	females	female	NOUN
iajs-3367	6	6	diagnosed	diagnose	VERB
iajs-3367	6	7	sle	sle	PROPN
iajs-3367	6	8	patients	patient	NOUN
iajs-3367	6	9	and	and	CCONJ
iajs-3367	6	10	healthy	healthy	ADJ
iajs-3367	6	11	control	control	NOUN
iajs-3367	6	12	(	(	PUNCT
iajs-3367	6	13	60	60	NUM
iajs-3367	6	14	females	female	NOUN
iajs-3367	6	15	as	as	ADV
iajs-3367	6	16	early	early	ADV
iajs-3367	6	17	diagnosed	diagnose	VERB
iajs-3367	6	18	patients	patient	NOUN
iajs-3367	6	19	without	without	ADP
iajs-3367	6	20	treatment	treatment	NOUN
iajs-3367	6	21	,	,	PUNCT
iajs-3367	6	22	60	60	NUM
iajs-3367	6	23	females	female	NOUN
iajs-3367	6	24	as	as	ADP
iajs-3367	6	25	patients	patient	NOUN
iajs-3367	6	26	under	under	ADP
iajs-3367	6	27	treatment	treatment	NOUN
iajs-3367	6	28	with	with	ADP
iajs-3367	6	29	(	(	PUNCT
iajs-3367	6	30	prednisolone	prednisolone	NOUN
iajs-3367	6	31	,	,	PUNCT
iajs-3367	6	32	and	and	CCONJ
iajs-3367	6	33	hydroxychloroquine	hydroxychloroquine	PROPN
iajs-3367	6	34	)	)	PUNCT
iajs-3367	6	35	,	,	PUNCT
iajs-3367	6	36	and	and	CCONJ
iajs-3367	6	37	60	60	NUM
iajs-3367	6	38	females	female	NOUN
iajs-3367	6	39	healthy	healthy	ADJ
iajs-3367	6	40	as	as	ADP
iajs-3367	6	41	a	a	DET
iajs-3367	6	42	control	control	NOUN
iajs-3367	6	43	group	group	NOUN
iajs-3367	6	44	,	,	PUNCT
iajs-3367	6	45	with	with	ADP
iajs-3367	6	46	ages	age	NOUN
iajs-3367	6	47	ranging	range	VERB
iajs-3367	6	48	from	from	ADP
iajs-3367	6	49	20	20	NUM
iajs-3367	6	50	to	to	PART
iajs-3367	6	51	45	45	NUM
iajs-3367	6	52	years	year	NOUN
iajs-3367	6	53	.	.	PUNCT
iajs-3367	7	1	the	the	DET
iajs-3367	7	2	serum	serum	NOUN
iajs-3367	7	3	concentration	concentration	NOUN
iajs-3367	7	4	levels	level	NOUN
iajs-3367	7	5	of	of	ADP
iajs-3367	7	6	rankl	rankl	PROPN
iajs-3367	7	7	,	,	PUNCT
iajs-3367	7	8	sclerostin	sclerostin	ADJ
iajs-3367	7	9	,	,	PUNCT
iajs-3367	7	10	pd-1	pd-1	ADJ
iajs-3367	7	11	and	and	CCONJ
iajs-3367	7	12	vitamin	vitamin	NOUN
iajs-3367	7	13	d	d	NOUN
iajs-3367	7	14	were	be	AUX
iajs-3367	7	15	assessed	assess	VERB
iajs-3367	7	16	by	by	ADP
iajs-3367	7	17	enzyme	enzyme	NOUN
iajs-3367	7	18	linked	link	VERB
iajs-3367	7	19	immunosorbent	immunosorbent	ADJ
iajs-3367	7	20	assay	assay	PROPN
iajs-3367	7	21	(	(	PUNCT
iajs-3367	7	22	elisa	elisa	NOUN
iajs-3367	7	23	)	)	PUNCT
iajs-3367	7	24	.	.	PUNCT
iajs-3367	8	1	the	the	DET
iajs-3367	8	2	results	result	NOUN
iajs-3367	8	3	of	of	ADP
iajs-3367	8	4	the	the	DET
iajs-3367	8	5	current	current	ADJ
iajs-3367	8	6	study	study	NOUN
iajs-3367	8	7	showed	show	VERB
iajs-3367	8	8	no	no	DET
iajs-3367	8	9	significant	significant	ADJ
iajs-3367	8	10	differences	difference	NOUN
iajs-3367	8	11	in	in	ADP
iajs-3367	8	12	the	the	DET
iajs-3367	8	13	serum	serum	NOUN
iajs-3367	8	14	levels	level	NOUN
iajs-3367	8	15	of	of	ADP
iajs-3367	8	16	rankl	rankl	NOUN
iajs-3367	8	17	and	and	CCONJ
iajs-3367	8	18	sclerostin	sclerostin	ADJ
iajs-3367	8	19	in	in	ADP
iajs-3367	8	20	both	both	DET
iajs-3367	8	21	sle	sle	PROPN
iajs-3367	8	22	patients	patient	NOUN
iajs-3367	8	23	’	'	PUNCT
iajs-3367	8	24	groups	group	NOUN
iajs-3367	8	25	(	(	PUNCT
iajs-3367	8	26	early	early	ADV
iajs-3367	8	27	diagnosed	diagnose	VERB
iajs-3367	8	28	group	group	NOUN
iajs-3367	8	29	and	and	CCONJ
iajs-3367	8	30	treated	treat	VERB
iajs-3367	8	31	)	)	PUNCT
iajs-3367	8	32	compared	compare	VERB
iajs-3367	8	33	with	with	ADP
iajs-3367	8	34	the	the	DET
iajs-3367	8	35	control	control	NOUN
iajs-3367	8	36	group	group	NOUN
iajs-3367	8	37	(	(	PUNCT
iajs-3367	8	38	p<0.05	p<0.05	PROPN
iajs-3367	8	39	)	)	PUNCT
iajs-3367	8	40	.	.	PUNCT
iajs-3367	9	1	the	the	DET
iajs-3367	9	2	serum	serum	NOUN
iajs-3367	9	3	level	level	NOUN
iajs-3367	9	4	of	of	ADP
iajs-3367	9	5	pd-1	pd-1	NOUN
iajs-3367	9	6	was	be	AUX
iajs-3367	9	7	significantly	significantly	ADV
iajs-3367	9	8	higher	high	ADJ
iajs-3367	9	9	in	in	ADP
iajs-3367	9	10	both	both	DET
iajs-3367	9	11	sle	sle	PROPN
iajs-3367	9	12	patients	patient	NOUN
iajs-3367	9	13	’	'	PUNCT
iajs-3367	9	14	groups	group	NOUN
iajs-3367	9	15	compared	compare	VERB
iajs-3367	9	16	with	with	ADP
iajs-3367	9	17	the	the	DET
iajs-3367	9	18	control	control	NOUN
iajs-3367	9	19	group	group	NOUN
iajs-3367	9	20	(	(	PUNCT
iajs-3367	9	21	p<0.05	p<0.05	PROPN
iajs-3367	9	22	)	)	PUNCT
iajs-3367	9	23	.	.	PUNCT
iajs-3367	10	1	the	the	DET
iajs-3367	10	2	serum	serum	NOUN
iajs-3367	10	3	level	level	NOUN
iajs-3367	10	4	of	of	ADP
iajs-3367	10	5	vitamin	vitamin	NOUN
iajs-3367	10	6	d	d	NOUN
iajs-3367	10	7	was	be	AUX
iajs-3367	10	8	significantly	significantly	ADV
iajs-3367	10	9	lower	low	ADJ
iajs-3367	10	10	in	in	ADP
iajs-3367	10	11	both	both	PRON
iajs-3367	10	12	sle	sle	NOUN
iajs-3367	10	13	patient	patient	NOUN
iajs-3367	10	14	groups	group	NOUN
iajs-3367	10	15	compared	compare	VERB
iajs-3367	10	16	with	with	ADP
iajs-3367	10	17	the	the	DET
iajs-3367	10	18	control	control	NOUN
iajs-3367	10	19	group	group	NOUN
iajs-3367	10	20	(	(	PUNCT
iajs-3367	10	21	p<0.05	p<0.05	PROPN
iajs-3367	10	22	)	)	PUNCT
iajs-3367	10	23	.	.	PUNCT
iajs-3367	11	1	based	base	VERB
iajs-3367	11	2	on	on	ADP
iajs-3367	11	3	these	these	DET
iajs-3367	11	4	results	result	NOUN
iajs-3367	11	5	,	,	PUNCT
iajs-3367	11	6	pd-1	pd-1	ADV
iajs-3367	11	7	may	may	AUX
iajs-3367	11	8	be	be	AUX
iajs-3367	11	9	considered	consider	VERB
iajs-3367	11	10	a	a	DET
iajs-3367	11	11	good	good	ADJ
iajs-3367	11	12	therapeutic	therapeutic	ADJ
iajs-3367	11	13	target	target	NOUN
iajs-3367	11	14	for	for	ADP
iajs-3367	11	15	sle	sle	PROPN
iajs-3367	11	16	and	and	CCONJ
iajs-3367	11	17	the	the	DET
iajs-3367	11	18	level	level	NOUN
iajs-3367	11	19	of	of	ADP
iajs-3367	11	20	vitamin	vitamin	NOUN
iajs-3367	11	21	d	d	NOUN
iajs-3367	11	22	must	must	AUX
iajs-3367	11	23	be	be	AUX
iajs-3367	11	24	sufficient	sufficient	ADJ
iajs-3367	11	25	level	level	NOUN
iajs-3367	11	26	especially	especially	ADV
iajs-3367	11	27	in	in	ADP
iajs-3367	11	28	sle	sle	PROPN
iajs-3367	11	29	patients	patient	NOUN
iajs-3367	11	30	.	.	PUNCT
iajs-3367	12	1	keywords	keyword	NOUN
iajs-3367	12	2	:	:	PUNCT
iajs-3367	12	3	sle	sle	PROPN
iajs-3367	12	4	,	,	PUNCT
iajs-3367	12	5	rankl	rankl	VERB
iajs-3367	12	6	,	,	PUNCT
iajs-3367	12	7	sclerostin	sclerostin	ADJ
iajs-3367	12	8	,	,	PUNCT
iajs-3367	12	9	pd-1	pd-1	ADV
iajs-3367	12	10	,	,	PUNCT
iajs-3367	12	11	vitamin	vitamin	NOUN
iajs-3367	12	12	d.	d.	PROPN
iajs-3367	12	13	1	1	NUM
iajs-3367	12	14	.	.	PUNCT
iajs-3367	13	1	introduction	introduction	NOUN
iajs-3367	13	2	sle	sle	PROPN
iajs-3367	13	3	is	be	AUX
iajs-3367	13	4	a	a	DET
iajs-3367	13	5	type	type	NOUN
iajs-3367	13	6	of	of	ADP
iajs-3367	13	7	chronic	chronic	ADJ
iajs-3367	13	8	inflammatory	inflammatory	ADJ
iajs-3367	13	9	autoimmune	autoimmune	ADJ
iajs-3367	13	10	disease	disease	NOUN
iajs-3367	13	11	caused	cause	VERB
iajs-3367	13	12	by	by	ADP
iajs-3367	13	13	autoantibodies	autoantibody	NOUN
iajs-3367	13	14	[	[	X
iajs-3367	13	15	1	1	NUM
iajs-3367	13	16	,	,	PUNCT
iajs-3367	13	17	2	2	NUM
iajs-3367	13	18	]	]	PUNCT
iajs-3367	13	19	.	.	PUNCT
iajs-3367	14	1	sle	sle	PROPN
iajs-3367	14	2	can	can	AUX
iajs-3367	14	3	have	have	VERB
iajs-3367	14	4	an	an	DET
iajs-3367	14	5	impact	impact	NOUN
iajs-3367	14	6	on	on	ADP
iajs-3367	14	7	numerous	numerous	ADJ
iajs-3367	14	8	human	human	ADJ
iajs-3367	14	9	organs	organ	NOUN
iajs-3367	14	10	,	,	PUNCT
iajs-3367	14	11	including	include	VERB
iajs-3367	14	12	the	the	DET
iajs-3367	14	13	skin	skin	NOUN
iajs-3367	14	14	,	,	PUNCT
iajs-3367	14	15	kidneys	kidney	NOUN
iajs-3367	14	16	,	,	PUNCT
iajs-3367	14	17	joints	joint	NOUN
iajs-3367	14	18	,	,	PUNCT
iajs-3367	14	19	blood	blood	NOUN
iajs-3367	14	20	cells	cell	NOUN
iajs-3367	14	21	,	,	PUNCT
iajs-3367	14	22	neurological	neurological	ADJ
iajs-3367	14	23	system	system	NOUN
iajs-3367	14	24	,	,	PUNCT
iajs-3367	14	25	and	and	CCONJ
iajs-3367	14	26	blood	blood	NOUN
iajs-3367	14	27	vessels	vessel	NOUN
iajs-3367	14	28	[	[	X
iajs-3367	14	29	3	3	NUM
iajs-3367	14	30	]	]	PUNCT
iajs-3367	14	31	.	.	PUNCT
iajs-3367	15	1	also	also	ADV
iajs-3367	15	2	,	,	PUNCT
iajs-3367	15	3	sle	sle	PROPN
iajs-3367	15	4	patients	patient	NOUN
iajs-3367	15	5	have	have	VERB
iajs-3367	15	6	a	a	DET
iajs-3367	15	7	higher	high	ADJ
iajs-3367	15	8	risk	risk	NOUN
iajs-3367	15	9	of	of	ADP
iajs-3367	15	10	losing	lose	VERB
iajs-3367	15	11	their	their	PRON
iajs-3367	15	12	bone	bone	NOUN
iajs-3367	15	13	density	density	NOUN
iajs-3367	15	14	[	[	X
iajs-3367	15	15	4	4	NUM
iajs-3367	15	16	]	]	PUNCT
iajs-3367	15	17	.	.	PUNCT
iajs-3367	16	1	this	this	DET
iajs-3367	16	2	disease	disease	NOUN
iajs-3367	16	3	is	be	AUX
iajs-3367	16	4	associated	associate	VERB
iajs-3367	16	5	with	with	ADP
iajs-3367	16	6	significant	significant	ADJ
iajs-3367	16	7	morbidity	morbidity	NOUN
iajs-3367	16	8	and	and	CCONJ
iajs-3367	16	9	mortality	mortality	NOUN
iajs-3367	16	10	and	and	CCONJ
iajs-3367	16	11	affects	affect	VERB
iajs-3367	16	12	mainly	mainly	ADV
iajs-3367	16	13	young	young	ADJ
iajs-3367	16	14	females	female	NOUN
iajs-3367	16	15	[	[	X
iajs-3367	16	16	5	5	NUM
iajs-3367	16	17	,	,	PUNCT
iajs-3367	16	18	6	6	NUM
iajs-3367	16	19	]	]	PUNCT
iajs-3367	16	20	.	.	PUNCT
iajs-3367	17	1	the	the	DET
iajs-3367	17	2	main	main	ADJ
iajs-3367	17	3	characteristic	characteristic	NOUN
iajs-3367	17	4	of	of	ADP
iajs-3367	17	5	this	this	DET
iajs-3367	17	6	disease	disease	NOUN
iajs-3367	17	7	is	be	AUX
iajs-3367	17	8	the	the	DET
iajs-3367	17	9	loss	loss	NOUN
iajs-3367	17	10	of	of	ADP
iajs-3367	17	11	immunological	immunological	ADJ
iajs-3367	17	12	tolerance	tolerance	NOUN
iajs-3367	17	13	,	,	PUNCT
iajs-3367	17	14	which	which	PRON
iajs-3367	17	15	leads	lead	VERB
iajs-3367	17	16	to	to	ADP
iajs-3367	17	17	the	the	DET
iajs-3367	17	18	production	production	NOUN
iajs-3367	17	19	of	of	ADP
iajs-3367	17	20	a	a	DET
iajs-3367	17	21	wide	wide	ADJ
iajs-3367	17	22	range	range	NOUN
iajs-3367	17	23	of	of	ADP
iajs-3367	17	24	autoantibodies	autoantibody	NOUN
iajs-3367	17	25	[	[	X
iajs-3367	17	26	7	7	NUM
iajs-3367	17	27	]	]	PUNCT
iajs-3367	17	28	.	.	PUNCT
iajs-3367	18	1	programmed	program	VERB
iajs-3367	18	2	cell	cell	NOUN
iajs-3367	18	3	death	death	NOUN
iajs-3367	18	4	protein	protein	NOUN
iajs-3367	18	5	1	1	NUM
iajs-3367	18	6	(	(	PUNCT
iajs-3367	18	7	pd-1	pd-1	ADV
iajs-3367	18	8	)	)	PUNCT
iajs-3367	18	9	is	be	AUX
iajs-3367	18	10	a	a	DET
iajs-3367	18	11	surface	surface	NOUN
iajs-3367	18	12	protein	protein	NOUN
iajs-3367	18	13	that	that	PRON
iajs-3367	18	14	is	be	AUX
iajs-3367	18	15	a	a	DET
iajs-3367	18	16	member	member	NOUN
iajs-3367	18	17	of	of	ADP
iajs-3367	18	18	the	the	DET
iajs-3367	18	19	immunoglobulin	immunoglobulin	NOUN
iajs-3367	18	20	superfamily	superfamily	ADV
iajs-3367	18	21	and	and	CCONJ
iajs-3367	18	22	serves	serve	VERB
iajs-3367	18	23	as	as	ADP
iajs-3367	18	24	an	an	DET
iajs-3367	18	25	immunomodulatory	immunomodulatory	ADJ
iajs-3367	18	26	molecule	molecule	NOUN
iajs-3367	18	27	.	.	PUNCT
iajs-3367	19	1	when	when	SCONJ
iajs-3367	19	2	pd-1	pd-1	ADV
iajs-3367	19	3	binds	bind	VERB
iajs-3367	19	4	doi.org/10.30526/37.1.3367	doi.org/10.30526/37.1.3367	VERB
iajs-3367	19	5	the	the	DET
iajs-3367	19	6	dynamic	dynamic	ADJ
iajs-3367	19	7	role	role	NOUN
iajs-3367	19	8	of	of	ADP
iajs-3367	19	9	pd-1	pd-1	ADJ
iajs-3367	19	10	,	,	PUNCT
iajs-3367	19	11	vitamin	vitamin	NOUN
iajs-3367	19	12	d	d	PROPN
iajs-3367	19	13	,	,	PUNCT
iajs-3367	19	14	rankl	rankl	VERB
iajs-3367	19	15	,	,	PUNCT
iajs-3367	19	16	and	and	CCONJ
iajs-3367	19	17	sclerostin	sclerostin	ADJ
iajs-3367	19	18	in	in	ADP
iajs-3367	19	19	iraqi	iraqi	ADJ
iajs-3367	19	20	patients	patient	NOUN
iajs-3367	19	21	with	with	ADP
iajs-3367	19	22	systemic	systemic	ADJ
iajs-3367	19	23	lupus	lupus	NOUN
iajs-3367	19	24	erythematosus	erythematosus	NOUN
iajs-3367	19	25	received	receive	VERB
iajs-3367	19	26	27	27	NUM
iajs-3367	19	27	march	march	NOUN
iajs-3367	19	28	2023	2023	NUM
iajs-3367	19	29	,	,	PUNCT
iajs-3367	19	30	received	receive	VERB
iajs-3367	19	31	25	25	NUM
iajs-3367	19	32	april	april	PROPN
iajs-3367	19	33	2023	2023	NUM
iajs-3367	19	34	,	,	PUNCT
iajs-3367	19	35	accepted	accept	VERB
iajs-3367	19	36	30	30	NUM
iajs-3367	19	37	april	april	PROPN
iajs-3367	19	38	2023	2023	NUM
iajs-3367	19	39	,	,	PUNCT
iajs-3367	19	40	published	publish	VERB
iajs-3367	19	41	in	in	ADP
iajs-3367	19	42	20	20	NUM
iajs-3367	19	43	january	january	NOUN
iajs-3367	19	44	2024	2024	NUM
iajs-3367	19	45	1,2department	1,2department	NUM
iajs-3367	19	46	of	of	ADP
iajs-3367	19	47	biology	biology	NOUN
iajs-3367	19	48	,	,	PUNCT
iajs-3367	19	49	college	college	NOUN
iajs-3367	19	50	of	of	ADP
iajs-3367	19	51	education	education	NOUN
iajs-3367	19	52	pure	pure	ADJ
iajs-3367	19	53	science	science	PROPN
iajs-3367	19	54	ibn	ibn	PROPN
iajs-3367	19	55	al	al	PROPN
iajs-3367	19	56	-	-	PUNCT
iajs-3367	19	57	haitham	haitham	PROPN
iajs-3367	19	58	,	,	PUNCT
iajs-3367	19	59	university	university	PROPN
iajs-3367	19	60	of	of	ADP
iajs-3367	19	61	baghdad	baghdad	PROPN
iajs-3367	19	62	,	,	PUNCT
iajs-3367	19	63	baghdad	baghdad	PROPN
iajs-3367	19	64	,	,	PUNCT
iajs-3367	19	65	iraq	iraq	PROPN
iajs-3367	19	66	.	.	PUNCT
iajs-3367	20	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3367	20	2	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3367	20	3	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	NOUN
iajs-3367	20	4	mailto:anwaarkhalil9@gmail.com	mailto:anwaarkhalil9@gmail.com	PROPN
iajs-3367	20	5	https://orcid.org/0000-0001-9031-9856	https://orcid.org/0000-0001-9031-9856	NOUN
iajs-3367	20	6	mailto:anwaarkhalil9@gmail.com	mailto:anwaarkhalil9@gmail.com	X
iajs-3367	20	7	https://orcid.org/0000-0002-9218-8762	https://orcid.org/0000-0002-9218-8762	PRON
iajs-3367	20	8	mailto:hazima.m.k@ihcoedu.uobaghdad.edu.iq	mailto:hazima.m.k@ihcoedu.uobaghdad.edu.iq	NOUN
iajs-3367	20	9	ihjpas	ihjpa	VERB
iajs-3367	20	10	.	.	PUNCT
iajs-3367	21	1	37	37	NUM
iajs-3367	21	2	(	(	PUNCT
iajs-3367	21	3	1	1	NUM
iajs-3367	21	4	)	)	PUNCT
iajs-3367	21	5	2024	2024	NUM
iajs-3367	21	6	10	10	NUM
iajs-3367	21	7	with	with	ADP
iajs-3367	21	8	its	its	PRON
iajs-3367	21	9	ligand	ligand	ADJ
iajs-3367	21	10	pd	pd	PROPN
iajs-3367	21	11	-	-	PUNCT
iajs-3367	21	12	l1	l1	PROPN
iajs-3367	21	13	,	,	PUNCT
iajs-3367	21	14	which	which	PRON
iajs-3367	21	15	negatively	negatively	ADV
iajs-3367	21	16	regulates	regulate	VERB
iajs-3367	21	17	the	the	DET
iajs-3367	21	18	immunological	immunological	ADJ
iajs-3367	21	19	response	response	NOUN
iajs-3367	21	20	after	after	ADP
iajs-3367	21	21	t	t	PROPN
iajs-3367	21	22	cell	cell	NOUN
iajs-3367	21	23	activation	activation	NOUN
iajs-3367	21	24	and	and	CCONJ
iajs-3367	21	25	upholds	uphold	VERB
iajs-3367	21	26	the	the	DET
iajs-3367	21	27	equilibrium	equilibrium	NOUN
iajs-3367	21	28	of	of	ADP
iajs-3367	21	29	immune	immune	ADJ
iajs-3367	21	30	tolerance	tolerance	NOUN
iajs-3367	21	31	,	,	PUNCT
iajs-3367	21	32	it	it	PRON
iajs-3367	21	33	sends	send	VERB
iajs-3367	21	34	out	out	ADP
iajs-3367	21	35	inhibitory	inhibitory	ADJ
iajs-3367	21	36	signals	signal	NOUN
iajs-3367	21	37	[	[	X
iajs-3367	21	38	8	8	NUM
iajs-3367	21	39	]	]	PUNCT
iajs-3367	21	40	.	.	PUNCT
iajs-3367	22	1	in	in	ADP
iajs-3367	22	2	order	order	NOUN
iajs-3367	22	3	to	to	PART
iajs-3367	22	4	stop	stop	VERB
iajs-3367	22	5	autoimmune	autoimmune	ADJ
iajs-3367	22	6	tissue	tissue	NOUN
iajs-3367	22	7	damage	damage	NOUN
iajs-3367	22	8	,	,	PUNCT
iajs-3367	22	9	pd-1	pd-1	VERB
iajs-3367	22	10	down	down	ADV
iajs-3367	22	11	-	-	PUNCT
iajs-3367	22	12	regulates	regulate	VERB
iajs-3367	22	13	t	t	NOUN
iajs-3367	22	14	cell	cell	NOUN
iajs-3367	22	15	activation	activation	NOUN
iajs-3367	22	16	during	during	ADP
iajs-3367	22	17	immunological	immunological	ADJ
iajs-3367	22	18	responses	response	NOUN
iajs-3367	22	19	.	.	PUNCT
iajs-3367	23	1	long	long	ADJ
iajs-3367	23	2	-	-	PUNCT
iajs-3367	23	3	term	term	NOUN
iajs-3367	23	4	exposure	exposure	NOUN
iajs-3367	23	5	to	to	ADP
iajs-3367	23	6	antigens	antigen	NOUN
iajs-3367	23	7	can	can	AUX
iajs-3367	23	8	cause	cause	VERB
iajs-3367	23	9	pd-1	pd-1	ADJ
iajs-3367	23	10	expression	expression	NOUN
iajs-3367	23	11	in	in	ADP
iajs-3367	23	12	tumors	tumor	NOUN
iajs-3367	23	13	or	or	CCONJ
iajs-3367	23	14	chronic	chronic	ADJ
iajs-3367	23	15	infections	infection	NOUN
iajs-3367	23	16	,	,	PUNCT
iajs-3367	23	17	which	which	PRON
iajs-3367	23	18	can	can	AUX
iajs-3367	23	19	make	make	VERB
iajs-3367	23	20	it	it	PRON
iajs-3367	23	21	harder	hard	ADJ
iajs-3367	23	22	for	for	ADP
iajs-3367	23	23	the	the	DET
iajs-3367	23	24	immune	immune	ADJ
iajs-3367	23	25	system	system	NOUN
iajs-3367	23	26	to	to	PART
iajs-3367	23	27	get	get	AUX
iajs-3367	23	28	rid	rid	VERB
iajs-3367	23	29	of	of	ADP
iajs-3367	23	30	damaged	damage	VERB
iajs-3367	23	31	cells	cell	NOUN
iajs-3367	23	32	or	or	CCONJ
iajs-3367	23	33	pathogens	pathogen	NOUN
iajs-3367	23	34	[	[	X
iajs-3367	23	35	9	9	NUM
iajs-3367	23	36	]	]	PUNCT
iajs-3367	23	37	.	.	PUNCT
iajs-3367	24	1	the	the	DET
iajs-3367	24	2	pd-1	pd-1	ADJ
iajs-3367	24	3	receptor	receptor	NOUN
iajs-3367	24	4	and	and	CCONJ
iajs-3367	24	5	its	its	PRON
iajs-3367	24	6	ligands	ligand	NOUN
iajs-3367	24	7	have	have	AUX
iajs-3367	24	8	been	be	AUX
iajs-3367	24	9	associated	associate	VERB
iajs-3367	24	10	with	with	ADP
iajs-3367	24	11	sle	sle	PROPN
iajs-3367	24	12	development	development	PROPN
iajs-3367	25	1	[	[	X
iajs-3367	25	2	10	10	NUM
iajs-3367	25	3	]	]	PUNCT
iajs-3367	25	4	.	.	PUNCT
iajs-3367	26	1	in	in	ADP
iajs-3367	26	2	sle	sle	PROPN
iajs-3367	26	3	,	,	PUNCT
iajs-3367	26	4	the	the	DET
iajs-3367	26	5	pd-1	pd-1	ADJ
iajs-3367	26	6	axis	axis	NOUN
iajs-3367	26	7	plays	play	VERB
iajs-3367	26	8	a	a	DET
iajs-3367	26	9	role	role	NOUN
iajs-3367	26	10	in	in	ADP
iajs-3367	26	11	regulating	regulate	VERB
iajs-3367	26	12	innate	innate	ADJ
iajs-3367	26	13	and	and	CCONJ
iajs-3367	26	14	adaptive	adaptive	ADJ
iajs-3367	26	15	immune	immune	ADJ
iajs-3367	26	16	subsets	subset	NOUN
iajs-3367	26	17	[	[	X
iajs-3367	26	18	11	11	NUM
iajs-3367	26	19	]	]	PUNCT
iajs-3367	26	20	.	.	PUNCT
iajs-3367	27	1	antibodies	antibodie	VERB
iajs-3367	27	2	that	that	SCONJ
iajs-3367	27	3	target	target	NOUN
iajs-3367	27	4	pd-1	pd-1	ADP
iajs-3367	27	5	receptors	receptor	NOUN
iajs-3367	27	6	to	to	PART
iajs-3367	27	7	prevent	prevent	VERB
iajs-3367	27	8	their	their	PRON
iajs-3367	27	9	activation	activation	NOUN
iajs-3367	27	10	are	be	AUX
iajs-3367	27	11	a	a	DET
iajs-3367	27	12	well	well	ADV
iajs-3367	27	13	-	-	PUNCT
iajs-3367	27	14	established	establish	VERB
iajs-3367	27	15	treatment	treatment	NOUN
iajs-3367	27	16	for	for	ADP
iajs-3367	27	17	a	a	DET
iajs-3367	27	18	variety	variety	NOUN
iajs-3367	27	19	of	of	ADP
iajs-3367	27	20	malignancies	malignancy	NOUN
iajs-3367	27	21	[	[	X
iajs-3367	27	22	12	12	NUM
iajs-3367	27	23	]	]	PUNCT
iajs-3367	27	24	.	.	PUNCT
iajs-3367	28	1	this	this	DET
iajs-3367	28	2	antibody	antibody	NOUN
iajs-3367	28	3	therapy	therapy	NOUN
iajs-3367	28	4	may	may	AUX
iajs-3367	28	5	also	also	ADV
iajs-3367	28	6	result	result	VERB
iajs-3367	28	7	in	in	ADP
iajs-3367	28	8	clinical	clinical	ADJ
iajs-3367	28	9	symptoms	symptom	NOUN
iajs-3367	28	10	like	like	ADP
iajs-3367	28	11	those	those	PRON
iajs-3367	28	12	of	of	ADP
iajs-3367	28	13	autoimmune	autoimmune	ADJ
iajs-3367	28	14	diseases	disease	NOUN
iajs-3367	28	15	such	such	ADJ
iajs-3367	28	16	as	as	ADP
iajs-3367	28	17	sle	sle	PROPN
iajs-3367	28	18	[	[	X
iajs-3367	28	19	13	13	NUM
iajs-3367	28	20	,	,	PUNCT
iajs-3367	28	21	12	12	NUM
iajs-3367	28	22	]	]	PUNCT
iajs-3367	28	23	.	.	PUNCT
iajs-3367	29	1	vitamin	vitamin	NOUN
iajs-3367	29	2	d	d	NOUN
iajs-3367	29	3	,	,	PUNCT
iajs-3367	29	4	unique	unique	ADJ
iajs-3367	29	5	among	among	ADP
iajs-3367	29	6	vitamins	vitamin	NOUN
iajs-3367	29	7	,	,	PUNCT
iajs-3367	29	8	can	can	AUX
iajs-3367	29	9	be	be	AUX
iajs-3367	29	10	generated	generate	VERB
iajs-3367	29	11	on	on	ADP
iajs-3367	29	12	the	the	DET
iajs-3367	29	13	skin	skin	NOUN
iajs-3367	29	14	as	as	ADP
iajs-3367	29	15	a	a	DET
iajs-3367	29	16	result	result	NOUN
iajs-3367	29	17	of	of	ADP
iajs-3367	29	18	sunlight	sunlight	NOUN
iajs-3367	29	19	exposure	exposure	NOUN
iajs-3367	29	20	.	.	PUNCT
iajs-3367	30	1	vitamin	vitamin	NOUN
iajs-3367	30	2	d	d	NOUN
iajs-3367	30	3	is	be	AUX
iajs-3367	30	4	involved	involve	VERB
iajs-3367	30	5	in	in	ADP
iajs-3367	30	6	regulating	regulate	VERB
iajs-3367	30	7	calcium	calcium	NOUN
iajs-3367	30	8	and	and	CCONJ
iajs-3367	30	9	phosphorus	phosphorus	NOUN
iajs-3367	30	10	metabolism	metabolism	NOUN
iajs-3367	30	11	[	[	X
iajs-3367	30	12	14	14	NUM
iajs-3367	30	13	]	]	PUNCT
iajs-3367	30	14	.	.	PUNCT
iajs-3367	31	1	many	many	ADJ
iajs-3367	31	2	autoimmune	autoimmune	ADJ
iajs-3367	31	3	diseases	disease	NOUN
iajs-3367	31	4	,	,	PUNCT
iajs-3367	31	5	including	include	VERB
iajs-3367	31	6	sle	sle	PROPN
iajs-3367	31	7	,	,	PUNCT
iajs-3367	31	8	scleroderma	scleroderma	NOUN
iajs-3367	31	9	,	,	PUNCT
iajs-3367	31	10	and	and	CCONJ
iajs-3367	31	11	rheumatoid	rheumatoid	VERB
iajs-3367	31	12	arthritis	arthritis	NOUN
iajs-3367	31	13	,	,	PUNCT
iajs-3367	31	14	are	be	AUX
iajs-3367	31	15	thought	think	VERB
iajs-3367	31	16	to	to	PART
iajs-3367	31	17	be	be	AUX
iajs-3367	31	18	linked	link	VERB
iajs-3367	31	19	to	to	ADP
iajs-3367	31	20	a	a	DET
iajs-3367	31	21	deficiency	deficiency	NOUN
iajs-3367	31	22	of	of	ADP
iajs-3367	31	23	vitamin	vitamin	NOUN
iajs-3367	31	24	d	d	NOUN
iajs-3367	32	1	[	[	X
iajs-3367	32	2	15	15	NUM
iajs-3367	32	3	]	]	PUNCT
iajs-3367	32	4	.	.	PUNCT
iajs-3367	33	1	although	although	SCONJ
iajs-3367	33	2	there	there	PRON
iajs-3367	33	3	is	be	VERB
iajs-3367	33	4	evidence	evidence	NOUN
iajs-3367	33	5	linking	link	VERB
iajs-3367	33	6	low	low	ADJ
iajs-3367	33	7	vitamin	vitamin	NOUN
iajs-3367	33	8	d	d	NOUN
iajs-3367	33	9	levels	level	NOUN
iajs-3367	33	10	to	to	ADP
iajs-3367	33	11	sle	sle	PROPN
iajs-3367	33	12	,	,	PUNCT
iajs-3367	33	13	it	it	PRON
iajs-3367	33	14	is	be	AUX
iajs-3367	33	15	also	also	ADV
iajs-3367	33	16	critical	critical	ADJ
iajs-3367	33	17	to	to	PART
iajs-3367	33	18	take	take	VERB
iajs-3367	33	19	into	into	ADP
iajs-3367	33	20	account	account	NOUN
iajs-3367	33	21	the	the	DET
iajs-3367	33	22	possibility	possibility	NOUN
iajs-3367	33	23	that	that	SCONJ
iajs-3367	33	24	vitamin	vitamin	NOUN
iajs-3367	33	25	d	d	NOUN
iajs-3367	33	26	deficiency	deficiency	NOUN
iajs-3367	33	27	may	may	AUX
iajs-3367	33	28	be	be	AUX
iajs-3367	33	29	a	a	DET
iajs-3367	33	30	contributing	contribute	VERB
iajs-3367	33	31	factor	factor	NOUN
iajs-3367	33	32	in	in	ADP
iajs-3367	33	33	the	the	DET
iajs-3367	33	34	etiology	etiology	NOUN
iajs-3367	33	35	of	of	ADP
iajs-3367	33	36	sle	sle	PROPN
iajs-3367	33	37	[	[	X
iajs-3367	33	38	16	16	NUM
iajs-3367	33	39	]	]	PUNCT
iajs-3367	33	40	.	.	PUNCT
iajs-3367	34	1	many	many	ADJ
iajs-3367	34	2	variables	variable	NOUN
iajs-3367	34	3	may	may	AUX
iajs-3367	34	4	affect	affect	VERB
iajs-3367	34	5	vitamin	vitamin	NOUN
iajs-3367	34	6	d	d	NOUN
iajs-3367	34	7	levels	level	NOUN
iajs-3367	34	8	in	in	ADP
iajs-3367	34	9	sle	sle	PROPN
iajs-3367	34	10	patients	patient	NOUN
iajs-3367	34	11	,	,	PUNCT
iajs-3367	34	12	including	include	VERB
iajs-3367	34	13	photosensitivity	photosensitivity	NOUN
iajs-3367	34	14	,	,	PUNCT
iajs-3367	34	15	dark	dark	ADJ
iajs-3367	34	16	skin	skin	NOUN
iajs-3367	34	17	pigmentation	pigmentation	NOUN
iajs-3367	34	18	,	,	PUNCT
iajs-3367	34	19	renal	renal	ADJ
iajs-3367	34	20	failure	failure	NOUN
iajs-3367	34	21	,	,	PUNCT
iajs-3367	34	22	sunscreen	sunscreen	NOUN
iajs-3367	34	23	use	use	NOUN
iajs-3367	34	24	,	,	PUNCT
iajs-3367	34	25	and	and	CCONJ
iajs-3367	34	26	medication	medication	NOUN
iajs-3367	34	27	[	[	X
iajs-3367	34	28	17	17	NUM
iajs-3367	34	29	]	]	PUNCT
iajs-3367	34	30	.	.	PUNCT
iajs-3367	35	1	on	on	ADP
iajs-3367	35	2	the	the	DET
iajs-3367	35	3	other	other	ADJ
iajs-3367	35	4	hand	hand	NOUN
iajs-3367	35	5	,	,	PUNCT
iajs-3367	35	6	individuals	individual	NOUN
iajs-3367	35	7	with	with	ADP
iajs-3367	35	8	sle	sle	PROPN
iajs-3367	35	9	had	have	VERB
iajs-3367	35	10	a	a	DET
iajs-3367	35	11	significant	significant	ADJ
iajs-3367	35	12	frequency	frequency	NOUN
iajs-3367	35	13	of	of	ADP
iajs-3367	35	14	low	low	PROPN
iajs-3367	35	15	bmd	bmd	PROPN
iajs-3367	35	16	and	and	CCONJ
iajs-3367	35	17	vertebral	vertebral	ADJ
iajs-3367	35	18	fractures	fracture	NOUN
iajs-3367	35	19	,	,	PUNCT
iajs-3367	35	20	highlighting	highlight	VERB
iajs-3367	35	21	the	the	DET
iajs-3367	35	22	fact	fact	NOUN
iajs-3367	35	23	that	that	SCONJ
iajs-3367	35	24	osteoporosis	osteoporosis	NOUN
iajs-3367	35	25	is	be	AUX
iajs-3367	35	26	a	a	DET
iajs-3367	35	27	prevalent	prevalent	ADJ
iajs-3367	35	28	feature	feature	NOUN
iajs-3367	35	29	of	of	ADP
iajs-3367	35	30	sle	sle	PROPN
iajs-3367	36	1	[	[	X
iajs-3367	36	2	18	18	NUM
iajs-3367	36	3	]	]	PUNCT
iajs-3367	36	4	.	.	PUNCT
iajs-3367	37	1	osteoporosis	osteoporosis	NOUN
iajs-3367	37	2	is	be	AUX
iajs-3367	37	3	a	a	DET
iajs-3367	37	4	biomechanical	biomechanical	ADJ
iajs-3367	37	5	phenomenon	phenomenon	NOUN
iajs-3367	37	6	whereby	whereby	SCONJ
iajs-3367	37	7	mechanical	mechanical	ADJ
iajs-3367	37	8	stress	stress	NOUN
iajs-3367	37	9	on	on	ADP
iajs-3367	37	10	the	the	DET
iajs-3367	37	11	joints	joint	NOUN
iajs-3367	37	12	results	result	NOUN
iajs-3367	37	13	in	in	ADP
iajs-3367	37	14	pathological	pathological	ADJ
iajs-3367	37	15	responses	response	NOUN
iajs-3367	37	16	that	that	PRON
iajs-3367	37	17	cause	cause	VERB
iajs-3367	37	18	damage	damage	NOUN
iajs-3367	37	19	to	to	ADP
iajs-3367	37	20	the	the	DET
iajs-3367	37	21	articular	articular	ADJ
iajs-3367	37	22	cartilage	cartilage	NOUN
iajs-3367	37	23	and	and	CCONJ
iajs-3367	37	24	alterations	alteration	NOUN
iajs-3367	37	25	in	in	ADP
iajs-3367	37	26	other	other	ADJ
iajs-3367	37	27	tissues	tissue	NOUN
iajs-3367	37	28	.	.	PUNCT
iajs-3367	38	1	these	these	DET
iajs-3367	38	2	changes	change	NOUN
iajs-3367	38	3	often	often	ADV
iajs-3367	38	4	take	take	VERB
iajs-3367	38	5	time	time	NOUN
iajs-3367	38	6	to	to	PART
iajs-3367	38	7	manifest	manifest	VERB
iajs-3367	38	8	and	and	CCONJ
iajs-3367	38	9	deteriorate	deteriorate	VERB
iajs-3367	38	10	over	over	ADP
iajs-3367	38	11	time	time	NOUN
iajs-3367	38	12	[	[	X
iajs-3367	38	13	19	19	NUM
iajs-3367	38	14	,	,	PUNCT
iajs-3367	38	15	20	20	NUM
iajs-3367	38	16	]	]	PUNCT
iajs-3367	38	17	.	.	PUNCT
iajs-3367	39	1	osteoporosis	osteoporosis	NOUN
iajs-3367	39	2	is	be	AUX
iajs-3367	39	3	characterized	characterize	VERB
iajs-3367	39	4	by	by	ADP
iajs-3367	39	5	increased	increase	VERB
iajs-3367	39	6	bone	bone	NOUN
iajs-3367	39	7	fragility	fragility	NOUN
iajs-3367	39	8	and	and	CCONJ
iajs-3367	39	9	low	low	ADJ
iajs-3367	39	10	bone	bone	NOUN
iajs-3367	39	11	mass	mass	NOUN
iajs-3367	40	1	[	[	X
iajs-3367	40	2	21	21	NUM
iajs-3367	40	3	]	]	PUNCT
iajs-3367	40	4	.	.	PUNCT
iajs-3367	41	1	bone	bone	NOUN
iajs-3367	41	2	remodeling	remodeling	NOUN
iajs-3367	41	3	is	be	AUX
iajs-3367	41	4	a	a	DET
iajs-3367	41	5	dynamic	dynamic	ADJ
iajs-3367	41	6	equilibrium	equilibrium	NOUN
iajs-3367	41	7	biological	biological	ADJ
iajs-3367	41	8	process	process	NOUN
iajs-3367	41	9	that	that	PRON
iajs-3367	41	10	occurs	occur	VERB
iajs-3367	41	11	as	as	ADP
iajs-3367	41	12	a	a	DET
iajs-3367	41	13	result	result	NOUN
iajs-3367	41	14	of	of	ADP
iajs-3367	41	15	the	the	DET
iajs-3367	41	16	interaction	interaction	NOUN
iajs-3367	41	17	of	of	ADP
iajs-3367	41	18	osteoclasts	osteoclast	NOUN
iajs-3367	41	19	and	and	CCONJ
iajs-3367	41	20	osteoblasts	osteoblast	NOUN
iajs-3367	41	21	.	.	PUNCT
iajs-3367	42	1	when	when	SCONJ
iajs-3367	42	2	the	the	DET
iajs-3367	42	3	equilibrium	equilibrium	NOUN
iajs-3367	42	4	of	of	ADP
iajs-3367	42	5	bone	bone	NOUN
iajs-3367	42	6	remodeling	remodeling	NOUN
iajs-3367	42	7	is	be	AUX
iajs-3367	42	8	disturbed	disturb	VERB
iajs-3367	42	9	,	,	PUNCT
iajs-3367	42	10	diseases	disease	NOUN
iajs-3367	42	11	such	such	ADJ
iajs-3367	42	12	as	as	ADP
iajs-3367	42	13	bone	bone	NOUN
iajs-3367	42	14	loss	loss	NOUN
iajs-3367	42	15	and	and	CCONJ
iajs-3367	42	16	osteoporosis	osteoporosis	NOUN
iajs-3367	42	17	develop	develop	VERB
iajs-3367	42	18	[	[	X
iajs-3367	42	19	22	22	NUM
iajs-3367	42	20	]	]	PUNCT
iajs-3367	42	21	.	.	PUNCT
iajs-3367	43	1	receptor	receptor	NOUN
iajs-3367	43	2	activator	activator	NOUN
iajs-3367	43	3	of	of	ADP
iajs-3367	43	4	nuclear	nuclear	ADJ
iajs-3367	43	5	factor	factor	NOUN
iajs-3367	43	6	-	-	PUNCT
iajs-3367	43	7	κb	κb	PROPN
iajs-3367	43	8	(	(	PUNCT
iajs-3367	43	9	rank	rank	NOUN
iajs-3367	43	10	)	)	PUNCT
iajs-3367	43	11	is	be	AUX
iajs-3367	43	12	expressed	express	VERB
iajs-3367	43	13	on	on	ADP
iajs-3367	43	14	osteoclastic	osteoclastic	ADJ
iajs-3367	43	15	precursor	precursor	NOUN
iajs-3367	43	16	cells	cell	NOUN
iajs-3367	43	17	,	,	PUNCT
iajs-3367	43	18	and	and	CCONJ
iajs-3367	43	19	when	when	SCONJ
iajs-3367	43	20	rank	rank	PROPN
iajs-3367	43	21	ligand	ligand	NOUN
iajs-3367	43	22	(	(	PUNCT
iajs-3367	43	23	rankl	rankl	PROPN
iajs-3367	43	24	)	)	PUNCT
iajs-3367	43	25	binds	bind	VERB
iajs-3367	43	26	to	to	PART
iajs-3367	43	27	rank	rank	VERB
iajs-3367	43	28	,	,	PUNCT
iajs-3367	43	29	osteoclast	osteoclast	ADJ
iajs-3367	43	30	differentiation	differentiation	NOUN
iajs-3367	43	31	and	and	CCONJ
iajs-3367	43	32	activation	activation	NOUN
iajs-3367	43	33	are	be	AUX
iajs-3367	43	34	facilitated	facilitate	VERB
iajs-3367	43	35	[	[	PUNCT
iajs-3367	43	36	23	23	NUM
iajs-3367	43	37	]	]	PUNCT
iajs-3367	43	38	.	.	PUNCT
iajs-3367	44	1	moreover	moreover	ADV
iajs-3367	44	2	,	,	PUNCT
iajs-3367	44	3	it	it	PRON
iajs-3367	44	4	is	be	AUX
iajs-3367	44	5	crucial	crucial	ADJ
iajs-3367	44	6	for	for	ADP
iajs-3367	44	7	the	the	DET
iajs-3367	44	8	development	development	NOUN
iajs-3367	44	9	of	of	ADP
iajs-3367	44	10	the	the	DET
iajs-3367	44	11	lymphatic	lymphatic	ADJ
iajs-3367	44	12	system	system	NOUN
iajs-3367	44	13	,	,	PUNCT
iajs-3367	44	14	the	the	DET
iajs-3367	44	15	mammary	mammary	ADJ
iajs-3367	44	16	glands	gland	NOUN
iajs-3367	44	17	,	,	PUNCT
iajs-3367	44	18	and	and	CCONJ
iajs-3367	44	19	establishing	establish	VERB
iajs-3367	44	20	immunological	immunological	ADJ
iajs-3367	44	21	tolerance	tolerance	NOUN
iajs-3367	44	22	[	[	X
iajs-3367	44	23	24	24	NUM
iajs-3367	44	24	]	]	PUNCT
iajs-3367	44	25	.	.	PUNCT
iajs-3367	45	1	patients	patient	NOUN
iajs-3367	45	2	diagnosed	diagnose	VERB
iajs-3367	45	3	with	with	ADP
iajs-3367	45	4	sle	sle	PROPN
iajs-3367	45	5	exhibit	exhibit	VERB
iajs-3367	45	6	heightened	heightened	ADJ
iajs-3367	45	7	production	production	NOUN
iajs-3367	45	8	of	of	ADP
iajs-3367	45	9	rankl	rankl	NOUN
iajs-3367	45	10	,	,	PUNCT
iajs-3367	45	11	which	which	PRON
iajs-3367	45	12	leads	lead	VERB
iajs-3367	45	13	to	to	ADP
iajs-3367	45	14	an	an	DET
iajs-3367	45	15	acceleration	acceleration	NOUN
iajs-3367	45	16	in	in	ADP
iajs-3367	45	17	osteoclastogenesis	osteoclastogenesis	NOUN
iajs-3367	45	18	[	[	X
iajs-3367	45	19	25	25	NUM
iajs-3367	45	20	]	]	PUNCT
iajs-3367	45	21	.	.	PUNCT
iajs-3367	46	1	elevated	elevated	ADJ
iajs-3367	46	2	concentrations	concentration	NOUN
iajs-3367	46	3	of	of	ADP
iajs-3367	46	4	oxidized	oxidized	ADJ
iajs-3367	46	5	lowdensity	lowdensity	NOUN
iajs-3367	46	6	lipoproteins	lipoprotein	NOUN
iajs-3367	46	7	(	(	PUNCT
iajs-3367	46	8	ldl	ldl	NOUN
iajs-3367	46	9	)	)	PUNCT
iajs-3367	46	10	may	may	AUX
iajs-3367	46	11	potentially	potentially	ADV
iajs-3367	46	12	cause	cause	VERB
iajs-3367	46	13	t	t	NOUN
iajs-3367	46	14	-	-	PUNCT
iajs-3367	46	15	cell	cell	NOUN
iajs-3367	46	16	activation	activation	NOUN
iajs-3367	46	17	in	in	ADP
iajs-3367	46	18	sle	sle	PROPN
iajs-3367	46	19	,	,	PUNCT
iajs-3367	46	20	which	which	PRON
iajs-3367	46	21	raises	raise	VERB
iajs-3367	46	22	the	the	DET
iajs-3367	46	23	expression	expression	NOUN
iajs-3367	46	24	of	of	ADP
iajs-3367	46	25	rankl	rankl	NOUN
iajs-3367	46	26	and	and	CCONJ
iajs-3367	46	27	the	the	DET
iajs-3367	46	28	generation	generation	NOUN
iajs-3367	46	29	of	of	ADP
iajs-3367	46	30	tnf	tnf	PROPN
iajs-3367	46	31	.	.	PUNCT
iajs-3367	47	1	they	they	PRON
iajs-3367	47	2	may	may	AUX
iajs-3367	47	3	also	also	ADV
iajs-3367	47	4	have	have	VERB
iajs-3367	47	5	a	a	DET
iajs-3367	47	6	deleterious	deleterious	ADJ
iajs-3367	47	7	impact	impact	NOUN
iajs-3367	47	8	on	on	ADP
iajs-3367	47	9	bone	bone	NOUN
iajs-3367	47	10	formation	formation	NOUN
iajs-3367	47	11	by	by	ADP
iajs-3367	47	12	lowering	lower	VERB
iajs-3367	47	13	osteoblast	osteoblast	ADJ
iajs-3367	47	14	maturation	maturation	NOUN
iajs-3367	47	15	[	[	X
iajs-3367	47	16	25	25	NUM
iajs-3367	47	17	,	,	PUNCT
iajs-3367	47	18	26	26	NUM
iajs-3367	47	19	]	]	PUNCT
iajs-3367	47	20	.	.	PUNCT
iajs-3367	48	1	in	in	ADP
iajs-3367	48	2	the	the	DET
iajs-3367	48	3	same	same	ADJ
iajs-3367	48	4	context	context	NOUN
iajs-3367	48	5	,	,	PUNCT
iajs-3367	48	6	sclerostin	sclerostin	ADJ
iajs-3367	48	7	is	be	AUX
iajs-3367	48	8	a	a	DET
iajs-3367	48	9	190	190	NUM
iajs-3367	48	10	-	-	PUNCT
iajs-3367	48	11	amino	amino	NOUN
iajs-3367	48	12	acid	acid	NOUN
iajs-3367	48	13	glycoprotein	glycoprotein	NOUN
iajs-3367	48	14	that	that	PRON
iajs-3367	48	15	is	be	AUX
iajs-3367	48	16	mainly	mainly	ADV
iajs-3367	48	17	secreted	secrete	VERB
iajs-3367	48	18	by	by	ADP
iajs-3367	48	19	adult	adult	NOUN
iajs-3367	48	20	osteocytes	osteocyte	NOUN
iajs-3367	48	21	,	,	PUNCT
iajs-3367	48	22	even	even	ADV
iajs-3367	48	23	though	though	SCONJ
iajs-3367	48	24	chondrocytes	chondrocyte	NOUN
iajs-3367	48	25	and	and	CCONJ
iajs-3367	48	26	cementocytes	cementocyte	NOUN
iajs-3367	48	27	can	can	AUX
iajs-3367	48	28	also	also	ADV
iajs-3367	48	29	produce	produce	VERB
iajs-3367	48	30	it	it	PRON
iajs-3367	48	31	[	[	X
iajs-3367	48	32	27	27	NUM
iajs-3367	48	33	]	]	PUNCT
iajs-3367	48	34	.	.	PUNCT
iajs-3367	49	1	in	in	ADP
iajs-3367	49	2	many	many	ADJ
iajs-3367	49	3	rare	rare	ADJ
iajs-3367	49	4	genetic	genetic	ADJ
iajs-3367	49	5	bone	bone	NOUN
iajs-3367	49	6	diseases	disease	NOUN
iajs-3367	49	7	,	,	PUNCT
iajs-3367	49	8	the	the	DET
iajs-3367	49	9	deficiency	deficiency	NOUN
iajs-3367	49	10	of	of	ADP
iajs-3367	49	11	sclerostin	sclerostin	ADJ
iajs-3367	49	12	causes	cause	NOUN
iajs-3367	49	13	osteopetrosis	osteopetrosis	NOUN
iajs-3367	49	14	[	[	X
iajs-3367	49	15	28	28	NUM
iajs-3367	49	16	]	]	PUNCT
iajs-3367	49	17	.	.	PUNCT
iajs-3367	50	1	serum	serum	PROPN
iajs-3367	50	2	sclerostin	sclerostin	PROPN
iajs-3367	50	3	could	could	AUX
iajs-3367	50	4	be	be	AUX
iajs-3367	50	5	used	use	VERB
iajs-3367	50	6	as	as	ADP
iajs-3367	50	7	a	a	DET
iajs-3367	50	8	useful	useful	ADJ
iajs-3367	50	9	biomarker	biomarker	NOUN
iajs-3367	50	10	for	for	ADP
iajs-3367	50	11	lupus	lupus	ADJ
iajs-3367	50	12	nephritis	nephritis	NOUN
iajs-3367	50	13	[	[	X
iajs-3367	50	14	29	29	NUM
iajs-3367	50	15	]	]	PUNCT
iajs-3367	50	16	.	.	PUNCT
iajs-3367	51	1	the	the	DET
iajs-3367	51	2	current	current	ADJ
iajs-3367	51	3	study	study	NOUN
iajs-3367	51	4	aimed	aim	VERB
iajs-3367	51	5	to	to	PART
iajs-3367	51	6	evaluate	evaluate	VERB
iajs-3367	51	7	the	the	DET
iajs-3367	51	8	role	role	NOUN
iajs-3367	51	9	of	of	ADP
iajs-3367	51	10	rankl	rankl	NOUN
iajs-3367	51	11	,	,	PUNCT
iajs-3367	51	12	sclerostin	sclerostin	ADJ
iajs-3367	51	13	,	,	PUNCT
iajs-3367	51	14	pd-1	pd-1	ADV
iajs-3367	51	15	,	,	PUNCT
iajs-3367	51	16	and	and	CCONJ
iajs-3367	51	17	vitamin	vitamin	NOUN
iajs-3367	51	18	d	d	NOUN
iajs-3367	51	19	in	in	ADP
iajs-3367	51	20	the	the	DET
iajs-3367	51	21	pathogenesis	pathogenesis	NOUN
iajs-3367	51	22	of	of	ADP
iajs-3367	51	23	sle	sle	PROPN
iajs-3367	51	24	in	in	ADP
iajs-3367	51	25	early	early	ADV
iajs-3367	51	26	-	-	PUNCT
iajs-3367	51	27	diagnosed	diagnose	VERB
iajs-3367	51	28	patients	patient	NOUN
iajs-3367	51	29	and	and	CCONJ
iajs-3367	51	30	patients	patient	NOUN
iajs-3367	51	31	under	under	ADP
iajs-3367	51	32	treatment	treatment	NOUN
iajs-3367	51	33	.	.	PUNCT
iajs-3367	52	1	2	2	X
iajs-3367	52	2	.	.	X
iajs-3367	52	3	materials	material	NOUN
iajs-3367	52	4	and	and	CCONJ
iajs-3367	52	5	methods	method	NOUN
iajs-3367	52	6	2.1	2.1	NUM
iajs-3367	52	7	.	.	PUNCT
iajs-3367	53	1	subject	subject	ADJ
iajs-3367	53	2	collection	collection	NOUN
iajs-3367	53	3	from	from	ADP
iajs-3367	53	4	march	march	PROPN
iajs-3367	53	5	2022	2022	NUM
iajs-3367	53	6	to	to	ADP
iajs-3367	53	7	august	august	PROPN
iajs-3367	53	8	2022	2022	NUM
iajs-3367	53	9	,	,	PUNCT
iajs-3367	53	10	the	the	DET
iajs-3367	53	11	current	current	ADJ
iajs-3367	53	12	study	study	NOUN
iajs-3367	53	13	was	be	AUX
iajs-3367	53	14	carried	carry	VERB
iajs-3367	53	15	out	out	ADP
iajs-3367	53	16	in	in	ADP
iajs-3367	53	17	the	the	DET
iajs-3367	53	18	department	department	NOUN
iajs-3367	53	19	of	of	ADP
iajs-3367	53	20	rheumatology	rheumatology	NOUN
iajs-3367	53	21	at	at	ADP
iajs-3367	53	22	al	al	PROPN
iajs-3367	53	23	-	-	PUNCT
iajs-3367	53	24	yarmouk	yarmouk	ADV
iajs-3367	53	25	teaching	teaching	NOUN
iajs-3367	53	26	hospital	hospital	NOUN
iajs-3367	53	27	and	and	CCONJ
iajs-3367	53	28	the	the	DET
iajs-3367	53	29	medical	medical	ADJ
iajs-3367	53	30	city	city	NOUN
iajs-3367	53	31	(	(	PUNCT
iajs-3367	53	32	baghdad	baghdad	PROPN
iajs-3367	53	33	teaching	teaching	NOUN
iajs-3367	53	34	ihjpas	ihjpas	PROPN
iajs-3367	53	35	.	.	PUNCT
iajs-3367	54	1	37	37	NUM
iajs-3367	54	2	(	(	PUNCT
iajs-3367	54	3	1	1	NUM
iajs-3367	54	4	)	)	PUNCT
iajs-3367	54	5	2024	2024	NUM
iajs-3367	54	6	11	11	NUM
iajs-3367	54	7	hospital	hospital	NOUN
iajs-3367	54	8	)	)	PUNCT
iajs-3367	54	9	in	in	ADP
iajs-3367	54	10	baghdad	baghdad	PROPN
iajs-3367	54	11	.	.	PUNCT
iajs-3367	55	1	there	there	PRON
iajs-3367	55	2	were	be	VERB
iajs-3367	55	3	180	180	NUM
iajs-3367	55	4	participants	participant	NOUN
iajs-3367	55	5	(	(	PUNCT
iajs-3367	55	6	age	age	NOUN
iajs-3367	55	7	arranged	arrange	VERB
iajs-3367	55	8	between	between	ADP
iajs-3367	55	9	20	20	NUM
iajs-3367	55	10	to	to	PART
iajs-3367	55	11	45	45	NUM
iajs-3367	55	12	years	year	NOUN
iajs-3367	55	13	)	)	PUNCT
iajs-3367	55	14	which	which	PRON
iajs-3367	55	15	involved	involve	VERB
iajs-3367	55	16	in	in	ADP
iajs-3367	55	17	this	this	DET
iajs-3367	55	18	study	study	NOUN
iajs-3367	55	19	(	(	PUNCT
iajs-3367	55	20	60	60	NUM
iajs-3367	55	21	females	female	NOUN
iajs-3367	55	22	as	as	ADV
iajs-3367	55	23	early	early	ADV
iajs-3367	55	24	diagnosed	diagnose	VERB
iajs-3367	55	25	patients	patient	NOUN
iajs-3367	55	26	and	and	CCONJ
iajs-3367	55	27	60	60	NUM
iajs-3367	55	28	patients	patient	NOUN
iajs-3367	55	29	under	under	ADP
iajs-3367	55	30	treatment	treatment	NOUN
iajs-3367	55	31	with	with	ADP
iajs-3367	55	32	(	(	PUNCT
iajs-3367	55	33	prednisolone	prednisolone	PROPN
iajs-3367	55	34	,	,	PUNCT
iajs-3367	55	35	hydroxychloroquine	hydroxychloroquine	PROPN
iajs-3367	55	36	)	)	PUNCT
iajs-3367	55	37	in	in	ADP
iajs-3367	55	38	addition	addition	NOUN
iajs-3367	55	39	to	to	ADP
iajs-3367	55	40	60	60	NUM
iajs-3367	55	41	apparently	apparently	ADV
iajs-3367	55	42	healthy	healthy	ADJ
iajs-3367	55	43	individuals	individual	NOUN
iajs-3367	55	44	as	as	ADP
iajs-3367	55	45	control	control	NOUN
iajs-3367	55	46	)	)	PUNCT
iajs-3367	55	47	.	.	PUNCT
iajs-3367	56	1	all	all	DET
iajs-3367	56	2	patients	patient	NOUN
iajs-3367	56	3	were	be	AUX
iajs-3367	56	4	diagnosed	diagnose	VERB
iajs-3367	56	5	according	accord	VERB
iajs-3367	56	6	to	to	ADP
iajs-3367	56	7	clinical	clinical	ADJ
iajs-3367	56	8	examination	examination	NOUN
iajs-3367	56	9	by	by	ADP
iajs-3367	56	10	a	a	DET
iajs-3367	56	11	rheumatologist	rheumatologist	ADJ
iajs-3367	56	12	physician	physician	NOUN
iajs-3367	56	13	and	and	CCONJ
iajs-3367	56	14	selected	select	VERB
iajs-3367	56	15	based	base	VERB
iajs-3367	56	16	on	on	ADP
iajs-3367	56	17	the	the	DET
iajs-3367	56	18	sle	sle	NOUN
iajs-3367	56	19	revised	revise	VERB
iajs-3367	56	20	classification	classification	NOUN
iajs-3367	56	21	criteria	criterion	NOUN
iajs-3367	56	22	published	publish	VERB
iajs-3367	56	23	by	by	ADP
iajs-3367	56	24	the	the	DET
iajs-3367	56	25	american	american	PROPN
iajs-3367	56	26	college	college	PROPN
iajs-3367	56	27	of	of	ADP
iajs-3367	56	28	rheumatology	rheumatology	NOUN
iajs-3367	56	29	(	(	PUNCT
iajs-3367	56	30	acr	acr	PROPN
iajs-3367	56	31	)	)	PUNCT
iajs-3367	57	1	[	[	X
iajs-3367	57	2	30	30	NUM
iajs-3367	57	3	]	]	PUNCT
iajs-3367	57	4	.	.	PUNCT
iajs-3367	58	1	patients	patient	NOUN
iajs-3367	58	2	with	with	ADP
iajs-3367	58	3	other	other	ADJ
iajs-3367	58	4	diseases	disease	NOUN
iajs-3367	58	5	(	(	PUNCT
iajs-3367	58	6	hypertension	hypertension	NOUN
iajs-3367	58	7	,	,	PUNCT
iajs-3367	58	8	diabetes	diabetes	NOUN
iajs-3367	58	9	type	type	NOUN
iajs-3367	58	10	i	i	PRON
iajs-3367	58	11	,	,	PUNCT
iajs-3367	58	12	ii	ii	PROPN
iajs-3367	58	13	,	,	PUNCT
iajs-3367	58	14	cardiovascular	cardiovascular	ADJ
iajs-3367	58	15	disease	disease	NOUN
iajs-3367	58	16	)	)	PUNCT
iajs-3367	58	17	or	or	CCONJ
iajs-3367	58	18	any	any	DET
iajs-3367	58	19	other	other	ADJ
iajs-3367	58	20	chronic	chronic	ADJ
iajs-3367	58	21	disease	disease	NOUN
iajs-3367	58	22	including	include	VERB
iajs-3367	58	23	autoimmune	autoimmune	ADJ
iajs-3367	58	24	diseases	disease	NOUN
iajs-3367	58	25	were	be	AUX
iajs-3367	58	26	excluded	exclude	VERB
iajs-3367	58	27	from	from	ADP
iajs-3367	58	28	this	this	DET
iajs-3367	58	29	study	study	NOUN
iajs-3367	58	30	.	.	PUNCT
iajs-3367	59	1	2.2	2.2	NUM
iajs-3367	59	2	.	.	PUNCT
iajs-3367	59	3	blood	blood	NOUN
iajs-3367	59	4	collection	collection	NOUN
iajs-3367	59	5	5	5	NUM
iajs-3367	59	6	ml	ml	NOUN
iajs-3367	59	7	of	of	ADP
iajs-3367	59	8	a	a	DET
iajs-3367	59	9	sample	sample	NOUN
iajs-3367	59	10	of	of	ADP
iajs-3367	59	11	intravenous	intravenous	ADJ
iajs-3367	59	12	blood	blood	NOUN
iajs-3367	59	13	was	be	AUX
iajs-3367	59	14	withdrawn	withdraw	VERB
iajs-3367	59	15	from	from	ADP
iajs-3367	59	16	all	all	DET
iajs-3367	59	17	participants	participant	NOUN
iajs-3367	59	18	(	(	PUNCT
iajs-3367	59	19	patients	patient	NOUN
iajs-3367	59	20	and	and	CCONJ
iajs-3367	59	21	healthy	healthy	ADJ
iajs-3367	59	22	individuals	individual	NOUN
iajs-3367	59	23	)	)	PUNCT
iajs-3367	59	24	,	,	PUNCT
iajs-3367	59	25	then	then	ADV
iajs-3367	59	26	centrifuged	centrifuge	VERB
iajs-3367	59	27	at	at	ADP
iajs-3367	59	28	4000	4000	NUM
iajs-3367	59	29	rpm	rpm	NOUN
iajs-3367	59	30	for	for	ADP
iajs-3367	59	31	about	about	ADV
iajs-3367	59	32	10	10	NUM
iajs-3367	59	33	minutes	minute	NOUN
iajs-3367	59	34	and	and	CCONJ
iajs-3367	59	35	kept	keep	VERB
iajs-3367	59	36	at	at	ADP
iajs-3367	59	37	-20	-20	PROPN
iajs-3367	59	38	c	c	NOUN
iajs-3367	59	39	for	for	ADP
iajs-3367	59	40	subsequent	subsequent	ADJ
iajs-3367	59	41	analysis	analysis	NOUN
iajs-3367	59	42	.	.	PUNCT
iajs-3367	60	1	the	the	DET
iajs-3367	60	2	practical	practical	ADJ
iajs-3367	60	3	side	side	NOUN
iajs-3367	60	4	was	be	AUX
iajs-3367	60	5	carried	carry	VERB
iajs-3367	60	6	out	out	ADP
iajs-3367	60	7	in	in	ADP
iajs-3367	60	8	hia	hia	PROPN
iajs-3367	60	9	clinics	clinic	NOUN
iajs-3367	60	10	in	in	ADP
iajs-3367	60	11	baghdad	baghdad	PROPN
iajs-3367	60	12	.	.	PUNCT
iajs-3367	61	1	the	the	DET
iajs-3367	61	2	elisa	elisa	NOUN
iajs-3367	61	3	technique	technique	NOUN
iajs-3367	61	4	was	be	AUX
iajs-3367	61	5	used	use	VERB
iajs-3367	61	6	to	to	PART
iajs-3367	61	7	assess	assess	VERB
iajs-3367	61	8	serum	serum	NOUN
iajs-3367	61	9	levels	level	NOUN
iajs-3367	61	10	of	of	ADP
iajs-3367	61	11	rankl	rankl	PROPN
iajs-3367	61	12	,	,	PUNCT
iajs-3367	61	13	sclerostin	sclerostin	ADJ
iajs-3367	61	14	,	,	PUNCT
iajs-3367	61	15	and	and	CCONJ
iajs-3367	61	16	pd-1	pd-1	X
iajs-3367	61	17	.	.	PUNCT
iajs-3367	61	18	elisa	elisa	PROPN
iajs-3367	61	19	research	research	NOUN
iajs-3367	61	20	kits	kit	NOUN
iajs-3367	61	21	purchased	purchase	VERB
iajs-3367	61	22	from	from	ADP
iajs-3367	61	23	the	the	DET
iajs-3367	61	24	usa	usa	PROPN
iajs-3367	61	25	company	company	PROPN
iajs-3367	61	26	(	(	PUNCT
iajs-3367	61	27	cloud	cloud	NOUN
iajs-3367	61	28	-	-	PUNCT
iajs-3367	61	29	clone	clone	NOUN
iajs-3367	61	30	crop	crop	NOUN
iajs-3367	61	31	)	)	PUNCT
iajs-3367	61	32	were	be	AUX
iajs-3367	61	33	used	use	VERB
iajs-3367	61	34	for	for	ADP
iajs-3367	61	35	this	this	DET
iajs-3367	61	36	purpose	purpose	NOUN
iajs-3367	61	37	.	.	PUNCT
iajs-3367	62	1	elisa	elisa	PROPN
iajs-3367	62	2	research	research	NOUN
iajs-3367	62	3	kits	kit	NOUN
iajs-3367	62	4	purchased	purchase	VERB
iajs-3367	62	5	from	from	ADP
iajs-3367	62	6	a	a	DET
iajs-3367	62	7	german	german	ADJ
iajs-3367	62	8	company	company	NOUN
iajs-3367	62	9	(	(	PUNCT
iajs-3367	62	10	human	human	NOUN
iajs-3367	62	11	)	)	PUNCT
iajs-3367	62	12	were	be	AUX
iajs-3367	62	13	used	use	VERB
iajs-3367	62	14	to	to	PART
iajs-3367	62	15	assess	assess	VERB
iajs-3367	62	16	the	the	DET
iajs-3367	62	17	serum	serum	NOUN
iajs-3367	62	18	level	level	NOUN
iajs-3367	62	19	of	of	ADP
iajs-3367	62	20	vitamin	vitamin	NOUN
iajs-3367	62	21	d.	d.	PROPN
iajs-3367	62	22	2.3	2.3	NUM
iajs-3367	62	23	.	.	PUNCT
iajs-3367	63	1	statistics	statistic	NOUN
iajs-3367	63	2	the	the	DET
iajs-3367	63	3	data	datum	NOUN
iajs-3367	63	4	were	be	AUX
iajs-3367	63	5	analyzed	analyze	VERB
iajs-3367	63	6	using	use	VERB
iajs-3367	63	7	spss	spss	ADJ
iajs-3367	63	8	statistical	statistical	ADJ
iajs-3367	63	9	software	software	NOUN
iajs-3367	63	10	(	(	PUNCT
iajs-3367	63	11	ibm	ibm	PROPN
iajs-3367	63	12	spss	spss	PROPN
iajs-3367	63	13	26.0	26.0	NUM
iajs-3367	63	14	)	)	PUNCT
iajs-3367	63	15	.	.	PUNCT
iajs-3367	64	1	we	we	PRON
iajs-3367	64	2	used	use	VERB
iajs-3367	64	3	the	the	DET
iajs-3367	64	4	least	least	ADV
iajs-3367	64	5	significant	significant	ADJ
iajs-3367	64	6	difference	difference	NOUN
iajs-3367	64	7	(	(	PUNCT
iajs-3367	64	8	lsd	lsd	NOUN
iajs-3367	64	9	)	)	PUNCT
iajs-3367	64	10	test	test	NOUN
iajs-3367	64	11	with	with	ADP
iajs-3367	64	12	probability	probability	NOUN
iajs-3367	64	13	of	of	ADP
iajs-3367	64	14	less	less	ADJ
iajs-3367	64	15	than	than	ADP
iajs-3367	64	16	0.05	0.05	NUM
iajs-3367	64	17	(	(	PUNCT
iajs-3367	64	18	p<0.05	p<0.05	NOUN
iajs-3367	64	19	)	)	PUNCT
iajs-3367	64	20	.	.	PUNCT
iajs-3367	65	1	3	3	X
iajs-3367	65	2	.	.	NOUN
iajs-3367	65	3	results	result	VERB
iajs-3367	65	4	the	the	DET
iajs-3367	65	5	results	result	NOUN
iajs-3367	65	6	showed	show	VERB
iajs-3367	65	7	that	that	SCONJ
iajs-3367	65	8	,	,	PUNCT
iajs-3367	65	9	serum	serum	NOUN
iajs-3367	65	10	level	level	NOUN
iajs-3367	65	11	of	of	ADP
iajs-3367	65	12	rankl	rankl	NOUN
iajs-3367	65	13	recorded	record	VERB
iajs-3367	65	14	a	a	DET
iajs-3367	65	15	non	non	ADJ
iajs-3367	65	16	-	-	ADJ
iajs-3367	65	17	significant	significant	ADJ
iajs-3367	65	18	difference	difference	NOUN
iajs-3367	65	19	among	among	ADP
iajs-3367	65	20	the	the	DET
iajs-3367	65	21	three	three	NUM
iajs-3367	65	22	understudying	understudy	VERB
iajs-3367	65	23	groups	group	NOUN
iajs-3367	65	24	,	,	PUNCT
iajs-3367	65	25	the	the	DET
iajs-3367	65	26	results	result	NOUN
iajs-3367	65	27	for	for	ADP
iajs-3367	65	28	sle	sle	PROPN
iajs-3367	65	29	early	early	ADV
iajs-3367	65	30	diagnosed	diagnose	VERB
iajs-3367	65	31	group	group	NOUN
iajs-3367	65	32	,	,	PUNCT
iajs-3367	65	33	sle	sle	PROPN
iajs-3367	65	34	under	under	ADP
iajs-3367	65	35	treatment	treatment	NOUN
iajs-3367	65	36	group	group	NOUN
iajs-3367	65	37	and	and	CCONJ
iajs-3367	65	38	the	the	DET
iajs-3367	65	39	control	control	NOUN
iajs-3367	65	40	group	group	NOUN
iajs-3367	65	41	,	,	PUNCT
iajs-3367	65	42	the	the	DET
iajs-3367	65	43	results	result	NOUN
iajs-3367	65	44	were	be	AUX
iajs-3367	65	45	(	(	PUNCT
iajs-3367	65	46	1.203±0.29	1.203±0.29	NUM
iajs-3367	65	47	,	,	PUNCT
iajs-3367	65	48	0.921±0.28	0.921±0.28	PROPN
iajs-3367	65	49	,	,	PUNCT
iajs-3367	65	50	0.870±0.23	0.870±0.23	PUNCT
iajs-3367	66	1	pg\ml	pg\ml	NOUN
iajs-3367	66	2	)	)	PUNCT
iajs-3367	66	3	respectively	respectively	ADV
iajs-3367	66	4	.	.	PUNCT
iajs-3367	67	1	serum	serum	NOUN
iajs-3367	67	2	level	level	NOUN
iajs-3367	67	3	of	of	ADP
iajs-3367	67	4	sclerostin	sclerostin	NOUN
iajs-3367	67	5	also	also	ADV
iajs-3367	67	6	showed	show	VERB
iajs-3367	67	7	no	no	DET
iajs-3367	67	8	significant	significant	ADJ
iajs-3367	67	9	differences	difference	NOUN
iajs-3367	67	10	among	among	ADP
iajs-3367	67	11	three	three	NUM
iajs-3367	67	12	understudying	understudy	VERB
iajs-3367	67	13	groups	group	NOUN
iajs-3367	67	14	,	,	PUNCT
iajs-3367	67	15	the	the	DET
iajs-3367	67	16	results	result	NOUN
iajs-3367	67	17	were	be	AUX
iajs-3367	67	18	(	(	PUNCT
iajs-3367	67	19	0.686±0.09	0.686±0.09	NUM
iajs-3367	67	20	,	,	PUNCT
iajs-3367	67	21	0.588±0.09	0.588±0.09	NUM
iajs-3367	67	22	,	,	PUNCT
iajs-3367	67	23	0.462±0.0899	0.462±0.0899	PROPN
iajs-3367	67	24	ng	ng	PROPN
iajs-3367	67	25	/	/	SYM
iajs-3367	67	26	ml	ml	NOUN
iajs-3367	67	27	)	)	PUNCT
iajs-3367	67	28	respectively	respectively	ADV
iajs-3367	67	29	,	,	PUNCT
iajs-3367	67	30	as	as	SCONJ
iajs-3367	67	31	shown	show	VERB
iajs-3367	67	32	in	in	ADP
iajs-3367	67	33	table	table	NOUN
iajs-3367	67	34	1	1	NUM
iajs-3367	67	35	.	.	PUNCT
iajs-3367	67	36	table	table	NOUN
iajs-3367	67	37	1	1	NUM
iajs-3367	67	38	.	.	PUNCT
iajs-3367	68	1	serum	serum	NOUN
iajs-3367	68	2	levels	level	NOUN
iajs-3367	68	3	of	of	ADP
iajs-3367	68	4	rankl	rankl	NOUN
iajs-3367	68	5	and	and	CCONJ
iajs-3367	68	6	sclerostin	sclerostin	ADJ
iajs-3367	68	7	.	.	PUNCT
iajs-3367	69	1	groups	group	NOUN
iajs-3367	69	2	rankl	rankl	VERB
iajs-3367	69	3	(	(	PUNCT
iajs-3367	69	4	pg\ml	pg\ml	PROPN
iajs-3367	69	5	)	)	PUNCT
iajs-3367	69	6	(	(	PUNCT
iajs-3367	69	7	mean	mean	VERB
iajs-3367	69	8	±	±	NUM
iajs-3367	69	9	se	se	X
iajs-3367	69	10	)	)	PUNCT
iajs-3367	69	11	sclerostin	sclerostin	PROPN
iajs-3367	69	12	(	(	PUNCT
iajs-3367	69	13	ng	ng	PROPN
iajs-3367	69	14	/	/	SYM
iajs-3367	69	15	ml	ml	PROPN
iajs-3367	69	16	)	)	PUNCT
iajs-3367	69	17	(	(	PUNCT
iajs-3367	69	18	mean	mean	VERB
iajs-3367	69	19	±	±	NUM
iajs-3367	69	20	se	se	X
iajs-3367	69	21	)	)	PUNCT
iajs-3367	69	22	early	early	ADV
iajs-3367	69	23	diagnosed	diagnose	VERB
iajs-3367	69	24	patients	patient	NOUN
iajs-3367	69	25	1.203±0.29a	1.203±0.29a	NUM
iajs-3367	69	26	0.686±0.09a	0.686±0.09a	NUM
iajs-3367	69	27	treated	treat	VERB
iajs-3367	69	28	patients	patient	NOUN
iajs-3367	69	29	0.921±0.28a	0.921±0.28a	VERB
iajs-3367	69	30	0.588±0.09a	0.588±0.09a	NUM
iajs-3367	70	1	control	control	NOUN
iajs-3367	70	2	0.870±0.23a	0.870±0.23a	NUM
iajs-3367	70	3	0.462±0.08a	0.462±0.08a	NUM
iajs-3367	71	1	p	p	NOUN
iajs-3367	71	2	value	value	NOUN
iajs-3367	71	3	0.106	0.106	NUM
iajs-3367	71	4	0.11	0.11	NUM
iajs-3367	71	5	lsd(p<0.05	lsd(p<0.05	PROPN
iajs-3367	71	6	)	)	PUNCT
iajs-3367	71	7	0.755	0.755	NUM
iajs-3367	71	8	0.244	0.244	NUM
iajs-3367	71	9	similar	similar	ADJ
iajs-3367	71	10	letters	letter	NOUN
iajs-3367	71	11	denote	denote	VERB
iajs-3367	71	12	to	to	ADP
iajs-3367	71	13	the	the	DET
iajs-3367	71	14	non	non	ADJ
iajs-3367	71	15	-	-	ADJ
iajs-3367	71	16	significant	significant	ADJ
iajs-3367	71	17	difference	difference	NOUN
iajs-3367	71	18	at	at	ADP
iajs-3367	71	19	p<0.05	p<0.05	NOUN
iajs-3367	71	20	*	*	PUNCT
iajs-3367	71	21	the	the	DET
iajs-3367	71	22	serum	serum	NOUN
iajs-3367	71	23	level	level	NOUN
iajs-3367	71	24	of	of	ADP
iajs-3367	71	25	pd-1	pd-1	NOUN
iajs-3367	71	26	was	be	AUX
iajs-3367	71	27	significantly	significantly	ADV
iajs-3367	71	28	higher	high	ADJ
iajs-3367	71	29	in	in	ADP
iajs-3367	71	30	the	the	DET
iajs-3367	71	31	early	early	ADV
iajs-3367	71	32	-	-	PUNCT
iajs-3367	71	33	diagnosed	diagnose	VERB
iajs-3367	71	34	group	group	NOUN
iajs-3367	71	35	and	and	CCONJ
iajs-3367	71	36	the	the	DET
iajs-3367	71	37	undertreated	undertreated	ADJ
iajs-3367	71	38	group	group	NOUN
iajs-3367	71	39	compared	compare	VERB
iajs-3367	71	40	with	with	ADP
iajs-3367	71	41	the	the	DET
iajs-3367	71	42	control	control	NOUN
iajs-3367	71	43	(	(	PUNCT
iajs-3367	71	44	0.611±0.04	0.611±0.04	NUM
iajs-3367	71	45	,	,	PUNCT
iajs-3367	71	46	0.579±0.07	0.579±0.07	NUM
iajs-3367	71	47	,	,	PUNCT
iajs-3367	71	48	and	and	CCONJ
iajs-3367	71	49	0.256±0.04	0.256±0.04	NUM
iajs-3367	71	50	ng\ml	ng\ml	NOUN
iajs-3367	71	51	,	,	PUNCT
iajs-3367	71	52	respectively	respectively	ADV
iajs-3367	71	53	)	)	PUNCT
iajs-3367	71	54	.	.	PUNCT
iajs-3367	72	1	the	the	DET
iajs-3367	72	2	serum	serum	NOUN
iajs-3367	72	3	concentration	concentration	NOUN
iajs-3367	72	4	level	level	NOUN
iajs-3367	72	5	of	of	ADP
iajs-3367	72	6	vitamin	vitamin	NOUN
iajs-3367	72	7	d	d	NOUN
iajs-3367	72	8	was	be	AUX
iajs-3367	72	9	significantly	significantly	ADV
iajs-3367	72	10	higher	high	ADJ
iajs-3367	72	11	in	in	ADP
iajs-3367	72	12	the	the	DET
iajs-3367	72	13	earlydiagnosed	earlydiagnose	VERB
iajs-3367	72	14	group	group	NOUN
iajs-3367	72	15	and	and	CCONJ
iajs-3367	72	16	treated	treat	VERB
iajs-3367	72	17	group	group	NOUN
iajs-3367	72	18	compared	compare	VERB
iajs-3367	72	19	with	with	ADP
iajs-3367	72	20	the	the	DET
iajs-3367	72	21	healthy	healthy	ADJ
iajs-3367	72	22	control	control	NOUN
iajs-3367	72	23	group	group	NOUN
iajs-3367	72	24	(	(	PUNCT
iajs-3367	72	25	56.87±4.45	56.87±4.45	NUM
iajs-3367	72	26	,	,	PUNCT
iajs-3367	72	27	56.62±2.08	56.62±2.08	NUM
iajs-3367	72	28	,	,	PUNCT
iajs-3367	72	29	46.02±1.57	46.02±1.57	NUM
iajs-3367	72	30	ng\ml	ng\ml	NOUN
iajs-3367	72	31	)	)	PUNCT
iajs-3367	72	32	,	,	PUNCT
iajs-3367	72	33	respectively	respectively	ADV
iajs-3367	72	34	,	,	PUNCT
iajs-3367	72	35	as	as	SCONJ
iajs-3367	72	36	shown	show	VERB
iajs-3367	72	37	in	in	ADP
iajs-3367	72	38	table	table	NOUN
iajs-3367	72	39	2	2	NUM
iajs-3367	72	40	.	.	PUNCT
iajs-3367	72	41	ihjpas	ihjpas	PROPN
iajs-3367	72	42	.	.	PUNCT
iajs-3367	73	1	37	37	NUM
iajs-3367	73	2	(	(	PUNCT
iajs-3367	73	3	1	1	NUM
iajs-3367	73	4	)	)	PUNCT
iajs-3367	73	5	2024	2024	NUM
iajs-3367	73	6	12	12	NUM
iajs-3367	73	7	table	table	NOUN
iajs-3367	73	8	2	2	NUM
iajs-3367	73	9	.	.	X
iajs-3367	73	10	serum	serum	NOUN
iajs-3367	73	11	levels	level	NOUN
iajs-3367	73	12	of	of	ADP
iajs-3367	73	13	pd-1	pd-1	ADJ
iajs-3367	73	14	and	and	CCONJ
iajs-3367	73	15	vitamin	vitamin	PROPN
iajs-3367	73	16	d.	d.	PROPN
iajs-3367	73	17	groups	groups	PROPN
iajs-3367	73	18	pd	pd	PROPN
iajs-3367	73	19	(	(	PUNCT
iajs-3367	73	20	ng\ml	ng\ml	PROPN
iajs-3367	73	21	)	)	PUNCT
iajs-3367	73	22	(	(	PUNCT
iajs-3367	73	23	mean	mean	NOUN
iajs-3367	73	24	±	±	NUM
iajs-3367	73	25	se	se	X
iajs-3367	73	26	)	)	PUNCT
iajs-3367	73	27	vitamin	vitamin	NOUN
iajs-3367	73	28	d	d	NOUN
iajs-3367	73	29	(	(	PUNCT
iajs-3367	73	30	ng\ml	ng\ml	PROPN
iajs-3367	73	31	)	)	PUNCT
iajs-3367	73	32	(	(	PUNCT
iajs-3367	73	33	mean	mean	NOUN
iajs-3367	73	34	±	±	NUM
iajs-3367	73	35	se	se	X
iajs-3367	73	36	)	)	PUNCT
iajs-3367	73	37	early	early	ADJ
iajs-3367	73	38	diagnostic	diagnostic	ADJ
iajs-3367	73	39	patients	patient	NOUN
iajs-3367	73	40	0.611±0.04a	0.611±0.04a	NUM
iajs-3367	73	41	56.87±4.45b	56.87±4.45b	NUM
iajs-3367	73	42	treated	treat	VERB
iajs-3367	73	43	patients	patient	NOUN
iajs-3367	73	44	0.579±0.07a	0.579±0.07a	NUM
iajs-3367	74	1	56.62±2.08b	56.62±2.08b	NUM
iajs-3367	74	2	control	control	NOUN
iajs-3367	74	3	0.256±0.04b	0.256±0.04b	NUM
iajs-3367	74	4	46.02±1.57a	46.02±1.57a	NUM
iajs-3367	75	1	p	p	NOUN
iajs-3367	75	2	value	value	NOUN
iajs-3367	75	3	0.009	0.009	NUM
iajs-3367	75	4	0.001	0.001	NUM
iajs-3367	75	5	lsd(p<0.05	lsd(p<0.05	PROPN
iajs-3367	75	6	)	)	PUNCT
iajs-3367	75	7	0.153	0.153	NUM
iajs-3367	75	8	5.38	5.38	NUM
iajs-3367	75	9	*	*	PUNCT
iajs-3367	75	10	different	different	ADJ
iajs-3367	75	11	letters	letter	NOUN
iajs-3367	75	12	denote	denote	VERB
iajs-3367	75	13	to	to	ADP
iajs-3367	75	14	the	the	DET
iajs-3367	75	15	significant	significant	ADJ
iajs-3367	75	16	difference	difference	NOUN
iajs-3367	75	17	at	at	ADP
iajs-3367	75	18	p<0.05	p<0.05	NOUN
iajs-3367	75	19	4	4	NUM
iajs-3367	75	20	.	.	PUNCT
iajs-3367	75	21	discussion	discussion	NOUN
iajs-3367	75	22	4.1	4.1	NUM
iajs-3367	75	23	.	.	PUNCT
iajs-3367	76	1	serum	serum	NOUN
iajs-3367	76	2	level	level	NOUN
iajs-3367	76	3	of	of	ADP
iajs-3367	76	4	pd-1	pd-1	NOUN
iajs-3367	76	5	pd-1	pd-1	ADJ
iajs-3367	76	6	receptors	receptor	NOUN
iajs-3367	76	7	and	and	CCONJ
iajs-3367	76	8	their	their	PRON
iajs-3367	76	9	ligands	ligand	NOUN
iajs-3367	76	10	have	have	AUX
iajs-3367	76	11	been	be	AUX
iajs-3367	76	12	implicated	implicate	VERB
iajs-3367	76	13	in	in	ADP
iajs-3367	76	14	the	the	DET
iajs-3367	76	15	pathogenesis	pathogenesis	NOUN
iajs-3367	76	16	of	of	ADP
iajs-3367	76	17	sle	sle	PROPN
iajs-3367	76	18	.	.	PUNCT
iajs-3367	77	1	[	[	X
iajs-3367	77	2	11	11	NUM
iajs-3367	77	3	]	]	PUNCT
iajs-3367	77	4	.	.	PUNCT
iajs-3367	78	1	the	the	DET
iajs-3367	78	2	higher	high	ADJ
iajs-3367	78	3	level	level	NOUN
iajs-3367	78	4	of	of	ADP
iajs-3367	78	5	serum	serum	NOUN
iajs-3367	78	6	pd-1	pd-1	ADJ
iajs-3367	78	7	in	in	ADP
iajs-3367	78	8	sle	sle	PROPN
iajs-3367	78	9	patients	patient	NOUN
iajs-3367	78	10	may	may	AUX
iajs-3367	78	11	be	be	AUX
iajs-3367	78	12	explained	explain	VERB
iajs-3367	78	13	by	by	ADP
iajs-3367	78	14	two	two	NUM
iajs-3367	78	15	theories	theory	NOUN
iajs-3367	78	16	.	.	PUNCT
iajs-3367	79	1	the	the	DET
iajs-3367	79	2	first	first	ADJ
iajs-3367	79	3	one	one	NUM
iajs-3367	79	4	is	be	AUX
iajs-3367	79	5	spd-1	spd-1	PRON
iajs-3367	79	6	,	,	PUNCT
iajs-3367	79	7	which	which	PRON
iajs-3367	79	8	is	be	AUX
iajs-3367	79	9	produced	produce	VERB
iajs-3367	79	10	by	by	ADP
iajs-3367	79	11	alternative	alternative	ADJ
iajs-3367	79	12	splicing	splicing	NOUN
iajs-3367	79	13	and	and	CCONJ
iajs-3367	79	14	can	can	AUX
iajs-3367	79	15	disrupt	disrupt	VERB
iajs-3367	79	16	the	the	DET
iajs-3367	79	17	regulatory	regulatory	ADJ
iajs-3367	79	18	impact	impact	NOUN
iajs-3367	79	19	of	of	ADP
iajs-3367	79	20	membrane	membrane	NOUN
iajs-3367	79	21	-	-	PUNCT
iajs-3367	79	22	bound	bind	VERB
iajs-3367	79	23	pd-1	pd-1	ADP
iajs-3367	79	24	on	on	ADP
iajs-3367	79	25	t	t	PROPN
iajs-3367	79	26	cell	cell	NOUN
iajs-3367	79	27	activation	activation	NOUN
iajs-3367	79	28	after	after	ADP
iajs-3367	79	29	raising	raise	VERB
iajs-3367	79	30	its	its	PRON
iajs-3367	79	31	level	level	NOUN
iajs-3367	79	32	in	in	ADP
iajs-3367	79	33	the	the	DET
iajs-3367	79	34	serum	serum	NOUN
iajs-3367	79	35	of	of	ADP
iajs-3367	79	36	sle	sle	PROPN
iajs-3367	79	37	patients	patient	NOUN
iajs-3367	80	1	[	[	X
iajs-3367	80	2	31	31	NUM
iajs-3367	80	3	]	]	PUNCT
iajs-3367	80	4	.	.	PUNCT
iajs-3367	81	1	the	the	DET
iajs-3367	81	2	second	second	ADJ
iajs-3367	81	3	says	say	VERB
iajs-3367	81	4	that	that	SCONJ
iajs-3367	81	5	there	there	PRON
iajs-3367	81	6	is	be	VERB
iajs-3367	81	7	a	a	DET
iajs-3367	81	8	noteworthy	noteworthy	ADJ
iajs-3367	81	9	correlation	correlation	NOUN
iajs-3367	81	10	between	between	ADP
iajs-3367	81	11	increased	increase	VERB
iajs-3367	81	12	pd-1	pd-1	ADP
iajs-3367	81	13	expression	expression	NOUN
iajs-3367	81	14	in	in	ADP
iajs-3367	81	15	t	t	NOUN
iajs-3367	81	16	cells	cell	NOUN
iajs-3367	81	17	and	and	CCONJ
iajs-3367	81	18	increased	increase	VERB
iajs-3367	81	19	expression	expression	NOUN
iajs-3367	81	20	in	in	ADP
iajs-3367	81	21	b	b	NOUN
iajs-3367	81	22	cells	cell	NOUN
iajs-3367	81	23	after	after	ADP
iajs-3367	81	24	stimulating	stimulate	VERB
iajs-3367	81	25	hyporesponsive	hyporesponsive	ADJ
iajs-3367	81	26	lupus	lupus	NOUN
iajs-3367	81	27	b	b	PROPN
iajs-3367	81	28	cells	cell	NOUN
iajs-3367	81	29	(	(	PUNCT
iajs-3367	81	30	which	which	PRON
iajs-3367	81	31	exhibit	exhibit	VERB
iajs-3367	81	32	an	an	DET
iajs-3367	81	33	elevated	elevated	ADJ
iajs-3367	81	34	pd-1	pd-1	ADV
iajs-3367	81	35	phenotype	phenotype	NOUN
iajs-3367	81	36	)	)	PUNCT
iajs-3367	81	37	.	.	PUNCT
iajs-3367	82	1	these	these	DET
iajs-3367	82	2	results	result	NOUN
iajs-3367	82	3	suggest	suggest	VERB
iajs-3367	82	4	that	that	SCONJ
iajs-3367	82	5	pd-1	pd-1	VERB
iajs-3367	82	6	membrane	membrane	NOUN
iajs-3367	82	7	expression	expression	NOUN
iajs-3367	82	8	in	in	ADP
iajs-3367	82	9	these	these	DET
iajs-3367	82	10	cells	cell	NOUN
iajs-3367	82	11	is	be	AUX
iajs-3367	82	12	reciprocally	reciprocally	ADV
iajs-3367	82	13	regulated	regulate	VERB
iajs-3367	82	14	in	in	ADP
iajs-3367	82	15	sle	sle	PROPN
iajs-3367	82	16	[	[	X
iajs-3367	82	17	32	32	NUM
iajs-3367	82	18	]	]	PUNCT
iajs-3367	82	19	.	.	PUNCT
iajs-3367	83	1	also	also	ADV
iajs-3367	83	2	,	,	PUNCT
iajs-3367	83	3	pd-1	pd-1	ADV
iajs-3367	83	4	may	may	AUX
iajs-3367	83	5	play	play	VERB
iajs-3367	83	6	a	a	DET
iajs-3367	83	7	role	role	NOUN
iajs-3367	83	8	in	in	ADP
iajs-3367	83	9	sle	sle	PROPN
iajs-3367	83	10	pathogenesis	pathogenesis	NOUN
iajs-3367	83	11	by	by	ADP
iajs-3367	83	12	other	other	ADJ
iajs-3367	83	13	means	mean	NOUN
iajs-3367	83	14	in	in	ADP
iajs-3367	83	15	addition	addition	NOUN
iajs-3367	83	16	to	to	ADP
iajs-3367	83	17	its	its	PRON
iajs-3367	83	18	inhibitory	inhibitory	ADJ
iajs-3367	83	19	function	function	NOUN
iajs-3367	83	20	as	as	ADP
iajs-3367	83	21	a	a	DET
iajs-3367	83	22	negative	negative	ADJ
iajs-3367	83	23	costimulatory	costimulatory	NOUN
iajs-3367	83	24	molecule	molecule	NOUN
iajs-3367	83	25	.	.	PUNCT
iajs-3367	84	1	it	it	PRON
iajs-3367	84	2	may	may	AUX
iajs-3367	84	3	also	also	ADV
iajs-3367	84	4	be	be	AUX
iajs-3367	84	5	associated	associate	VERB
iajs-3367	84	6	with	with	ADP
iajs-3367	84	7	disease	disease	NOUN
iajs-3367	84	8	severity	severity	NOUN
iajs-3367	84	9	and	and	CCONJ
iajs-3367	84	10	act	act	VERB
iajs-3367	84	11	as	as	ADP
iajs-3367	84	12	a	a	DET
iajs-3367	84	13	negative	negative	ADJ
iajs-3367	84	14	feedback	feedback	NOUN
iajs-3367	84	15	mechanism	mechanism	NOUN
iajs-3367	84	16	for	for	ADP
iajs-3367	84	17	preventing	prevent	VERB
iajs-3367	84	18	potential	potential	ADJ
iajs-3367	84	19	tissue	tissue	NOUN
iajs-3367	84	20	damage	damage	NOUN
iajs-3367	84	21	brought	bring	VERB
iajs-3367	84	22	on	on	ADP
iajs-3367	84	23	by	by	ADP
iajs-3367	84	24	excessive	excessive	ADJ
iajs-3367	84	25	autoimmune	autoimmune	ADJ
iajs-3367	84	26	responses	response	NOUN
iajs-3367	84	27	in	in	ADP
iajs-3367	84	28	sle	sle	PROPN
iajs-3367	84	29	patients	patient	NOUN
iajs-3367	85	1	[	[	X
iajs-3367	85	2	33	33	NUM
iajs-3367	85	3	]	]	PUNCT
iajs-3367	85	4	.	.	PUNCT
iajs-3367	86	1	based	base	VERB
iajs-3367	86	2	on	on	ADP
iajs-3367	86	3	the	the	DET
iajs-3367	86	4	findings	finding	NOUN
iajs-3367	86	5	of	of	ADP
iajs-3367	86	6	the	the	DET
iajs-3367	86	7	study	study	NOUN
iajs-3367	86	8	,	,	PUNCT
iajs-3367	86	9	the	the	DET
iajs-3367	86	10	increased	increase	VERB
iajs-3367	86	11	pd-1	pd-1	ADP
iajs-3367	86	12	expression	expression	NOUN
iajs-3367	86	13	in	in	ADP
iajs-3367	86	14	sle	sle	PROPN
iajs-3367	86	15	patients	patient	NOUN
iajs-3367	86	16	may	may	AUX
iajs-3367	86	17	be	be	AUX
iajs-3367	86	18	related	relate	VERB
iajs-3367	86	19	to	to	ADP
iajs-3367	86	20	the	the	DET
iajs-3367	86	21	pathogenesis	pathogenesis	NOUN
iajs-3367	86	22	of	of	ADP
iajs-3367	86	23	the	the	DET
iajs-3367	86	24	disease	disease	NOUN
iajs-3367	86	25	and	and	CCONJ
iajs-3367	86	26	may	may	AUX
iajs-3367	86	27	be	be	AUX
iajs-3367	86	28	helpful	helpful	ADJ
iajs-3367	86	29	in	in	ADP
iajs-3367	86	30	sle	sle	PROPN
iajs-3367	86	31	treatment	treatment	NOUN
iajs-3367	86	32	.	.	PUNCT
iajs-3367	87	1	the	the	DET
iajs-3367	87	2	current	current	ADJ
iajs-3367	87	3	study	study	NOUN
iajs-3367	87	4	agrees	agree	VERB
iajs-3367	87	5	with	with	ADP
iajs-3367	87	6	the	the	DET
iajs-3367	87	7	previous	previous	ADJ
iajs-3367	87	8	study	study	NOUN
iajs-3367	87	9	done	do	VERB
iajs-3367	87	10	by	by	ADP
iajs-3367	87	11	bassiouni	bassiouni	PROPN
iajs-3367	87	12	et	et	PROPN
iajs-3367	87	13	al	al	PROPN
iajs-3367	87	14	.	.	PUNCT
iajs-3367	88	1	[	[	X
iajs-3367	88	2	34	34	NUM
iajs-3367	88	3	]	]	PUNCT
iajs-3367	88	4	,	,	PUNCT
iajs-3367	88	5	who	who	PRON
iajs-3367	88	6	discovered	discover	VERB
iajs-3367	88	7	that	that	SCONJ
iajs-3367	88	8	serum	serum	NOUN
iajs-3367	88	9	pd-1	pd-1	ADP
iajs-3367	88	10	levels	level	NOUN
iajs-3367	88	11	are	be	AUX
iajs-3367	88	12	significantly	significantly	ADV
iajs-3367	88	13	higher	high	ADJ
iajs-3367	88	14	in	in	ADP
iajs-3367	88	15	patients	patient	NOUN
iajs-3367	88	16	with	with	ADP
iajs-3367	88	17	early	early	ADV
iajs-3367	88	18	-	-	PUNCT
iajs-3367	88	19	diagnosed	diagnose	VERB
iajs-3367	88	20	sle	sle	NOUN
iajs-3367	88	21	compared	compare	VERB
iajs-3367	88	22	to	to	ADP
iajs-3367	88	23	healthy	healthy	ADJ
iajs-3367	88	24	individuals	individual	NOUN
iajs-3367	88	25	.	.	PUNCT
iajs-3367	89	1	while	while	SCONJ
iajs-3367	89	2	the	the	DET
iajs-3367	89	3	present	present	ADJ
iajs-3367	89	4	study	study	NOUN
iajs-3367	89	5	disagrees	disagree	VERB
iajs-3367	89	6	with	with	ADP
iajs-3367	89	7	her	she	PRON
iajs-3367	89	8	et	et	PROPN
iajs-3367	89	9	al	al	PROPN
iajs-3367	89	10	.	.	PROPN
iajs-3367	89	11	's	's	PART
iajs-3367	89	12	[	[	X
iajs-3367	89	13	35	35	NUM
iajs-3367	89	14	]	]	PUNCT
iajs-3367	89	15	study	study	NOUN
iajs-3367	89	16	,	,	PUNCT
iajs-3367	89	17	which	which	PRON
iajs-3367	89	18	recorded	record	VERB
iajs-3367	89	19	that	that	SCONJ
iajs-3367	89	20	pd-1	pd-1	ADP
iajs-3367	89	21	serum	serum	NOUN
iajs-3367	89	22	levels	level	NOUN
iajs-3367	89	23	in	in	ADP
iajs-3367	89	24	patients	patient	NOUN
iajs-3367	89	25	with	with	ADP
iajs-3367	89	26	sle	sle	PROPN
iajs-3367	89	27	were	be	AUX
iajs-3367	89	28	comparable	comparable	ADJ
iajs-3367	89	29	to	to	ADP
iajs-3367	89	30	those	those	PRON
iajs-3367	89	31	in	in	ADP
iajs-3367	89	32	the	the	DET
iajs-3367	89	33	control	control	NOUN
iajs-3367	89	34	group	group	NOUN
iajs-3367	89	35	,	,	PUNCT
iajs-3367	89	36	4.2	4.2	NUM
iajs-3367	89	37	.	.	PUNCT
iajs-3367	90	1	vitamin	vitamin	NOUN
iajs-3367	90	2	d	d	NOUN
iajs-3367	90	3	evidence	evidence	NOUN
iajs-3367	90	4	has	have	AUX
iajs-3367	90	5	accumulated	accumulate	VERB
iajs-3367	90	6	in	in	ADP
iajs-3367	90	7	recent	recent	ADJ
iajs-3367	90	8	years	year	NOUN
iajs-3367	90	9	on	on	ADP
iajs-3367	90	10	the	the	DET
iajs-3367	90	11	influence	influence	NOUN
iajs-3367	90	12	of	of	ADP
iajs-3367	90	13	vitamin	vitamin	NOUN
iajs-3367	90	14	d	d	NOUN
iajs-3367	90	15	on	on	ADP
iajs-3367	90	16	the	the	DET
iajs-3367	90	17	immune	immune	ADJ
iajs-3367	90	18	system	system	NOUN
iajs-3367	90	19	.	.	PUNCT
iajs-3367	91	1	given	give	VERB
iajs-3367	91	2	that	that	DET
iajs-3367	91	3	vitamin	vitamin	NOUN
iajs-3367	91	4	d	d	NOUN
iajs-3367	91	5	supplements	supplement	NOUN
iajs-3367	91	6	are	be	AUX
iajs-3367	91	7	inexpensive	inexpensive	ADJ
iajs-3367	91	8	and	and	CCONJ
iajs-3367	91	9	infrequently	infrequently	ADV
iajs-3367	91	10	harmful	harmful	ADJ
iajs-3367	91	11	,	,	PUNCT
iajs-3367	91	12	it	it	PRON
iajs-3367	91	13	may	may	AUX
iajs-3367	91	14	be	be	AUX
iajs-3367	91	15	advised	advise	VERB
iajs-3367	91	16	that	that	SCONJ
iajs-3367	91	17	all	all	DET
iajs-3367	91	18	sle	sle	PROPN
iajs-3367	91	19	patients	patient	NOUN
iajs-3367	91	20	take	take	VERB
iajs-3367	91	21	them	they	PRON
iajs-3367	91	22	regularly	regularly	ADV
iajs-3367	91	23	[	[	X
iajs-3367	91	24	36	36	NUM
iajs-3367	91	25	]	]	PUNCT
iajs-3367	91	26	.	.	PUNCT
iajs-3367	92	1	it	it	PRON
iajs-3367	92	2	is	be	AUX
iajs-3367	92	3	generally	generally	ADV
iajs-3367	92	4	safe	safe	ADJ
iajs-3367	92	5	,	,	PUNCT
iajs-3367	92	6	considerably	considerably	ADV
iajs-3367	92	7	raises	raise	VERB
iajs-3367	92	8	serum	serum	NOUN
iajs-3367	92	9	vitamin	vitamin	NOUN
iajs-3367	92	10	d	d	PROPN
iajs-3367	92	11	levels	level	NOUN
iajs-3367	92	12	in	in	ADP
iajs-3367	92	13	sle	sle	PROPN
iajs-3367	92	14	patients	patient	NOUN
iajs-3367	92	15	,	,	PUNCT
iajs-3367	92	16	extends	extend	VERB
iajs-3367	92	17	life	life	NOUN
iajs-3367	92	18	,	,	PUNCT
iajs-3367	92	19	lowers	lower	VERB
iajs-3367	92	20	proteinuria	proteinuria	NOUN
iajs-3367	92	21	,	,	PUNCT
iajs-3367	92	22	and	and	CCONJ
iajs-3367	92	23	improves	improve	VERB
iajs-3367	92	24	knee	knee	NOUN
iajs-3367	92	25	arthritis	arthritis	NOUN
iajs-3367	93	1	[	[	X
iajs-3367	93	2	37	37	NUM
iajs-3367	93	3	,	,	PUNCT
iajs-3367	93	4	38	38	NUM
iajs-3367	93	5	]	]	PUNCT
iajs-3367	93	6	.	.	PUNCT
iajs-3367	94	1	therefore	therefore	ADV
iajs-3367	94	2	,	,	PUNCT
iajs-3367	94	3	the	the	DET
iajs-3367	94	4	current	current	ADJ
iajs-3367	94	5	results	result	NOUN
iajs-3367	94	6	showed	show	VERB
iajs-3367	94	7	an	an	DET
iajs-3367	94	8	increase	increase	NOUN
iajs-3367	94	9	in	in	ADP
iajs-3367	94	10	vitamin	vitamin	NOUN
iajs-3367	94	11	d	d	NOUN
iajs-3367	94	12	levels	level	NOUN
iajs-3367	94	13	in	in	ADP
iajs-3367	94	14	sle	sle	PROPN
iajs-3367	94	15	patients	patient	NOUN
iajs-3367	94	16	compared	compare	VERB
iajs-3367	94	17	to	to	ADP
iajs-3367	94	18	the	the	DET
iajs-3367	94	19	healthy	healthy	ADJ
iajs-3367	94	20	group	group	NOUN
iajs-3367	94	21	.	.	PUNCT
iajs-3367	95	1	in	in	ADP
iajs-3367	95	2	the	the	DET
iajs-3367	95	3	same	same	ADJ
iajs-3367	95	4	context	context	NOUN
iajs-3367	95	5	,	,	PUNCT
iajs-3367	95	6	vitamin	vitamin	NOUN
iajs-3367	95	7	d	d	NOUN
iajs-3367	95	8	insufficiency	insufficiency	NOUN
iajs-3367	95	9	is	be	AUX
iajs-3367	95	10	frequent	frequent	ADJ
iajs-3367	95	11	in	in	ADP
iajs-3367	95	12	the	the	DET
iajs-3367	95	13	general	general	ADJ
iajs-3367	95	14	population	population	NOUN
iajs-3367	95	15	;	;	PUNCT
iajs-3367	95	16	an	an	DET
iajs-3367	95	17	estimated	estimate	VERB
iajs-3367	95	18	one	one	NUM
iajs-3367	95	19	billion	billion	NUM
iajs-3367	95	20	individuals	individual	NOUN
iajs-3367	95	21	worldwide	worldwide	ADV
iajs-3367	95	22	are	be	AUX
iajs-3367	95	23	thought	think	VERB
iajs-3367	95	24	to	to	PART
iajs-3367	95	25	suffer	suffer	VERB
iajs-3367	95	26	from	from	ADP
iajs-3367	95	27	vitamin	vitamin	NOUN
iajs-3367	95	28	d	d	NOUN
iajs-3367	95	29	deficiency	deficiency	NOUN
iajs-3367	95	30	or	or	CCONJ
iajs-3367	95	31	insufficiency	insufficiency	NOUN
iajs-3367	95	32	[	[	X
iajs-3367	95	33	38	38	NUM
iajs-3367	95	34	,	,	PUNCT
iajs-3367	95	35	39	39	NUM
iajs-3367	95	36	]	]	PUNCT
iajs-3367	95	37	.	.	PUNCT
iajs-3367	96	1	according	accord	VERB
iajs-3367	96	2	to	to	ADP
iajs-3367	96	3	certain	certain	ADJ
iajs-3367	96	4	research	research	NOUN
iajs-3367	96	5	,	,	PUNCT
iajs-3367	96	6	women	woman	NOUN
iajs-3367	96	7	are	be	AUX
iajs-3367	96	8	more	more	ADV
iajs-3367	96	9	likely	likely	ADJ
iajs-3367	96	10	to	to	PART
iajs-3367	96	11	suffer	suffer	VERB
iajs-3367	96	12	from	from	ADP
iajs-3367	96	13	vitamin	vitamin	NOUN
iajs-3367	96	14	d	d	NOUN
iajs-3367	96	15	deficiency	deficiency	NOUN
iajs-3367	96	16	than	than	ADP
iajs-3367	96	17	men	man	NOUN
iajs-3367	96	18	because	because	SCONJ
iajs-3367	96	19	they	they	PRON
iajs-3367	96	20	spend	spend	VERB
iajs-3367	96	21	less	less	ADJ
iajs-3367	96	22	time	time	NOUN
iajs-3367	96	23	outdoors	outdoors	ADV
iajs-3367	96	24	and	and	CCONJ
iajs-3367	96	25	use	use	VERB
iajs-3367	96	26	sunscreen	sunscreen	NOUN
iajs-3367	96	27	more	more	ADV
iajs-3367	96	28	frequently	frequently	ADV
iajs-3367	96	29	.	.	PUNCT
iajs-3367	97	1	this	this	DET
iajs-3367	97	2	finding	finding	NOUN
iajs-3367	97	3	may	may	AUX
iajs-3367	97	4	also	also	ADV
iajs-3367	97	5	be	be	AUX
iajs-3367	97	6	related	relate	VERB
iajs-3367	97	7	to	to	ADP
iajs-3367	97	8	the	the	DET
iajs-3367	97	9	islamic	islamic	ADJ
iajs-3367	97	10	custom	custom	NOUN
iajs-3367	97	11	of	of	ADP
iajs-3367	97	12	covering	cover	VERB
iajs-3367	97	13	the	the	DET
iajs-3367	97	14	body	body	NOUN
iajs-3367	97	15	from	from	ADP
iajs-3367	97	16	head	head	NOUN
iajs-3367	97	17	to	to	ADP
iajs-3367	97	18	toe	toe	NOUN
iajs-3367	97	19	[	[	X
iajs-3367	97	20	40	40	NUM
iajs-3367	97	21	;	;	PUNCT
iajs-3367	97	22	41	41	NUM
iajs-3367	97	23	]	]	PUNCT
iajs-3367	97	24	.	.	PUNCT
iajs-3367	98	1	and	and	CCONJ
iajs-3367	98	2	this	this	PRON
iajs-3367	98	3	explains	explain	VERB
iajs-3367	98	4	the	the	DET
iajs-3367	98	5	low	low	ADJ
iajs-3367	98	6	vitamin	vitamin	NOUN
iajs-3367	98	7	d	d	NOUN
iajs-3367	98	8	level	level	NOUN
iajs-3367	98	9	in	in	ADP
iajs-3367	98	10	the	the	DET
iajs-3367	98	11	healthy	healthy	ADJ
iajs-3367	98	12	control	control	NOUN
iajs-3367	98	13	group	group	NOUN
iajs-3367	98	14	.	.	PUNCT
iajs-3367	99	1	a	a	DET
iajs-3367	99	2	previous	previous	ADJ
iajs-3367	99	3	study	study	NOUN
iajs-3367	99	4	showed	show	VERB
iajs-3367	99	5	no	no	DET
iajs-3367	99	6	significant	significant	ADJ
iajs-3367	99	7	differences	difference	NOUN
iajs-3367	99	8	in	in	ADP
iajs-3367	99	9	vitamin	vitamin	NOUN
iajs-3367	99	10	d	d	NOUN
iajs-3367	99	11	levels	level	NOUN
iajs-3367	99	12	between	between	ADP
iajs-3367	99	13	sle	sle	PROPN
iajs-3367	99	14	ihjpas	ihjpa	VERB
iajs-3367	99	15	.	.	PUNCT
iajs-3367	100	1	37	37	NUM
iajs-3367	100	2	(	(	PUNCT
iajs-3367	100	3	1	1	NUM
iajs-3367	100	4	)	)	PUNCT
iajs-3367	100	5	2024	2024	NUM
iajs-3367	100	6	13	13	NUM
iajs-3367	100	7	patients	patient	NOUN
iajs-3367	100	8	taking	take	VERB
iajs-3367	100	9	anti	anti	ADJ
iajs-3367	100	10	-	-	ADJ
iajs-3367	100	11	malarial	malarial	ADJ
iajs-3367	100	12	and	and	CCONJ
iajs-3367	100	13	corticosteroids	corticosteroid	NOUN
iajs-3367	100	14	and	and	CCONJ
iajs-3367	100	15	those	those	PRON
iajs-3367	100	16	who	who	PRON
iajs-3367	100	17	were	be	AUX
iajs-3367	100	18	not	not	PART
iajs-3367	100	19	taking	take	VERB
iajs-3367	100	20	them	they	PRON
iajs-3367	100	21	[	[	X
iajs-3367	100	22	37	37	NUM
iajs-3367	100	23	]	]	PUNCT
iajs-3367	100	24	.	.	PUNCT
iajs-3367	101	1	the	the	DET
iajs-3367	101	2	current	current	ADJ
iajs-3367	101	3	study	study	NOUN
iajs-3367	101	4	disagrees	disagree	VERB
iajs-3367	101	5	with	with	ADP
iajs-3367	101	6	previous	previous	ADJ
iajs-3367	101	7	studies	study	NOUN
iajs-3367	101	8	conducted	conduct	VERB
iajs-3367	101	9	by	by	ADP
iajs-3367	101	10	islam	islam	PROPN
iajs-3367	101	11	et	et	PROPN
iajs-3367	101	12	al	al	PROPN
iajs-3367	101	13	.	.	PUNCT
iajs-3367	102	1	[	[	X
iajs-3367	102	2	42	42	NUM
iajs-3367	102	3	]	]	PUNCT
iajs-3367	102	4	and	and	CCONJ
iajs-3367	102	5	attar	attar	PROPN
iajs-3367	102	6	et	et	PROPN
iajs-3367	102	7	al	al	PROPN
iajs-3367	102	8	.	.	PUNCT
iajs-3367	103	1	[	[	X
iajs-3367	103	2	43	43	NUM
iajs-3367	103	3	]	]	X
iajs-3367	103	4	,	,	PUNCT
iajs-3367	103	5	who	who	PRON
iajs-3367	103	6	discovered	discover	VERB
iajs-3367	103	7	a	a	DET
iajs-3367	103	8	link	link	NOUN
iajs-3367	103	9	between	between	ADP
iajs-3367	103	10	low	low	ADJ
iajs-3367	103	11	vitamin	vitamin	NOUN
iajs-3367	103	12	d	d	NOUN
iajs-3367	103	13	levels	level	NOUN
iajs-3367	103	14	in	in	ADP
iajs-3367	103	15	sle	sle	PROPN
iajs-3367	103	16	patients	patient	NOUN
iajs-3367	103	17	and	and	CCONJ
iajs-3367	103	18	healthy	healthy	ADJ
iajs-3367	103	19	individuals	individual	NOUN
iajs-3367	103	20	.	.	PUNCT
iajs-3367	104	1	a	a	DET
iajs-3367	104	2	study	study	NOUN
iajs-3367	104	3	performed	perform	VERB
iajs-3367	104	4	by	by	ADP
iajs-3367	104	5	stockton	stockton	PROPN
iajs-3367	104	6	did	do	AUX
iajs-3367	104	7	not	not	PART
iajs-3367	104	8	record	record	VERB
iajs-3367	104	9	a	a	DET
iajs-3367	104	10	difference	difference	NOUN
iajs-3367	104	11	between	between	ADP
iajs-3367	104	12	patients	patient	NOUN
iajs-3367	104	13	and	and	CCONJ
iajs-3367	104	14	controls	control	VERB
iajs-3367	104	15	[	[	X
iajs-3367	104	16	44	44	NUM
iajs-3367	104	17	]	]	PUNCT
iajs-3367	104	18	.	.	PUNCT
iajs-3367	105	1	it	it	PRON
iajs-3367	105	2	's	be	AUX
iajs-3367	105	3	possible	possible	ADJ
iajs-3367	105	4	that	that	SCONJ
iajs-3367	105	5	the	the	DET
iajs-3367	105	6	literature	literature	NOUN
iajs-3367	105	7	on	on	ADP
iajs-3367	105	8	sle	sle	PROPN
iajs-3367	105	9	exaggerated	exaggerate	VERB
iajs-3367	105	10	the	the	DET
iajs-3367	105	11	vitamin	vitamin	NOUN
iajs-3367	105	12	d	d	NOUN
iajs-3367	105	13	insufficiency	insufficiency	NOUN
iajs-3367	105	14	in	in	ADP
iajs-3367	105	15	lupus	lupus	NOUN
iajs-3367	105	16	because	because	SCONJ
iajs-3367	105	17	the	the	DET
iajs-3367	105	18	majority	majority	NOUN
iajs-3367	105	19	of	of	ADP
iajs-3367	105	20	research	research	NOUN
iajs-3367	105	21	included	include	VERB
iajs-3367	105	22	healthy	healthy	ADJ
iajs-3367	105	23	hospital	hospital	NOUN
iajs-3367	105	24	-	-	PUNCT
iajs-3367	105	25	based	base	VERB
iajs-3367	105	26	controls	control	NOUN
iajs-3367	105	27	.	.	PUNCT
iajs-3367	106	1	the	the	DET
iajs-3367	106	2	healthy	healthy	ADJ
iajs-3367	106	3	controls	control	NOUN
iajs-3367	106	4	might	might	AUX
iajs-3367	106	5	not	not	PART
iajs-3367	106	6	have	have	AUX
iajs-3367	106	7	represented	represent	VERB
iajs-3367	106	8	the	the	DET
iajs-3367	106	9	overall	overall	ADJ
iajs-3367	106	10	population	population	NOUN
iajs-3367	106	11	,	,	PUNCT
iajs-3367	106	12	and	and	CCONJ
iajs-3367	106	13	the	the	DET
iajs-3367	106	14	hospital	hospital	NOUN
iajs-3367	106	15	-	-	PUNCT
iajs-3367	106	16	based	base	VERB
iajs-3367	106	17	recruiting	recruiting	NOUN
iajs-3367	106	18	process	process	NOUN
iajs-3367	106	19	could	could	AUX
iajs-3367	106	20	have	have	AUX
iajs-3367	106	21	resulted	result	VERB
iajs-3367	106	22	in	in	ADP
iajs-3367	106	23	selection	selection	NOUN
iajs-3367	106	24	bias	bias	NOUN
iajs-3367	107	1	[	[	X
iajs-3367	107	2	45	45	NUM
iajs-3367	107	3	]	]	PUNCT
iajs-3367	107	4	.	.	PUNCT
iajs-3367	108	1	therefore	therefore	ADV
iajs-3367	108	2	,	,	PUNCT
iajs-3367	108	3	despite	despite	SCONJ
iajs-3367	108	4	the	the	DET
iajs-3367	108	5	widespread	widespread	ADJ
iajs-3367	108	6	belief	belief	NOUN
iajs-3367	108	7	that	that	SCONJ
iajs-3367	108	8	people	people	NOUN
iajs-3367	108	9	with	with	ADP
iajs-3367	108	10	sle	sle	PROPN
iajs-3367	108	11	have	have	AUX
iajs-3367	108	12	significantly	significantly	ADV
iajs-3367	108	13	lower	low	ADJ
iajs-3367	108	14	levels	level	NOUN
iajs-3367	108	15	of	of	ADP
iajs-3367	108	16	vitamin	vitamin	NOUN
iajs-3367	108	17	d	d	PROPN
iajs-3367	108	18	,	,	PUNCT
iajs-3367	108	19	differences	difference	NOUN
iajs-3367	108	20	in	in	ADP
iajs-3367	108	21	assay	assay	ADJ
iajs-3367	108	22	methods	method	NOUN
iajs-3367	108	23	,	,	PUNCT
iajs-3367	108	24	ethnicity	ethnicity	NOUN
iajs-3367	108	25	,	,	PUNCT
iajs-3367	108	26	cut	cut	NOUN
iajs-3367	108	27	-	-	PUNCT
iajs-3367	108	28	off	off	ADP
iajs-3367	108	29	values	value	NOUN
iajs-3367	108	30	,	,	PUNCT
iajs-3367	108	31	seasonality	seasonality	NOUN
iajs-3367	108	32	,	,	PUNCT
iajs-3367	108	33	latitude	latitude	NOUN
iajs-3367	108	34	,	,	PUNCT
iajs-3367	108	35	age	age	NOUN
iajs-3367	108	36	,	,	PUNCT
iajs-3367	108	37	disease	disease	NOUN
iajs-3367	108	38	duration	duration	NOUN
iajs-3367	108	39	,	,	PUNCT
iajs-3367	108	40	and	and	CCONJ
iajs-3367	108	41	sex	sex	NOUN
iajs-3367	108	42	all	all	PRON
iajs-3367	108	43	affect	affect	VERB
iajs-3367	108	44	the	the	DET
iajs-3367	108	45	frequency	frequency	NOUN
iajs-3367	108	46	of	of	ADP
iajs-3367	108	47	vitamin	vitamin	NOUN
iajs-3367	108	48	d	d	NOUN
iajs-3367	109	1	[	[	X
iajs-3367	109	2	46	46	NUM
iajs-3367	109	3	]	]	PUNCT
iajs-3367	109	4	,	,	PUNCT
iajs-3367	109	5	and	and	CCONJ
iajs-3367	109	6	may	may	AUX
iajs-3367	109	7	all	all	DET
iajs-3367	109	8	people	people	NOUN
iajs-3367	109	9	in	in	ADP
iajs-3367	109	10	the	the	DET
iajs-3367	109	11	same	same	ADJ
iajs-3367	109	12	society	society	NOUN
iajs-3367	109	13	have	have	VERB
iajs-3367	109	14	a	a	DET
iajs-3367	109	15	deficiency	deficiency	NOUN
iajs-3367	109	16	in	in	ADP
iajs-3367	109	17	vitamin	vitamin	NOUN
iajs-3367	109	18	d	d	NOUN
iajs-3367	109	19	level	level	NOUN
iajs-3367	109	20	.	.	PUNCT
iajs-3367	110	1	4.3	4.3	NUM
iajs-3367	110	2	.	.	PUNCT
iajs-3367	110	3	serum	serum	NOUN
iajs-3367	110	4	level	level	NOUN
iajs-3367	110	5	of	of	SCONJ
iajs-3367	110	6	rankl	rankl	VERB
iajs-3367	110	7	the	the	DET
iajs-3367	110	8	development	development	NOUN
iajs-3367	110	9	of	of	ADP
iajs-3367	110	10	rankl	rankl	NOUN
iajs-3367	110	11	assay	assay	PROPN
iajs-3367	110	12	has	have	AUX
iajs-3367	110	13	generated	generate	VERB
iajs-3367	110	14	significant	significant	ADJ
iajs-3367	110	15	interest	interest	NOUN
iajs-3367	110	16	in	in	ADP
iajs-3367	110	17	utilizing	utilize	VERB
iajs-3367	110	18	them	they	PRON
iajs-3367	110	19	as	as	ADP
iajs-3367	110	20	markers	marker	NOUN
iajs-3367	110	21	for	for	ADP
iajs-3367	110	22	metabolic	metabolic	NOUN
iajs-3367	110	23	bone	bone	NOUN
iajs-3367	110	24	diseases	disease	NOUN
iajs-3367	110	25	.	.	PUNCT
iajs-3367	111	1	nevertheless	nevertheless	ADV
iajs-3367	111	2	,	,	PUNCT
iajs-3367	111	3	it	it	PRON
iajs-3367	111	4	is	be	AUX
iajs-3367	111	5	worth	worth	ADJ
iajs-3367	111	6	noting	note	VERB
iajs-3367	111	7	that	that	SCONJ
iajs-3367	111	8	changes	change	NOUN
iajs-3367	111	9	at	at	ADP
iajs-3367	111	10	the	the	DET
iajs-3367	111	11	cellular	cellular	ADJ
iajs-3367	111	12	level	level	NOUN
iajs-3367	111	13	may	may	AUX
iajs-3367	111	14	not	not	PART
iajs-3367	111	15	necessarily	necessarily	ADV
iajs-3367	111	16	lead	lead	VERB
iajs-3367	111	17	to	to	ADP
iajs-3367	111	18	corresponding	correspond	VERB
iajs-3367	111	19	alterations	alteration	NOUN
iajs-3367	111	20	in	in	ADP
iajs-3367	111	21	serum	serum	NOUN
iajs-3367	111	22	levels	level	NOUN
iajs-3367	111	23	[	[	X
iajs-3367	111	24	47	47	NUM
iajs-3367	111	25	]	]	PUNCT
iajs-3367	111	26	.	.	PUNCT
iajs-3367	112	1	because	because	SCONJ
iajs-3367	112	2	most	most	ADJ
iajs-3367	112	3	rankl	rankl	VERB
iajs-3367	112	4	is	be	AUX
iajs-3367	112	5	membrane	membrane	NOUN
iajs-3367	112	6	bound	bind	VERB
iajs-3367	112	7	,	,	PUNCT
iajs-3367	112	8	studies	study	NOUN
iajs-3367	112	9	using	use	VERB
iajs-3367	112	10	serum	serum	NOUN
iajs-3367	112	11	rankl	rankl	NOUN
iajs-3367	112	12	can	can	AUX
iajs-3367	112	13	sometimes	sometimes	ADV
iajs-3367	112	14	be	be	AUX
iajs-3367	112	15	constrained	constrain	VERB
iajs-3367	112	16	by	by	ADP
iajs-3367	112	17	the	the	DET
iajs-3367	112	18	significant	significant	ADJ
iajs-3367	112	19	percentage	percentage	NOUN
iajs-3367	112	20	of	of	ADP
iajs-3367	112	21	individuals	individual	NOUN
iajs-3367	112	22	with	with	ADP
iajs-3367	112	23	undetectable	undetectable	ADJ
iajs-3367	112	24	circulating	circulating	NOUN
iajs-3367	112	25	[	[	X
iajs-3367	112	26	48	48	NUM
iajs-3367	112	27	]	]	PUNCT
iajs-3367	112	28	.	.	PUNCT
iajs-3367	113	1	therefore	therefore	ADV
iajs-3367	113	2	,	,	PUNCT
iajs-3367	113	3	maybe	maybe	ADV
iajs-3367	113	4	rankl	rankl	VERB
iajs-3367	113	5	is	be	AUX
iajs-3367	113	6	only	only	ADV
iajs-3367	113	7	detectable	detectable	ADJ
iajs-3367	113	8	in	in	ADP
iajs-3367	113	9	vivo	vivo	NOUN
iajs-3367	113	10	by	by	ADP
iajs-3367	113	11	flow	flow	NOUN
iajs-3367	113	12	cytometry	cytometry	NOUN
iajs-3367	113	13	following	follow	VERB
iajs-3367	113	14	bone	bone	NOUN
iajs-3367	113	15	biopsy	biopsy	NOUN
iajs-3367	113	16	[	[	X
iajs-3367	113	17	49	49	NUM
iajs-3367	113	18	]	]	PUNCT
iajs-3367	113	19	.	.	PUNCT
iajs-3367	114	1	in	in	ADP
iajs-3367	114	2	humans	human	NOUN
iajs-3367	114	3	,	,	PUNCT
iajs-3367	114	4	this	this	DET
iajs-3367	114	5	technique	technique	NOUN
iajs-3367	114	6	is	be	AUX
iajs-3367	114	7	very	very	ADV
iajs-3367	114	8	impractical	impractical	ADJ
iajs-3367	114	9	[	[	X
iajs-3367	114	10	47	47	NUM
iajs-3367	114	11	]	]	PUNCT
iajs-3367	114	12	.	.	PUNCT
iajs-3367	115	1	because	because	SCONJ
iajs-3367	115	2	only	only	ADV
iajs-3367	115	3	a	a	DET
iajs-3367	115	4	tiny	tiny	ADJ
iajs-3367	115	5	amount	amount	NOUN
iajs-3367	115	6	of	of	ADP
iajs-3367	115	7	serum	serum	NOUN
iajs-3367	115	8	rankl	rankl	NOUN
iajs-3367	115	9	may	may	AUX
iajs-3367	115	10	enter	enter	VERB
iajs-3367	115	11	the	the	DET
iajs-3367	115	12	systemic	systemic	ADJ
iajs-3367	115	13	circulation	circulation	NOUN
iajs-3367	115	14	and	and	CCONJ
iajs-3367	115	15	because	because	SCONJ
iajs-3367	115	16	some	some	PRON
iajs-3367	115	17	of	of	ADP
iajs-3367	115	18	the	the	DET
iajs-3367	115	19	serum	serum	NOUN
iajs-3367	115	20	rankl	rankl	NOUN
iajs-3367	115	21	concentrations	concentration	NOUN
iajs-3367	115	22	may	may	AUX
iajs-3367	115	23	come	come	VERB
iajs-3367	115	24	from	from	ADP
iajs-3367	115	25	nonskeletal	nonskeletal	ADJ
iajs-3367	115	26	sources	source	NOUN
iajs-3367	115	27	,	,	PUNCT
iajs-3367	115	28	serum	serum	NOUN
iajs-3367	115	29	rankl	rankl	PROPN
iajs-3367	115	30	may	may	AUX
iajs-3367	115	31	not	not	PART
iajs-3367	115	32	accurately	accurately	ADV
iajs-3367	115	33	reflect	reflect	VERB
iajs-3367	115	34	its	its	PRON
iajs-3367	115	35	level	level	NOUN
iajs-3367	115	36	in	in	ADP
iajs-3367	115	37	the	the	DET
iajs-3367	115	38	bone	bone	NOUN
iajs-3367	115	39	microenvironment	microenvironment	NOUN
iajs-3367	115	40	[	[	X
iajs-3367	115	41	50	50	NUM
iajs-3367	115	42	]	]	PUNCT
iajs-3367	115	43	,	,	PUNCT
iajs-3367	115	44	and	and	CCONJ
iajs-3367	115	45	this	this	PRON
iajs-3367	115	46	may	may	AUX
iajs-3367	115	47	explain	explain	VERB
iajs-3367	115	48	why	why	SCONJ
iajs-3367	115	49	the	the	DET
iajs-3367	115	50	current	current	ADJ
iajs-3367	115	51	result	result	NOUN
iajs-3367	115	52	did	do	AUX
iajs-3367	115	53	not	not	PART
iajs-3367	115	54	record	record	VERB
iajs-3367	115	55	a	a	DET
iajs-3367	115	56	significancy	significancy	NOUN
iajs-3367	115	57	in	in	ADP
iajs-3367	115	58	serum	serum	NOUN
iajs-3367	115	59	level	level	NOUN
iajs-3367	115	60	of	of	ADP
iajs-3367	115	61	sle	sle	PROPN
iajs-3367	115	62	patients	patient	NOUN
iajs-3367	115	63	compared	compare	VERB
iajs-3367	115	64	to	to	ADP
iajs-3367	115	65	healthy	healthy	ADJ
iajs-3367	115	66	individuals	individual	NOUN
iajs-3367	115	67	.	.	PUNCT
iajs-3367	116	1	the	the	DET
iajs-3367	116	2	current	current	ADJ
iajs-3367	116	3	study	study	NOUN
iajs-3367	116	4	disagrees	disagree	VERB
iajs-3367	116	5	with	with	ADP
iajs-3367	116	6	previous	previous	ADJ
iajs-3367	116	7	studies	study	NOUN
iajs-3367	116	8	done	do	VERB
iajs-3367	116	9	by	by	ADP
iajs-3367	116	10	hao	hao	PROPN
iajs-3367	116	11	et	et	PROPN
iajs-3367	116	12	al	al	PROPN
iajs-3367	116	13	.	.	PROPN
iajs-3367	116	14	,	,	PUNCT
iajs-3367	117	1	[	[	X
iajs-3367	117	2	51	51	NUM
iajs-3367	117	3	]	]	PUNCT
iajs-3367	117	4	and	and	CCONJ
iajs-3367	117	5	ali	ali	PROPN
iajs-3367	117	6	et	et	PROPN
iajs-3367	117	7	al	al	PROPN
iajs-3367	117	8	.	.	PROPN
iajs-3367	117	9	,	,	PUNCT
iajs-3367	118	1	[	[	X
iajs-3367	118	2	52	52	NUM
iajs-3367	118	3	]	]	PUNCT
iajs-3367	118	4	who	who	PRON
iajs-3367	118	5	showed	show	VERB
iajs-3367	118	6	that	that	SCONJ
iajs-3367	118	7	rankl	rankl	NOUN
iajs-3367	118	8	was	be	AUX
iajs-3367	118	9	significantly	significantly	ADV
iajs-3367	118	10	higher	high	ADJ
iajs-3367	118	11	in	in	ADP
iajs-3367	118	12	children	child	NOUN
iajs-3367	118	13	with	with	ADP
iajs-3367	118	14	sle	sle	PROPN
iajs-3367	118	15	.	.	PUNCT
iajs-3367	119	1	another	another	DET
iajs-3367	119	2	study	study	NOUN
iajs-3367	119	3	done	do	VERB
iajs-3367	119	4	by	by	ADP
iajs-3367	119	5	sandal	sandal	NOUN
iajs-3367	119	6	et	et	PROPN
iajs-3367	119	7	al	al	PROPN
iajs-3367	119	8	.	.	PROPN
iajs-3367	119	9	,	,	PUNCT
iajs-3367	120	1	[	[	X
iajs-3367	120	2	53	53	NUM
iajs-3367	120	3	]	]	PUNCT
iajs-3367	120	4	on	on	ADP
iajs-3367	120	5	children	child	NOUN
iajs-3367	120	6	with	with	ADP
iajs-3367	120	7	sle	sle	PROPN
iajs-3367	120	8	found	find	VERB
iajs-3367	120	9	that	that	PRON
iajs-3367	120	10	rankl	rankl	VERB
iajs-3367	120	11	levels	level	NOUN
iajs-3367	120	12	were	be	AUX
iajs-3367	120	13	unrelated	unrelated	ADJ
iajs-3367	120	14	to	to	ADP
iajs-3367	120	15	disease	disease	NOUN
iajs-3367	120	16	activity	activity	NOUN
iajs-3367	120	17	.	.	PUNCT
iajs-3367	121	1	the	the	DET
iajs-3367	121	2	current	current	ADJ
iajs-3367	121	3	study	study	NOUN
iajs-3367	121	4	agrees	agree	VERB
iajs-3367	121	5	with	with	ADP
iajs-3367	121	6	a	a	DET
iajs-3367	121	7	previous	previous	ADJ
iajs-3367	121	8	study	study	NOUN
iajs-3367	121	9	conducted	conduct	VERB
iajs-3367	121	10	by	by	ADP
iajs-3367	121	11	carmona	carmona	PROPN
iajs-3367	121	12	-	-	PUNCT
iajs-3367	121	13	fernandes	fernandes	PROPN
iajs-3367	121	14	et	et	PROPN
iajs-3367	121	15	al	al	PROPN
iajs-3367	121	16	.	.	PROPN
iajs-3367	121	17	,	,	PUNCT
iajs-3367	122	1	[	[	X
iajs-3367	122	2	48	48	NUM
iajs-3367	122	3	]	]	PUNCT
iajs-3367	122	4	who	who	PRON
iajs-3367	122	5	found	find	VERB
iajs-3367	122	6	srankl	srankl	NOUN
iajs-3367	122	7	levels	level	NOUN
iajs-3367	122	8	to	to	PART
iajs-3367	122	9	be	be	AUX
iajs-3367	122	10	similar	similar	ADJ
iajs-3367	122	11	between	between	ADP
iajs-3367	122	12	sle	sle	PROPN
iajs-3367	122	13	and	and	CCONJ
iajs-3367	122	14	healthy	healthy	ADJ
iajs-3367	122	15	control	control	NOUN
iajs-3367	122	16	women	woman	NOUN
iajs-3367	122	17	.	.	PUNCT
iajs-3367	123	1	the	the	DET
iajs-3367	123	2	reason	reason	NOUN
iajs-3367	123	3	for	for	ADP
iajs-3367	123	4	the	the	DET
iajs-3367	123	5	discrepancy	discrepancy	NOUN
iajs-3367	123	6	in	in	ADP
iajs-3367	123	7	the	the	DET
iajs-3367	123	8	results	result	NOUN
iajs-3367	123	9	of	of	ADP
iajs-3367	123	10	different	different	ADJ
iajs-3367	123	11	studies	study	NOUN
iajs-3367	123	12	may	may	AUX
iajs-3367	123	13	be	be	AUX
iajs-3367	123	14	attributed	attribute	VERB
iajs-3367	123	15	to	to	ADP
iajs-3367	123	16	the	the	DET
iajs-3367	123	17	many	many	ADJ
iajs-3367	123	18	factors	factor	NOUN
iajs-3367	123	19	that	that	PRON
iajs-3367	123	20	influence	influence	VERB
iajs-3367	123	21	these	these	DET
iajs-3367	123	22	measurements	measurement	NOUN
iajs-3367	123	23	,	,	PUNCT
iajs-3367	123	24	such	such	ADJ
iajs-3367	123	25	as	as	ADP
iajs-3367	123	26	differing	differ	VERB
iajs-3367	123	27	designs	design	NOUN
iajs-3367	123	28	and	and	CCONJ
iajs-3367	123	29	methodologies	methodology	NOUN
iajs-3367	123	30	.	.	PUNCT
iajs-3367	124	1	4.4	4.4	NUM
iajs-3367	124	2	.	.	PUNCT
iajs-3367	124	3	serum	serum	NOUN
iajs-3367	124	4	level	level	NOUN
iajs-3367	124	5	of	of	ADP
iajs-3367	124	6	sclerostin	sclerostin	NOUN
iajs-3367	124	7	in	in	ADP
iajs-3367	124	8	various	various	ADJ
iajs-3367	124	9	autoimmune	autoimmune	ADJ
iajs-3367	124	10	diseases	disease	NOUN
iajs-3367	124	11	,	,	PUNCT
iajs-3367	124	12	sclerostin	sclerostin	ADJ
iajs-3367	124	13	levels	level	NOUN
iajs-3367	124	14	seem	seem	VERB
iajs-3367	124	15	to	to	PART
iajs-3367	124	16	have	have	VERB
iajs-3367	124	17	a	a	DET
iajs-3367	124	18	heterogeneous	heterogeneous	ADJ
iajs-3367	124	19	pattern	pattern	NOUN
iajs-3367	124	20	[	[	X
iajs-3367	124	21	54	54	NUM
iajs-3367	124	22	]	]	PUNCT
iajs-3367	124	23	.	.	PUNCT
iajs-3367	125	1	a	a	DET
iajs-3367	125	2	previous	previous	ADJ
iajs-3367	125	3	study	study	NOUN
iajs-3367	125	4	conducted	conduct	VERB
iajs-3367	125	5	on	on	ADP
iajs-3367	125	6	rheumatoid	rheumatoid	NOUN
iajs-3367	125	7	arthritis	arthritis	NOUN
iajs-3367	125	8	(	(	PUNCT
iajs-3367	125	9	ra	ra	NOUN
iajs-3367	125	10	)	)	PUNCT
iajs-3367	125	11	patients	patient	NOUN
iajs-3367	125	12	attributed	attribute	VERB
iajs-3367	125	13	the	the	DET
iajs-3367	125	14	reason	reason	NOUN
iajs-3367	125	15	why	why	SCONJ
iajs-3367	125	16	serum	serum	NOUN
iajs-3367	125	17	sclerostin	sclerostin	ADJ
iajs-3367	125	18	levels	level	NOUN
iajs-3367	125	19	did	do	AUX
iajs-3367	125	20	not	not	PART
iajs-3367	125	21	increase	increase	VERB
iajs-3367	125	22	in	in	ADP
iajs-3367	125	23	those	those	DET
iajs-3367	125	24	patients	patient	NOUN
iajs-3367	125	25	to	to	ADP
iajs-3367	125	26	the	the	DET
iajs-3367	125	27	fact	fact	NOUN
iajs-3367	125	28	that	that	SCONJ
iajs-3367	125	29	increased	increase	VERB
iajs-3367	125	30	osteocyte	osteocyte	NOUN
iajs-3367	125	31	death	death	NOUN
iajs-3367	125	32	in	in	ADP
iajs-3367	125	33	bone	bone	NOUN
iajs-3367	125	34	samples	sample	NOUN
iajs-3367	125	35	from	from	ADP
iajs-3367	125	36	ra	ra	PROPN
iajs-3367	125	37	patients	patient	NOUN
iajs-3367	125	38	may	may	AUX
iajs-3367	125	39	decrease	decrease	VERB
iajs-3367	125	40	sclerostin	sclerostin	ADJ
iajs-3367	125	41	synthesis	synthesis	NOUN
iajs-3367	125	42	and	and	CCONJ
iajs-3367	125	43	release	release	NOUN
iajs-3367	125	44	from	from	ADP
iajs-3367	125	45	osteocytes	osteocyte	NOUN
iajs-3367	125	46	into	into	ADP
iajs-3367	125	47	their	their	PRON
iajs-3367	125	48	circulation	circulation	NOUN
iajs-3367	125	49	[	[	X
iajs-3367	125	50	55	55	NUM
iajs-3367	125	51	]	]	PUNCT
iajs-3367	125	52	.	.	PUNCT
iajs-3367	126	1	also	also	ADV
iajs-3367	126	2	,	,	PUNCT
iajs-3367	126	3	sclerostin	sclerostin	ADJ
iajs-3367	126	4	serum	serum	NOUN
iajs-3367	126	5	levels	level	NOUN
iajs-3367	126	6	may	may	AUX
iajs-3367	126	7	not	not	PART
iajs-3367	126	8	reflect	reflect	VERB
iajs-3367	126	9	its	its	PRON
iajs-3367	126	10	tissue	tissue	NOUN
iajs-3367	126	11	concentration	concentration	NOUN
iajs-3367	126	12	or	or	CCONJ
iajs-3367	126	13	reflect	reflect	VERB
iajs-3367	126	14	changes	change	NOUN
iajs-3367	126	15	in	in	ADP
iajs-3367	126	16	the	the	DET
iajs-3367	126	17	microenvironment	microenvironment	NOUN
iajs-3367	126	18	of	of	ADP
iajs-3367	126	19	the	the	DET
iajs-3367	126	20	joints	joint	NOUN
iajs-3367	126	21	[	[	X
iajs-3367	126	22	56	56	NUM
iajs-3367	126	23	]	]	PUNCT
iajs-3367	126	24	.	.	PUNCT
iajs-3367	127	1	and	and	CCONJ
iajs-3367	127	2	this	this	PRON
iajs-3367	127	3	maybe	maybe	ADV
iajs-3367	127	4	explains	explain	VERB
iajs-3367	127	5	why	why	SCONJ
iajs-3367	127	6	the	the	DET
iajs-3367	127	7	current	current	ADJ
iajs-3367	127	8	study	study	NOUN
iajs-3367	127	9	did	do	AUX
iajs-3367	127	10	not	not	PART
iajs-3367	127	11	record	record	VERB
iajs-3367	127	12	a	a	DET
iajs-3367	127	13	significant	significant	ADJ
iajs-3367	127	14	difference	difference	NOUN
iajs-3367	127	15	in	in	ADP
iajs-3367	127	16	the	the	DET
iajs-3367	127	17	sclerostin	sclerostin	ADJ
iajs-3367	127	18	serum	serum	NOUN
iajs-3367	127	19	level	level	NOUN
iajs-3367	127	20	of	of	ADP
iajs-3367	127	21	sle	sle	PROPN
iajs-3367	127	22	patients	patient	NOUN
iajs-3367	127	23	compared	compare	VERB
iajs-3367	127	24	to	to	ADP
iajs-3367	127	25	healthy	healthy	ADJ
iajs-3367	127	26	individuals	individual	NOUN
iajs-3367	127	27	.	.	PUNCT
iajs-3367	128	1	the	the	DET
iajs-3367	128	2	current	current	ADJ
iajs-3367	128	3	study	study	NOUN
iajs-3367	128	4	agrees	agree	VERB
iajs-3367	128	5	with	with	ADP
iajs-3367	128	6	previous	previous	ADJ
iajs-3367	128	7	studies	study	NOUN
iajs-3367	128	8	done	do	VERB
iajs-3367	128	9	by	by	ADP
iajs-3367	128	10	[	[	X
iajs-3367	128	11	57	57	NUM
iajs-3367	128	12	]	]	PUNCT
iajs-3367	128	13	and	and	CCONJ
iajs-3367	128	14	[	[	X
iajs-3367	128	15	58	58	NUM
iajs-3367	128	16	]	]	PUNCT
iajs-3367	128	17	,	,	PUNCT
iajs-3367	128	18	who	who	PRON
iajs-3367	128	19	observed	observe	VERB
iajs-3367	128	20	that	that	SCONJ
iajs-3367	128	21	sclerostin	sclerostin	ADJ
iajs-3367	128	22	levels	level	NOUN
iajs-3367	128	23	found	find	VERB
iajs-3367	128	24	in	in	ADP
iajs-3367	128	25	sle	sle	PROPN
iajs-3367	128	26	patients	patient	NOUN
iajs-3367	128	27	were	be	AUX
iajs-3367	128	28	comparable	comparable	ADJ
iajs-3367	128	29	to	to	ADP
iajs-3367	128	30	those	those	PRON
iajs-3367	128	31	found	find	VERB
iajs-3367	128	32	in	in	ADP
iajs-3367	128	33	healthy	healthy	ADJ
iajs-3367	128	34	individuals	individual	NOUN
iajs-3367	128	35	.	.	PUNCT
iajs-3367	129	1	the	the	DET
iajs-3367	129	2	current	current	ADJ
iajs-3367	129	3	study	study	NOUN
iajs-3367	129	4	disagrees	disagree	VERB
iajs-3367	129	5	with	with	ADP
iajs-3367	129	6	the	the	DET
iajs-3367	129	7	study	study	NOUN
iajs-3367	129	8	done	do	VERB
iajs-3367	129	9	by	by	ADP
iajs-3367	129	10	[	[	X
iajs-3367	129	11	59	59	NUM
iajs-3367	129	12	]	]	PUNCT
iajs-3367	129	13	,	,	PUNCT
iajs-3367	129	14	who	who	PRON
iajs-3367	129	15	recorded	record	VERB
iajs-3367	129	16	a	a	DET
iajs-3367	129	17	decrease	decrease	NOUN
iajs-3367	129	18	in	in	ADP
iajs-3367	129	19	ihjpas	ihjpas	PROPN
iajs-3367	129	20	.	.	PUNCT
iajs-3367	130	1	37	37	NUM
iajs-3367	130	2	(	(	PUNCT
iajs-3367	130	3	1	1	NUM
iajs-3367	130	4	)	)	PUNCT
iajs-3367	130	5	2024	2024	NUM
iajs-3367	130	6	14	14	NUM
iajs-3367	130	7	serum	serum	NOUN
iajs-3367	130	8	levels	level	NOUN
iajs-3367	130	9	of	of	ADP
iajs-3367	130	10	sclerostin	sclerostin	NOUN
iajs-3367	130	11	in	in	ADP
iajs-3367	130	12	sle	sle	PROPN
iajs-3367	130	13	,	,	PUNCT
iajs-3367	130	14	and	and	CCONJ
iajs-3367	130	15	also	also	ADV
iajs-3367	130	16	disagrees	disagree	VERB
iajs-3367	130	17	with	with	ADP
iajs-3367	130	18	[	[	X
iajs-3367	130	19	29	29	NUM
iajs-3367	130	20	]	]	PUNCT
iajs-3367	130	21	,	,	PUNCT
iajs-3367	130	22	who	who	PRON
iajs-3367	130	23	reported	report	VERB
iajs-3367	130	24	a	a	DET
iajs-3367	130	25	high	high	ADJ
iajs-3367	130	26	sclerostin	sclerostin	ADJ
iajs-3367	130	27	level	level	NOUN
iajs-3367	130	28	in	in	ADP
iajs-3367	130	29	sle	sle	PROPN
iajs-3367	130	30	patients	patient	NOUN
iajs-3367	130	31	compared	compare	VERB
iajs-3367	130	32	to	to	ADP
iajs-3367	130	33	healthy	healthy	ADJ
iajs-3367	130	34	controls	control	NOUN
iajs-3367	130	35	.	.	PUNCT
iajs-3367	131	1	the	the	DET
iajs-3367	131	2	reason	reason	NOUN
iajs-3367	131	3	for	for	ADP
iajs-3367	131	4	the	the	DET
iajs-3367	131	5	disparity	disparity	NOUN
iajs-3367	131	6	in	in	ADP
iajs-3367	131	7	the	the	DET
iajs-3367	131	8	results	result	NOUN
iajs-3367	131	9	of	of	ADP
iajs-3367	131	10	different	different	ADJ
iajs-3367	131	11	studies	study	NOUN
iajs-3367	131	12	may	may	AUX
iajs-3367	131	13	be	be	AUX
iajs-3367	131	14	attributed	attribute	VERB
iajs-3367	131	15	to	to	ADP
iajs-3367	131	16	the	the	DET
iajs-3367	131	17	many	many	ADJ
iajs-3367	131	18	factors	factor	NOUN
iajs-3367	131	19	that	that	PRON
iajs-3367	131	20	influence	influence	VERB
iajs-3367	131	21	these	these	DET
iajs-3367	131	22	measurements	measurement	NOUN
iajs-3367	131	23	,	,	PUNCT
iajs-3367	131	24	such	such	ADJ
iajs-3367	131	25	as	as	ADP
iajs-3367	131	26	the	the	DET
iajs-3367	131	27	number	number	NOUN
iajs-3367	131	28	of	of	ADP
iajs-3367	131	29	samples	sample	NOUN
iajs-3367	131	30	or	or	CCONJ
iajs-3367	131	31	the	the	DET
iajs-3367	131	32	examination	examination	NOUN
iajs-3367	131	33	method	method	NOUN
iajs-3367	131	34	.	.	PUNCT
iajs-3367	132	1	5	5	X
iajs-3367	132	2	.	.	X
iajs-3367	132	3	conclusions	conclusion	NOUN
iajs-3367	132	4	based	base	VERB
iajs-3367	132	5	on	on	ADP
iajs-3367	132	6	our	our	PRON
iajs-3367	132	7	findings	finding	NOUN
iajs-3367	132	8	,	,	PUNCT
iajs-3367	132	9	pd-1	pd-1	ADV
iajs-3367	132	10	may	may	AUX
iajs-3367	132	11	be	be	AUX
iajs-3367	132	12	considered	consider	VERB
iajs-3367	132	13	a	a	DET
iajs-3367	132	14	good	good	ADJ
iajs-3367	132	15	therapeutic	therapeutic	ADJ
iajs-3367	132	16	target	target	NOUN
iajs-3367	132	17	for	for	ADP
iajs-3367	132	18	sle	sle	PROPN
iajs-3367	132	19	,	,	PUNCT
iajs-3367	132	20	and	and	CCONJ
iajs-3367	132	21	the	the	DET
iajs-3367	132	22	level	level	NOUN
iajs-3367	132	23	of	of	ADP
iajs-3367	132	24	vitamin	vitamin	NOUN
iajs-3367	132	25	d	d	NOUN
iajs-3367	132	26	must	must	AUX
iajs-3367	132	27	be	be	AUX
iajs-3367	132	28	at	at	ADP
iajs-3367	132	29	a	a	DET
iajs-3367	132	30	sufficient	sufficient	ADJ
iajs-3367	132	31	level	level	NOUN
iajs-3367	132	32	,	,	PUNCT
iajs-3367	132	33	especially	especially	ADV
iajs-3367	132	34	in	in	ADP
iajs-3367	132	35	sle	sle	PROPN
iajs-3367	132	36	patients	patient	NOUN
iajs-3367	132	37	.	.	PUNCT
iajs-3367	133	1	acknowledgment	acknowledgment	NOUN
iajs-3367	133	2	many	many	ADJ
iajs-3367	133	3	thanks	thank	NOUN
iajs-3367	133	4	to	to	ADP
iajs-3367	133	5	the	the	DET
iajs-3367	133	6	department	department	NOUN
iajs-3367	133	7	of	of	ADP
iajs-3367	133	8	biology	biology	NOUN
iajs-3367	133	9	,	,	PUNCT
iajs-3367	133	10	college	college	NOUN
iajs-3367	133	11	of	of	ADP
iajs-3367	133	12	education	education	NOUN
iajs-3367	133	13	for	for	ADP
iajs-3367	133	14	pure	pure	ADJ
iajs-3367	133	15	sciences	science	NOUN
iajs-3367	133	16	,	,	PUNCT
iajs-3367	133	17	ibn	ibn	PROPN
iajs-3367	133	18	-	-	PUNCT
iajs-3367	133	19	al	al	PROPN
iajs-3367	133	20	haitham	haitham	PROPN
iajs-3367	133	21	,	,	PUNCT
iajs-3367	133	22	university	university	NOUN
iajs-3367	133	23	of	of	ADP
iajs-3367	133	24	baghdad	baghdad	PROPN
iajs-3367	133	25	for	for	ADP
iajs-3367	133	26	facilitating	facilitate	VERB
iajs-3367	133	27	the	the	DET
iajs-3367	133	28	work	work	NOUN
iajs-3367	133	29	of	of	ADP
iajs-3367	133	30	the	the	DET
iajs-3367	133	31	practice	practice	NOUN
iajs-3367	133	32	parts	part	NOUN
iajs-3367	133	33	in	in	ADP
iajs-3367	133	34	this	this	DET
iajs-3367	133	35	article	article	NOUN
iajs-3367	133	36	.	.	PUNCT
iajs-3367	134	1	conflict	conflict	NOUN
iajs-3367	134	2	of	of	ADP
iajs-3367	134	3	interest	interest	NOUN
iajs-3367	134	4	there	there	PRON
iajs-3367	134	5	are	be	VERB
iajs-3367	134	6	no	no	DET
iajs-3367	134	7	conflicts	conflict	NOUN
iajs-3367	134	8	of	of	ADP
iajs-3367	134	9	interest	interest	NOUN
iajs-3367	134	10	.	.	PUNCT
iajs-3367	135	1	funding	funding	NOUN
iajs-3367	135	2	there	there	PRON
iajs-3367	135	3	is	be	VERB
iajs-3367	135	4	no	no	DET
iajs-3367	135	5	funding	funding	NOUN
iajs-3367	135	6	for	for	ADP
iajs-3367	135	7	the	the	DET
iajs-3367	135	8	article	article	NOUN
iajs-3367	135	9	.	.	PUNCT
iajs-3367	136	1	ethical	ethical	ADJ
iajs-3367	136	2	clearance	clearance	NOUN
iajs-3367	136	3	the	the	DET
iajs-3367	136	4	samples	sample	NOUN
iajs-3367	136	5	were	be	AUX
iajs-3367	136	6	gained	gain	VERB
iajs-3367	136	7	according	accord	VERB
iajs-3367	136	8	to	to	ADP
iajs-3367	136	9	local	local	ADJ
iajs-3367	136	10	research	research	NOUN
iajs-3367	136	11	ethics	ethic	NOUN
iajs-3367	136	12	committee	committee	PROPN
iajs-3367	136	13	approval	approval	NOUN
iajs-3367	136	14	in	in	ADP
iajs-3367	136	15	iraqi	iraqi	ADJ
iajs-3367	136	16	ministry	ministry	PROPN
iajs-3367	136	17	of	of	ADP
iajs-3367	136	18	health	health	PROPN
iajs-3367	136	19	no	no	PROPN
iajs-3367	136	20	.	.	PROPN
iajs-3367	136	21	3616	3616	NUM
iajs-3367	136	22	in	in	ADP
iajs-3367	136	23	24/1/2022	24/1/2022	NOUN
iajs-3367	136	24	.	.	PUNCT
iajs-3367	137	1	references	reference	NOUN
iajs-3367	137	2	1	1	NUM
iajs-3367	137	3	.	.	PUNCT
iajs-3367	138	1	kamil	kamil	PROPN
iajs-3367	138	2	,	,	PUNCT
iajs-3367	138	3	m.a	m.a	PROPN
iajs-3367	138	4	.	.	PROPN
iajs-3367	138	5	;	;	PUNCT
iajs-3367	138	6	kadr	kadr	PROPN
iajs-3367	138	7	,	,	PUNCT
iajs-3367	138	8	z.h.m	z.h.m	PROPN
iajs-3367	138	9	.	.	PUNCT
iajs-3367	138	10	;	;	PUNCT
iajs-3367	138	11	alabassi	alabassi	ADV
iajs-3367	138	12	,	,	PUNCT
iajs-3367	138	13	h.m	h.m	PROPN
iajs-3367	138	14	.	.	PROPN
iajs-3367	138	15	role	role	NOUN
iajs-3367	138	16	of	of	ADP
iajs-3367	138	17	cxcl9	cxcl9	NOUN
iajs-3367	138	18	-	-	PUNCT
iajs-3367	138	19	cxcr3	cxcr3	NOUN
iajs-3367	138	20	axis	axis	NOUN
iajs-3367	138	21	,	,	PUNCT
iajs-3367	138	22	ana	ana	PROPN
iajs-3367	138	23	&	&	CCONJ
iajs-3367	138	24	ds	ds	PROPN
iajs-3367	138	25	-	-	PUNCT
iajs-3367	138	26	dna	dna	NOUN
iajs-3367	138	27	abs	ab	NOUN
iajs-3367	138	28	in	in	ADP
iajs-3367	138	29	pathogenicity	pathogenicity	NOUN
iajs-3367	138	30	of	of	ADP
iajs-3367	138	31	sle	sle	PROPN
iajs-3367	138	32	in	in	ADP
iajs-3367	138	33	iraqi	iraqi	ADJ
iajs-3367	138	34	patients	patient	NOUN
iajs-3367	138	35	.	.	PUNCT
iajs-3367	139	1	pak	pak	PROPN
iajs-3367	139	2	.	.	PUNCT
iajs-3367	140	1	j.	j.	PROPN
iajs-3367	140	2	med	med	PROPN
iajs-3367	140	3	.	.	PUNCT
iajs-3367	141	1	health	health	PROPN
iajs-3367	141	2	sci	sci	PROPN
iajs-3367	141	3	.	.	PROPN
iajs-3367	141	4	,	,	PUNCT
iajs-3367	141	5	2022	2022	NUM
iajs-3367	141	6	;	;	PUNCT
iajs-3367	141	7	16	16	NUM
iajs-3367	141	8	,	,	PUNCT
iajs-3367	141	9	04	04	NUM
iajs-3367	141	10	,	,	PUNCT
iajs-3367	141	11	398398	398398	NUM
iajs-3367	141	12	.	.	PUNCT
iajs-3367	142	1	2	2	X
iajs-3367	142	2	.	.	X
iajs-3367	142	3	abbas	abbas	PROPN
iajs-3367	142	4	,	,	PUNCT
iajs-3367	142	5	a.h	a.h	PROPN
iajs-3367	142	6	.	.	PROPN
iajs-3367	142	7	;	;	PUNCT
iajs-3367	142	8	melconian	melconian	PROPN
iajs-3367	142	9	,	,	PUNCT
iajs-3367	142	10	a.k	a.k	PROPN
iajs-3367	142	11	.	.	PROPN
iajs-3367	142	12	;	;	PUNCT
iajs-3367	142	13	ad’hiah	ad’hiah	PROPN
iajs-3367	142	14	,	,	PUNCT
iajs-3367	142	15	a.h	a.h	PROPN
iajs-3367	142	16	.	.	PROPN
iajs-3367	142	17	detection	detection	NOUN
iajs-3367	142	18	of	of	ADP
iajs-3367	142	19	anti	anti	ADJ
iajs-3367	142	20	-	-	ADJ
iajs-3367	142	21	cytomegalovirus	cytomegalovirus	NOUN
iajs-3367	142	22	antibodies	antibodie	VERB
iajs-3367	142	23	in	in	ADP
iajs-3367	142	24	sera	sera	NOUN
iajs-3367	142	25	of	of	ADP
iajs-3367	142	26	iraqi	iraqi	ADJ
iajs-3367	142	27	systemic	systemic	ADJ
iajs-3367	142	28	lupus	lupus	PROPN
iajs-3367	142	29	erythematosus	erythematosus	NOUN
iajs-3367	142	30	women	woman	NOUN
iajs-3367	142	31	patients	patient	NOUN
iajs-3367	142	32	.	.	PUNCT
iajs-3367	143	1	iraqi	iraqi	ADJ
iajs-3367	143	2	j.	j.	PROPN
iajs-3367	143	3	sci	sci	PROPN
iajs-3367	143	4	.	.	PROPN
iajs-3367	143	5	,	,	PUNCT
iajs-3367	143	6	2016	2016	NUM
iajs-3367	143	7	;	;	PUNCT
iajs-3367	143	8	317	317	NUM
iajs-3367	143	9	-	-	SYM
iajs-3367	143	10	320	320	NUM
iajs-3367	143	11	.	.	PUNCT
iajs-3367	144	1	3	3	NUM
iajs-3367	144	2	.	.	X
iajs-3367	144	3	ibrahim	ibrahim	PROPN
iajs-3367	144	4	,	,	PUNCT
iajs-3367	144	5	n.k	n.k	PROPN
iajs-3367	144	6	.	.	PUNCT
iajs-3367	144	7	;	;	PUNCT
iajs-3367	144	8	ghudhaib	ghudhaib	NOUN
iajs-3367	144	9	,	,	PUNCT
iajs-3367	144	10	k.k	k.k	PROPN
iajs-3367	144	11	.	.	PROPN
iajs-3367	144	12	;	;	PUNCT
iajs-3367	144	13	allawi	allawi	ADJ
iajs-3367	144	14	,	,	PUNCT
iajs-3367	144	15	a.a.d	a.a.d	PROPN
iajs-3367	144	16	.	.	PUNCT
iajs-3367	144	17	;	;	PUNCT
iajs-3367	144	18	hammoudi	hammoudi	PROPN
iajs-3367	144	19	,	,	PUNCT
iajs-3367	144	20	f.a	f.a	PROPN
iajs-3367	144	21	.	.	PROPN
iajs-3367	144	22	evaluation	evaluation	NOUN
iajs-3367	144	23	of	of	ADP
iajs-3367	144	24	he4	he4	NOUN
iajs-3367	144	25	and	and	CCONJ
iajs-3367	144	26	igfbps	igfbps	NOUN
iajs-3367	144	27	as	as	ADP
iajs-3367	144	28	novel	novel	ADJ
iajs-3367	144	29	biomarkers	biomarker	NOUN
iajs-3367	144	30	of	of	ADP
iajs-3367	144	31	systemic	systemic	ADJ
iajs-3367	144	32	lupus	lupus	NOUN
iajs-3367	144	33	erythematosus	erythematosus	NOUN
iajs-3367	144	34	with	with	ADP
iajs-3367	144	35	lupus	lupus	PROPN
iajs-3367	144	36	nephritis	nephritis	PROPN
iajs-3367	144	37	.	.	PUNCT
iajs-3367	145	1	indian	indian	PROPN
iajs-3367	145	2	j.	j.	PROPN
iajs-3367	145	3	forensic	forensic	PROPN
iajs-3367	145	4	med	med	PROPN
iajs-3367	145	5	.	.	PUNCT
iajs-3367	146	1	toxicol	toxicol	PROPN
iajs-3367	146	2	.	.	PUNCT
iajs-3367	146	3	,	,	PUNCT
iajs-3367	146	4	2020	2020	NUM
iajs-3367	146	5	;	;	PUNCT
iajs-3367	146	6	14	14	NUM
iajs-3367	146	7	,	,	PUNCT
iajs-3367	146	8	4124	4124	NUM
iajs-3367	146	9	-	-	SYM
iajs-3367	146	10	4130	4130	NUM
iajs-3367	146	11	.	.	PUNCT
iajs-3367	147	1	4	4	X
iajs-3367	147	2	.	.	X
iajs-3367	147	3	gorial	gorial	ADJ
iajs-3367	147	4	,	,	PUNCT
iajs-3367	147	5	f.i	f.i	PROPN
iajs-3367	147	6	.	.	PROPN
iajs-3367	147	7	;	;	PUNCT
iajs-3367	148	1	mahmood	mahmood	PROPN
iajs-3367	148	2	,	,	PUNCT
iajs-3367	148	3	z.a	z.a	PROPN
iajs-3367	148	4	.	.	PROPN
iajs-3367	148	5	;	;	PUNCT
iajs-3367	148	6	al	al	PROPN
iajs-3367	148	7	obaidi	obaidi	PROPN
iajs-3367	148	8	,	,	PUNCT
iajs-3367	148	9	s.	s.	PROPN
iajs-3367	148	10	body	body	PROPN
iajs-3367	148	11	composition	composition	NOUN
iajs-3367	148	12	in	in	ADP
iajs-3367	148	13	iraqi	iraqi	ADJ
iajs-3367	148	14	women	woman	NOUN
iajs-3367	148	15	with	with	ADP
iajs-3367	148	16	systemic	systemic	ADJ
iajs-3367	148	17	lupus	lupus	PROPN
iajs-3367	148	18	erythematosus	erythematosus	PROPN
iajs-3367	148	19	.	.	PUNCT
iajs-3367	149	1	glob	glob	PROPN
iajs-3367	149	2	.	.	PUNCT
iajs-3367	150	1	j.	j.	PROPN
iajs-3367	150	2	health	health	PROPN
iajs-3367	150	3	sci	sci	PROPN
iajs-3367	150	4	,	,	PUNCT
iajs-3367	150	5	2019	2019	NUM
iajs-3367	150	6	;	;	PUNCT
iajs-3367	150	7	11	11	NUM
iajs-3367	150	8	,	,	PUNCT
iajs-3367	150	9	63	63	NUM
iajs-3367	150	10	-	-	SYM
iajs-3367	150	11	70	70	NUM
iajs-3367	150	12	.	.	PUNCT
iajs-3367	151	1	5	5	NUM
iajs-3367	151	2	.	.	X
iajs-3367	151	3	ali	ali	PROPN
iajs-3367	151	4	,	,	PUNCT
iajs-3367	151	5	n.s.m	n.s.m	PROPN
iajs-3367	151	6	.	.	PROPN
iajs-3367	151	7	;	;	PUNCT
iajs-3367	151	8	zaidan	zaidan	PROPN
iajs-3367	151	9	,	,	PUNCT
iajs-3367	151	10	t.f	t.f	PROPN
iajs-3367	151	11	.	.	NOUN
iajs-3367	151	12	oral	oral	ADJ
iajs-3367	151	13	manifestations	manifestation	NOUN
iajs-3367	151	14	,	,	PUNCT
iajs-3367	151	15	oral	oral	ADJ
iajs-3367	151	16	health	health	NOUN
iajs-3367	151	17	status	status	NOUN
iajs-3367	151	18	and	and	CCONJ
iajs-3367	151	19	saliva	saliva	NOUN
iajs-3367	151	20	composition	composition	NOUN
iajs-3367	151	21	changes	change	NOUN
iajs-3367	151	22	in	in	ADP
iajs-3367	151	23	a	a	DET
iajs-3367	151	24	sample	sample	NOUN
iajs-3367	151	25	of	of	ADP
iajs-3367	151	26	iraqi	iraqi	ADJ
iajs-3367	151	27	systemic	systemic	ADJ
iajs-3367	151	28	lupus	lupus	PROPN
iajs-3367	151	29	erythematosus	erythematosus	PROPN
iajs-3367	151	30	patients	patient	NOUN
iajs-3367	151	31	.	.	PUNCT
iajs-3367	152	1	j.	j.	PROPN
iajs-3367	152	2	baghdad	baghdad	PROPN
iajs-3367	152	3	coll	coll	PROPN
iajs-3367	152	4	.	.	PUNCT
iajs-3367	153	1	dent	dent	PROPN
iajs-3367	153	2	.	.	PUNCT
iajs-3367	153	3	,	,	PUNCT
iajs-3367	153	4	2012	2012	NUM
iajs-3367	153	5	;	;	PUNCT
iajs-3367	153	6	24	24	NUM
iajs-3367	153	7	,	,	PUNCT
iajs-3367	153	8	65	65	NUM
iajs-3367	153	9	.	.	NOUN
iajs-3367	153	10	6	6	NUM
iajs-3367	153	11	.	.	X
iajs-3367	154	1	nasir	nasir	PROPN
iajs-3367	154	2	,	,	PUNCT
iajs-3367	154	3	h.a	h.a	PROPN
iajs-3367	154	4	.	.	PROPN
iajs-3367	154	5	;	;	PUNCT
iajs-3367	154	6	sharba	sharba	NOUN
iajs-3367	154	7	,	,	PUNCT
iajs-3367	154	8	y.f	y.f	PROPN
iajs-3367	154	9	.	.	PUNCT
iajs-3367	154	10	;	;	PUNCT
iajs-3367	154	11	nasir	nasir	PROPN
iajs-3367	154	12	,	,	PUNCT
iajs-3367	154	13	n.a	n.a	PROPN
iajs-3367	154	14	.	.	PROPN
iajs-3367	154	15	lupus	lupus	PROPN
iajs-3367	154	16	nephritis	nephritis	PROPN
iajs-3367	154	17	,	,	PUNCT
iajs-3367	154	18	the	the	DET
iajs-3367	154	19	therapy	therapy	NOUN
iajs-3367	154	20	and	and	CCONJ
iajs-3367	154	21	the	the	DET
iajs-3367	154	22	role	role	NOUN
iajs-3367	154	23	of	of	ADP
iajs-3367	154	24	rituximab	rituximab	NOUN
iajs-3367	154	25	in	in	ADP
iajs-3367	154	26	resistant	resistant	ADJ
iajs-3367	154	27	cases	case	NOUN
iajs-3367	154	28	.	.	PUNCT
iajs-3367	155	1	j.	j.	PROPN
iajs-3367	155	2	fac	fac	PROPN
iajs-3367	155	3	.	.	PROPN
iajs-3367	155	4	med	med	PROPN
iajs-3367	155	5	.	.	PUNCT
iajs-3367	156	1	baghdad	baghdad	PROPN
iajs-3367	156	2	,	,	PUNCT
iajs-3367	156	3	2013	2013	NUM
iajs-3367	156	4	;	;	PUNCT
iajs-3367	156	5	55	55	NUM
iajs-3367	156	6	,	,	PUNCT
iajs-3367	156	7	327	327	NUM
iajs-3367	156	8	-	-	SYM
iajs-3367	156	9	332	332	NUM
iajs-3367	156	10	.	.	PUNCT
iajs-3367	157	1	7	7	X
iajs-3367	157	2	.	.	X
iajs-3367	157	3	abdulridha	abdulridha	PROPN
iajs-3367	157	4	,	,	PUNCT
iajs-3367	157	5	r.h	r.h	PROPN
iajs-3367	157	6	.	.	PROPN
iajs-3367	157	7	,	,	PUNCT
iajs-3367	157	8	saud	saud	PROPN
iajs-3367	157	9	,	,	PUNCT
iajs-3367	157	10	a.m.	a.m.	ADV
iajs-3367	157	11	;	;	PUNCT
iajs-3367	157	12	alosami	alosami	PROPN
iajs-3367	157	13	,	,	PUNCT
iajs-3367	157	14	m.h	m.h	PROPN
iajs-3367	157	15	.	.	PROPN
iajs-3367	157	16	assessment	assessment	NOUN
iajs-3367	157	17	of	of	ADP
iajs-3367	157	18	mir-146a	mir-146a	ADJ
iajs-3367	157	19	gene	gene	NOUN
iajs-3367	157	20	polymorphisms	polymorphism	NOUN
iajs-3367	157	21	in	in	ADP
iajs-3367	157	22	patients	patient	NOUN
iajs-3367	157	23	with	with	ADP
iajs-3367	157	24	systemic	systemic	ADJ
iajs-3367	157	25	lupus	lupus	PROPN
iajs-3367	157	26	erythematosus	erythematosus	PROPN
iajs-3367	157	27	.	.	PUNCT
iajs-3367	158	1	iraqi	iraqi	ADJ
iajs-3367	158	2	j.	j.	PROPN
iajs-3367	158	3	sci	sci	PROPN
iajs-3367	158	4	.	.	PROPN
iajs-3367	158	5	,	,	PUNCT
iajs-3367	158	6	2023	2023	NUM
iajs-3367	158	7	;	;	PUNCT
iajs-3367	158	8	573	573	NUM
iajs-3367	158	9	-	-	SYM
iajs-3367	158	10	582	582	NUM
iajs-3367	158	11	.	.	NOUN
iajs-3367	158	12	8	8	NUM
iajs-3367	158	13	.	.	X
iajs-3367	158	14	fife	fife	PROPN
iajs-3367	158	15	,	,	PUNCT
iajs-3367	158	16	b.t	b.t	PROPN
iajs-3367	158	17	.	.	PROPN
iajs-3367	158	18	;	;	PUNCT
iajs-3367	158	19	pauken	pauken	PROPN
iajs-3367	158	20	,	,	PUNCT
iajs-3367	158	21	k.e	k.e	PROPN
iajs-3367	158	22	.	.	PUNCT
iajs-3367	159	1	the	the	DET
iajs-3367	159	2	role	role	NOUN
iajs-3367	159	3	of	of	ADP
iajs-3367	159	4	the	the	DET
iajs-3367	159	5	pd‐1	pd‐1	NOUN
iajs-3367	159	6	pathway	pathway	NOUN
iajs-3367	159	7	in	in	ADP
iajs-3367	159	8	autoimmunity	autoimmunity	NOUN
iajs-3367	159	9	and	and	CCONJ
iajs-3367	159	10	peripheral	peripheral	ADJ
iajs-3367	159	11	tolerance	tolerance	NOUN
iajs-3367	159	12	.	.	PUNCT
iajs-3367	160	1	ann	ann	PROPN
iajs-3367	160	2	.	.	PUNCT
iajs-3367	160	3	n.	n.	PROPN
iajs-3367	160	4	y.	y.	PROPN
iajs-3367	160	5	acad	acad	PROPN
iajs-3367	160	6	.	.	PUNCT
iajs-3367	161	1	sci	sci	PROPN
iajs-3367	161	2	.	.	PROPN
iajs-3367	161	3	,	,	PUNCT
iajs-3367	161	4	2011;1217	2011;1217	NUM
iajs-3367	161	5	,	,	PUNCT
iajs-3367	161	6	45	45	NUM
iajs-3367	161	7	-	-	SYM
iajs-3367	161	8	59	59	NUM
iajs-3367	161	9	.	.	PUNCT
iajs-3367	162	1	ihjpas	ihjpas	PROPN
iajs-3367	162	2	.	.	PUNCT
iajs-3367	163	1	37	37	NUM
iajs-3367	163	2	(	(	PUNCT
iajs-3367	163	3	1	1	NUM
iajs-3367	163	4	)	)	PUNCT
iajs-3367	163	5	2024	2024	NUM
iajs-3367	163	6	15	15	NUM
iajs-3367	163	7	9	9	NUM
iajs-3367	163	8	.	.	PUNCT
iajs-3367	163	9	jubel	jubel	NOUN
iajs-3367	163	10	,	,	PUNCT
iajs-3367	163	11	j.m	j.m	PROPN
iajs-3367	163	12	.	.	PROPN
iajs-3367	163	13	;	;	PUNCT
iajs-3367	163	14	barbati	barbati	PROPN
iajs-3367	163	15	,	,	PUNCT
iajs-3367	163	16	z.r	z.r	PROPN
iajs-3367	163	17	.	.	PROPN
iajs-3367	163	18	;	;	PUNCT
iajs-3367	163	19	burger	burger	NOUN
iajs-3367	163	20	,	,	PUNCT
iajs-3367	163	21	c.	c.	PROPN
iajs-3367	163	22	;	;	PUNCT
iajs-3367	163	23	wirtz	wirtz	PROPN
iajs-3367	163	24	,	,	PUNCT
iajs-3367	163	25	d.c	d.c	PROPN
iajs-3367	163	26	.	.	PROPN
iajs-3367	163	27	;	;	PUNCT
iajs-3367	163	28	schildberg	schildberg	PROPN
iajs-3367	163	29	,	,	PUNCT
iajs-3367	163	30	f.a	f.a	PROPN
iajs-3367	163	31	.	.	PUNCT
iajs-3367	164	1	the	the	DET
iajs-3367	164	2	role	role	NOUN
iajs-3367	164	3	of	of	ADP
iajs-3367	164	4	pd-1	pd-1	ADJ
iajs-3367	164	5	in	in	ADP
iajs-3367	164	6	acute	acute	ADJ
iajs-3367	164	7	and	and	CCONJ
iajs-3367	164	8	chronic	chronic	ADJ
iajs-3367	164	9	infection	infection	NOUN
iajs-3367	164	10	.	.	PUNCT
iajs-3367	165	1	front	front	NOUN
iajs-3367	165	2	.	.	PUNCT
iajs-3367	166	1	immunol	immunol	NOUN
iajs-3367	166	2	.	.	PUNCT
iajs-3367	166	3	,	,	PUNCT
iajs-3367	166	4	2020	2020	NUM
iajs-3367	166	5	;	;	PUNCT
iajs-3367	166	6	11	11	NUM
iajs-3367	166	7	,	,	PUNCT
iajs-3367	166	8	487	487	NUM
iajs-3367	166	9	.	.	NOUN
iajs-3367	166	10	10	10	NUM
iajs-3367	166	11	.	.	PUNCT
iajs-3367	167	1	lee	lee	PROPN
iajs-3367	167	2	,	,	PUNCT
iajs-3367	167	3	y.h	y.h	PROPN
iajs-3367	167	4	.	.	PROPN
iajs-3367	167	5	;	;	PUNCT
iajs-3367	167	6	woo	woo	PROPN
iajs-3367	167	7	,	,	PUNCT
iajs-3367	167	8	j.h	j.h	PROPN
iajs-3367	167	9	.	.	PROPN
iajs-3367	167	10	;	;	PUNCT
iajs-3367	167	11	choi	choi	NOUN
iajs-3367	167	12	,	,	PUNCT
iajs-3367	167	13	s.j	s.j	PROPN
iajs-3367	167	14	.	.	PROPN
iajs-3367	167	15	;	;	PUNCT
iajs-3367	168	1	ji	ji	PROPN
iajs-3367	168	2	,	,	PUNCT
iajs-3367	168	3	j.d	j.d	PROPN
iajs-3367	168	4	.	.	PROPN
iajs-3367	168	5	;	;	PUNCT
iajs-3367	168	6	song	song	PROPN
iajs-3367	168	7	,	,	PUNCT
iajs-3367	168	8	g.g	g.g	PROPN
iajs-3367	168	9	.	.	PROPN
iajs-3367	168	10	association	association	NOUN
iajs-3367	168	11	of	of	ADP
iajs-3367	168	12	programmed	program	VERB
iajs-3367	168	13	cell	cell	NOUN
iajs-3367	168	14	death	death	NOUN
iajs-3367	168	15	1	1	NUM
iajs-3367	168	16	polymorphisms	polymorphism	NOUN
iajs-3367	168	17	and	and	CCONJ
iajs-3367	168	18	systemic	systemic	ADJ
iajs-3367	168	19	lupus	lupus	PROPN
iajs-3367	168	20	erythematosus	erythematosus	PROPN
iajs-3367	168	21	:	:	PUNCT
iajs-3367	168	22	a	a	DET
iajs-3367	168	23	meta	meta	ADJ
iajs-3367	168	24	-	-	PUNCT
iajs-3367	168	25	analysis	analysis	NOUN
iajs-3367	168	26	.	.	PUNCT
iajs-3367	169	1	lupus	lupus	NOUN
iajs-3367	169	2	,	,	PUNCT
iajs-3367	169	3	2009	2009	NUM
iajs-3367	169	4	;	;	PUNCT
iajs-3367	169	5	18	18	NUM
iajs-3367	169	6	,	,	PUNCT
iajs-3367	169	7	9	9	NUM
iajs-3367	169	8	-	-	SYM
iajs-3367	169	9	15	15	NUM
iajs-3367	169	10	.	.	PUNCT
iajs-3367	169	11	11	11	NUM
iajs-3367	169	12	.	.	X
iajs-3367	170	1	curran	curran	NOUN
iajs-3367	170	2	,	,	PUNCT
iajs-3367	170	3	c.s	c.s	PROPN
iajs-3367	170	4	.	.	PROPN
iajs-3367	170	5	;	;	PUNCT
iajs-3367	170	6	gupta	gupta	PROPN
iajs-3367	170	7	,	,	PUNCT
iajs-3367	170	8	s.	s.	PROPN
iajs-3367	170	9	;	;	PUNCT
iajs-3367	170	10	sanz	sanz	PROPN
iajs-3367	170	11	,	,	PUNCT
iajs-3367	170	12	i.	i.	PROPN
iajs-3367	170	13	;	;	PUNCT
iajs-3367	170	14	sharon	sharon	PROPN
iajs-3367	170	15	,	,	PUNCT
iajs-3367	170	16	e.	e.	PROPN
iajs-3367	170	17	pd-1	pd-1	ADP
iajs-3367	170	18	immunobiology	immunobiology	NOUN
iajs-3367	170	19	in	in	ADP
iajs-3367	170	20	systemic	systemic	ADJ
iajs-3367	170	21	lupus	lupus	PROPN
iajs-3367	170	22	erythematosus	erythematosus	PROPN
iajs-3367	170	23	.	.	PUNCT
iajs-3367	171	1	j.	j.	PROPN
iajs-3367	171	2	autoimmun	autoimmun	PROPN
iajs-3367	171	3	.	.	PROPN
iajs-3367	171	4	,	,	PUNCT
iajs-3367	171	5	2019	2019	NUM
iajs-3367	171	6	,	,	PUNCT
iajs-3367	171	7	97	97	NUM
iajs-3367	171	8	,	,	PUNCT
iajs-3367	171	9	1	1	NUM
iajs-3367	171	10	-	-	SYM
iajs-3367	171	11	9	9	NUM
iajs-3367	171	12	.	.	NOUN
iajs-3367	171	13	12	12	NUM
iajs-3367	171	14	.	.	PUNCT
iajs-3367	172	1	michot	michot	ADJ
iajs-3367	172	2	,	,	PUNCT
iajs-3367	172	3	j.m	j.m	PROPN
iajs-3367	172	4	.	.	PROPN
iajs-3367	172	5	;	;	PUNCT
iajs-3367	172	6	bigenwald	bigenwald	PROPN
iajs-3367	172	7	,	,	PUNCT
iajs-3367	172	8	c.	c.	PROPN
iajs-3367	172	9	;	;	PUNCT
iajs-3367	172	10	champiat	champiat	PROPN
iajs-3367	172	11	,	,	PUNCT
iajs-3367	172	12	s.	s.	PROPN
iajs-3367	172	13	;	;	PUNCT
iajs-3367	172	14	collins	collins	PROPN
iajs-3367	172	15	,	,	PUNCT
iajs-3367	172	16	m.	m.	NOUN
iajs-3367	172	17	;	;	PUNCT
iajs-3367	172	18	carbonnel	carbonnel	PROPN
iajs-3367	172	19	,	,	PUNCT
iajs-3367	172	20	f.	f.	PROPN
iajs-3367	172	21	;	;	PUNCT
iajs-3367	172	22	postel	postel	PROPN
iajs-3367	172	23	-	-	PUNCT
iajs-3367	172	24	vinay	vinay	PROPN
iajs-3367	172	25	,	,	PUNCT
iajs-3367	172	26	s.	s.	PROPN
iajs-3367	172	27	;	;	PUNCT
iajs-3367	172	28	berdelou	berdelou	PROPN
iajs-3367	172	29	,	,	PUNCT
iajs-3367	172	30	a.	a.	PROPN
iajs-3367	172	31	;	;	PUNCT
iajs-3367	172	32	varga	varga	PROPN
iajs-3367	172	33	,	,	PUNCT
iajs-3367	172	34	a.	a.	PROPN
iajs-3367	172	35	;	;	PUNCT
iajs-3367	172	36	bahleda	bahleda	PROPN
iajs-3367	172	37	,	,	PUNCT
iajs-3367	172	38	r.	r.	PROPN
iajs-3367	172	39	;	;	PUNCT
iajs-3367	172	40	hollebecque	hollebecque	ADJ
iajs-3367	172	41	,	,	PUNCT
iajs-3367	172	42	a.	a.	NOUN
iajs-3367	172	43	;	;	PUNCT
iajs-3367	172	44	massard	massard	NOUN
iajs-3367	172	45	,	,	PUNCT
iajs-3367	172	46	c.	c.	PROPN
iajs-3367	172	47	immune	immune	NOUN
iajs-3367	172	48	-	-	PUNCT
iajs-3367	172	49	related	relate	VERB
iajs-3367	172	50	adverse	adverse	ADJ
iajs-3367	172	51	events	event	NOUN
iajs-3367	172	52	with	with	ADP
iajs-3367	172	53	immune	immune	ADJ
iajs-3367	172	54	checkpoint	checkpoint	NOUN
iajs-3367	172	55	blockade	blockade	NOUN
iajs-3367	172	56	:	:	PUNCT
iajs-3367	172	57	a	a	DET
iajs-3367	172	58	comprehensive	comprehensive	ADJ
iajs-3367	172	59	review	review	NOUN
iajs-3367	172	60	.	.	PUNCT
iajs-3367	173	1	eur	eur	PROPN
iajs-3367	173	2	.	.	PUNCT
iajs-3367	174	1	j.	j.	PROPN
iajs-3367	174	2	cancer	cancer	PROPN
iajs-3367	174	3	,	,	PUNCT
iajs-3367	174	4	2016	2016	NUM
iajs-3367	174	5	;	;	PUNCT
iajs-3367	174	6	54	54	NUM
iajs-3367	174	7	,	,	PUNCT
iajs-3367	174	8	139	139	NUM
iajs-3367	174	9	-	-	SYM
iajs-3367	174	10	148	148	NUM
iajs-3367	174	11	.	.	PUNCT
iajs-3367	175	1	13	13	NUM
iajs-3367	175	2	.	.	PUNCT
iajs-3367	176	1	kuhn	kuhn	PROPN
iajs-3367	176	2	,	,	PUNCT
iajs-3367	176	3	a.	a.	PROPN
iajs-3367	176	4	;	;	PUNCT
iajs-3367	176	5	bonsmann	bonsmann	PROPN
iajs-3367	176	6	,	,	PUNCT
iajs-3367	176	7	g.	g.	PROPN
iajs-3367	176	8	;	;	PUNCT
iajs-3367	176	9	anders	ander	NOUN
iajs-3367	176	10	,	,	PUNCT
iajs-3367	176	11	h.j	h.j	PROPN
iajs-3367	176	12	.	.	PROPN
iajs-3367	176	13	;	;	PUNCT
iajs-3367	176	14	herzer	herzer	NOUN
iajs-3367	176	15	,	,	PUNCT
iajs-3367	176	16	p.	p.	NOUN
iajs-3367	176	17	;	;	PUNCT
iajs-3367	176	18	tenbrock	tenbrock	NOUN
iajs-3367	176	19	,	,	PUNCT
iajs-3367	176	20	k.	k.	PROPN
iajs-3367	176	21	;	;	PUNCT
iajs-3367	176	22	schneider	schneider	PROPN
iajs-3367	176	23	,	,	PUNCT
iajs-3367	176	24	m.	m.	VERB
iajs-3367	176	25	the	the	DET
iajs-3367	176	26	diagnosis	diagnosis	NOUN
iajs-3367	176	27	and	and	CCONJ
iajs-3367	176	28	treatment	treatment	NOUN
iajs-3367	176	29	of	of	ADP
iajs-3367	176	30	systemic	systemic	ADJ
iajs-3367	176	31	lupus	lupus	PROPN
iajs-3367	176	32	erythematosus	erythematosus	PROPN
iajs-3367	176	33	.	.	PUNCT
iajs-3367	177	1	dtsch	dtsch	PROPN
iajs-3367	177	2	.	.	PUNCT
iajs-3367	178	1	arztebl	arztebl	INTJ
iajs-3367	178	2	.	.	PUNCT
iajs-3367	179	1	int	int	NOUN
iajs-3367	179	2	.	.	PUNCT
iajs-3367	179	3	,	,	PUNCT
iajs-3367	179	4	2015	2015	NUM
iajs-3367	179	5	,	,	PUNCT
iajs-3367	179	6	112	112	NUM
iajs-3367	179	7	,	,	PUNCT
iajs-3367	179	8	423	423	NUM
iajs-3367	179	9	.	.	NOUN
iajs-3367	180	1	14	14	NUM
iajs-3367	180	2	.	.	PUNCT
iajs-3367	181	1	alves	alve	NOUN
iajs-3367	181	2	,	,	PUNCT
iajs-3367	181	3	m.	m.	NOUN
iajs-3367	181	4	;	;	PUNCT
iajs-3367	181	5	bastos	basto	NOUN
iajs-3367	181	6	,	,	PUNCT
iajs-3367	181	7	m.	m.	NOUN
iajs-3367	181	8	;	;	PUNCT
iajs-3367	181	9	leitão	leitão	PROPN
iajs-3367	181	10	,	,	PUNCT
iajs-3367	181	11	f.	f.	PROPN
iajs-3367	181	12	;	;	PUNCT
iajs-3367	181	13	marques	marques	PROPN
iajs-3367	181	14	,	,	PUNCT
iajs-3367	181	15	g.	g.	PROPN
iajs-3367	181	16	;	;	PUNCT
iajs-3367	181	17	ribeiro	ribeiro	PROPN
iajs-3367	181	18	,	,	PUNCT
iajs-3367	181	19	g.	g.	PROPN
iajs-3367	181	20	;	;	PUNCT
iajs-3367	181	21	carrilho	carrilho	PROPN
iajs-3367	181	22	,	,	PUNCT
iajs-3367	181	23	f.	f.	PROPN
iajs-3367	181	24	vitamina	vitamina	PROPN
iajs-3367	181	25	d	d	PROPN
iajs-3367	181	26	–	–	PUNCT
iajs-3367	181	27	importância	importância	PROPN
iajs-3367	181	28	da	da	PROPN
iajs-3367	181	29	avaliação	avaliação	PROPN
iajs-3367	181	30	laboratorial	laboratorial	PROPN
iajs-3367	181	31	.	.	PUNCT
iajs-3367	182	1	rev	rev	PROPN
iajs-3367	182	2	.	.	PROPN
iajs-3367	182	3	port	port	PROPN
iajs-3367	182	4	.	.	PUNCT
iajs-3367	183	1	endocrinol	endocrinol	NOUN
iajs-3367	183	2	.	.	PUNCT
iajs-3367	184	1	diabetes	diabetes	NOUN
iajs-3367	184	2	metabol	metabol	NOUN
iajs-3367	184	3	.	.	PUNCT
iajs-3367	184	4	,	,	PUNCT
iajs-3367	184	5	2013	2013	NUM
iajs-3367	184	6	,	,	PUNCT
iajs-3367	184	7	8	8	NUM
iajs-3367	184	8	,	,	PUNCT
iajs-3367	184	9	3239	3239	NUM
iajs-3367	184	10	.	.	PUNCT
iajs-3367	185	1	15	15	NUM
iajs-3367	185	2	.	.	PUNCT
iajs-3367	186	1	abo	abo	NOUN
iajs-3367	186	2	-	-	PUNCT
iajs-3367	186	3	shanab	shanab	NOUN
iajs-3367	186	4	,	,	PUNCT
iajs-3367	186	5	a.m.	a.m.	ADV
iajs-3367	186	6	;	;	PUNCT
iajs-3367	186	7	kholoussi	kholoussi	PROPN
iajs-3367	186	8	,	,	PUNCT
iajs-3367	186	9	s.	s.	PROPN
iajs-3367	186	10	;	;	PUNCT
iajs-3367	186	11	kandil	kandil	PROPN
iajs-3367	186	12	,	,	PUNCT
iajs-3367	186	13	r.	r.	PROPN
iajs-3367	186	14	;	;	PUNCT
iajs-3367	186	15	dorgham	dorgham	PROPN
iajs-3367	186	16	,	,	PUNCT
iajs-3367	186	17	d.	d.	PROPN
iajs-3367	186	18	cytokines	cytokine	NOUN
iajs-3367	186	19	,	,	PUNCT
iajs-3367	186	20	25	25	NUM
iajs-3367	186	21	-	-	SYM
iajs-3367	186	22	oh	oh	NUM
iajs-3367	186	23	vit	vit	NOUN
iajs-3367	186	24	d	d	NOUN
iajs-3367	186	25	and	and	CCONJ
iajs-3367	186	26	disease	disease	NOUN
iajs-3367	186	27	activity	activity	NOUN
iajs-3367	186	28	in	in	ADP
iajs-3367	186	29	patients	patient	NOUN
iajs-3367	186	30	with	with	ADP
iajs-3367	186	31	juvenile	juvenile	ADJ
iajs-3367	186	32	-	-	PUNCT
iajs-3367	186	33	onset	onset	NOUN
iajs-3367	186	34	systemic	systemic	ADJ
iajs-3367	186	35	lupus	lupus	PROPN
iajs-3367	186	36	erythematosus	erythematosus	PROPN
iajs-3367	186	37	.	.	PUNCT
iajs-3367	187	1	lupus	lupus	NOUN
iajs-3367	187	2	,	,	PUNCT
iajs-3367	187	3	2021	2021	NUM
iajs-3367	187	4	,	,	PUNCT
iajs-3367	187	5	30	30	NUM
iajs-3367	187	6	,	,	PUNCT
iajs-3367	187	7	459	459	NUM
iajs-3367	187	8	-	-	SYM
iajs-3367	187	9	464	464	NUM
iajs-3367	187	10	.	.	PUNCT
iajs-3367	188	1	16	16	NUM
iajs-3367	188	2	.	.	PUNCT
iajs-3367	189	1	hassanalilou	hassanalilou	ADJ
iajs-3367	189	2	,	,	PUNCT
iajs-3367	189	3	t.	t.	PROPN
iajs-3367	189	4	;	;	PUNCT
iajs-3367	189	5	khalili	khalili	PROPN
iajs-3367	189	6	,	,	PUNCT
iajs-3367	189	7	l.	l.	PROPN
iajs-3367	189	8	;	;	PUNCT
iajs-3367	189	9	ghavamzadeh	ghavamzadeh	PROPN
iajs-3367	189	10	,	,	PUNCT
iajs-3367	189	11	s.	s.	PROPN
iajs-3367	189	12	;	;	PUNCT
iajs-3367	189	13	shokri	shokri	PROPN
iajs-3367	189	14	,	,	PUNCT
iajs-3367	189	15	a.	a.	NOUN
iajs-3367	189	16	;	;	PUNCT
iajs-3367	189	17	payahoo	payahoo	PROPN
iajs-3367	189	18	,	,	PUNCT
iajs-3367	189	19	l.	l.	PROPN
iajs-3367	189	20	;	;	PUNCT
iajs-3367	189	21	bishak	bishak	PROPN
iajs-3367	189	22	,	,	PUNCT
iajs-3367	189	23	y.k	y.k	PROPN
iajs-3367	189	24	.	.	PROPN
iajs-3367	189	25	role	role	NOUN
iajs-3367	189	26	of	of	ADP
iajs-3367	189	27	vitamin	vitamin	NOUN
iajs-3367	189	28	d	d	NOUN
iajs-3367	189	29	deficiency	deficiency	NOUN
iajs-3367	189	30	in	in	ADP
iajs-3367	189	31	systemic	systemic	ADJ
iajs-3367	189	32	lupus	lupus	NOUN
iajs-3367	189	33	erythematosus	erythematosus	NOUN
iajs-3367	189	34	incidence	incidence	NOUN
iajs-3367	189	35	and	and	CCONJ
iajs-3367	189	36	aggravation	aggravation	NOUN
iajs-3367	189	37	.	.	PUNCT
iajs-3367	190	1	autoimmun	autoimmun	ADJ
iajs-3367	190	2	.	.	PUNCT
iajs-3367	191	1	highlights	highlight	NOUN
iajs-3367	191	2	,	,	PUNCT
iajs-3367	191	3	2018	2018	NUM
iajs-3367	191	4	,	,	PUNCT
iajs-3367	191	5	9	9	NUM
iajs-3367	191	6	,	,	PUNCT
iajs-3367	191	7	1	1	NUM
iajs-3367	191	8	-	-	SYM
iajs-3367	191	9	10	10	NUM
iajs-3367	191	10	.	.	PUNCT
iajs-3367	192	1	17	17	NUM
iajs-3367	192	2	.	.	X
iajs-3367	192	3	bultink	bultink	NOUN
iajs-3367	192	4	,	,	PUNCT
iajs-3367	192	5	i.e.	i.e.	X
iajs-3367	192	6	;	;	PUNCT
iajs-3367	192	7	lems	lem	NOUN
iajs-3367	192	8	,	,	PUNCT
iajs-3367	192	9	w.f	w.f	PROPN
iajs-3367	192	10	.	.	PROPN
iajs-3367	192	11	systemic	systemic	ADJ
iajs-3367	192	12	lupus	lupus	PROPN
iajs-3367	192	13	erythematosus	erythematosus	NOUN
iajs-3367	192	14	and	and	CCONJ
iajs-3367	192	15	fractures	fracture	NOUN
iajs-3367	192	16	.	.	PUNCT
iajs-3367	193	1	rmd	rmd	PROPN
iajs-3367	193	2	open	open	PROPN
iajs-3367	193	3	,	,	PUNCT
iajs-3367	193	4	2015	2015	NUM
iajs-3367	193	5	,	,	PUNCT
iajs-3367	193	6	1	1	NUM
iajs-3367	193	7	,	,	PUNCT
iajs-3367	193	8	e000069	e000069	NOUN
iajs-3367	193	9	.	.	NOUN
iajs-3367	193	10	18	18	NUM
iajs-3367	193	11	.	.	X
iajs-3367	194	1	bultink	bultink	NOUN
iajs-3367	194	2	,	,	PUNCT
iajs-3367	194	3	i.e.	i.e.	X
iajs-3367	194	4	complications	complication	NOUN
iajs-3367	194	5	of	of	ADP
iajs-3367	194	6	systemic	systemic	ADJ
iajs-3367	194	7	lupus	lupus	PROPN
iajs-3367	194	8	erythematosus	erythematosus	PROPN
iajs-3367	194	9	.	.	PUNCT
iajs-3367	195	1	doctoral	doctoral	ADJ
iajs-3367	195	2	dissertation	dissertation	NOUN
iajs-3367	195	3	.	.	PUNCT
iajs-3367	196	1	vrije	vrije	PROPN
iajs-3367	196	2	universiteit	universiteit	PROPN
iajs-3367	196	3	amsterdam	amsterdam	PROPN
iajs-3367	196	4	:	:	PUNCT
iajs-3367	196	5	amsterdam	amsterdam	PROPN
iajs-3367	196	6	,	,	PUNCT
iajs-3367	196	7	2008	2008	NUM
iajs-3367	196	8	.	.	PUNCT
iajs-3367	197	1	19	19	NUM
iajs-3367	197	2	.	.	X
iajs-3367	198	1	abdullah	abdullah	PROPN
iajs-3367	198	2	,	,	PUNCT
iajs-3367	198	3	d.a	d.a	PROPN
iajs-3367	198	4	.	.	PROPN
iajs-3367	198	5	;	;	PUNCT
iajs-3367	198	6	al	al	PROPN
iajs-3367	198	7	-	-	PUNCT
iajs-3367	198	8	sharqi	sharqi	PROPN
iajs-3367	198	9	,	,	PUNCT
iajs-3367	198	10	s.	s.	PROPN
iajs-3367	198	11	a.h	a.h	PROPN
iajs-3367	198	12	.	.	PROPN
iajs-3367	198	13	;	;	PUNCT
iajs-3367	198	14	alabbassi	alabbassi	PROPN
iajs-3367	198	15	,	,	PUNCT
iajs-3367	198	16	h.m	h.m	PROPN
iajs-3367	198	17	.	.	PROPN
iajs-3367	198	18	;	;	PUNCT
iajs-3367	198	19	swahab	swahab	PROPN
iajs-3367	198	20	,	,	PUNCT
iajs-3367	198	21	m.	m.	NOUN
iajs-3367	198	22	;	;	PUNCT
iajs-3367	198	23	almishhadany	almishhadany	ADJ
iajs-3367	198	24	,	,	PUNCT
iajs-3367	198	25	m.s	m.s	PROPN
iajs-3367	198	26	.	.	PROPN
iajs-3367	198	27	evaluation	evaluation	NOUN
iajs-3367	198	28	pathogenesis	pathogenesis	NOUN
iajs-3367	198	29	outcomes	outcome	NOUN
iajs-3367	198	30	of	of	ADP
iajs-3367	198	31	knee	knee	NOUN
iajs-3367	198	32	and	and	CCONJ
iajs-3367	198	33	hip	hip	NOUN
iajs-3367	198	34	in	in	ADP
iajs-3367	198	35	patients	patient	NOUN
iajs-3367	198	36	with	with	ADP
iajs-3367	198	37	osteoarthritis	osteoarthritis	NOUN
iajs-3367	198	38	based	base	VERB
iajs-3367	198	39	on	on	ADP
iajs-3367	198	40	:	:	PUNCT
iajs-3367	198	41	histopathological	histopathological	ADJ
iajs-3367	198	42	,	,	PUNCT
iajs-3367	198	43	hematological	hematological	ADJ
iajs-3367	198	44	,	,	PUNCT
iajs-3367	198	45	and	and	CCONJ
iajs-3367	198	46	indicators	indicator	NOUN
iajs-3367	198	47	of	of	ADP
iajs-3367	198	48	inflammation	inflammation	NOUN
iajs-3367	198	49	.	.	PUNCT
iajs-3367	199	1	j.	j.	PROPN
iajs-3367	199	2	res	res	PROPN
iajs-3367	199	3	.	.	PUNCT
iajs-3367	200	1	med	med	PROPN
iajs-3367	200	2	.	.	PUNCT
iajs-3367	200	3	dent	dent	PROPN
iajs-3367	200	4	.	.	PUNCT
iajs-3367	201	1	sci	sci	PROPN
iajs-3367	201	2	.	.	PROPN
iajs-3367	201	3	,	,	PUNCT
iajs-3367	201	4	2021	2021	NUM
iajs-3367	201	5	,	,	PUNCT
iajs-3367	201	6	9	9	NUM
iajs-3367	201	7	,	,	PUNCT
iajs-3367	201	8	178	178	NUM
iajs-3367	201	9	-	-	SYM
iajs-3367	201	10	184	184	NUM
iajs-3367	201	11	.	.	NOUN
iajs-3367	201	12	20	20	NUM
iajs-3367	201	13	.	.	PUNCT
iajs-3367	202	1	abdullah	abdullah	PROPN
iajs-3367	202	2	,	,	PUNCT
iajs-3367	202	3	d.a	d.a	PROPN
iajs-3367	202	4	.	.	PROPN
iajs-3367	202	5	;	;	PUNCT
iajs-3367	203	1	alabassi	alabassi	ADV
iajs-3367	203	2	,	,	PUNCT
iajs-3367	203	3	h.m	h.m	PROPN
iajs-3367	203	4	.	.	PROPN
iajs-3367	203	5	;	;	PUNCT
iajs-3367	203	6	al	al	PROPN
iajs-3367	203	7	-	-	PUNCT
iajs-3367	203	8	sharqi	sharqi	PROPN
iajs-3367	203	9	,	,	PUNCT
iajs-3367	203	10	s.a	s.a	PROPN
iajs-3367	203	11	.	.	PROPN
iajs-3367	203	12	and	and	CCONJ
iajs-3367	203	13	wahab	wahab	PROPN
iajs-3367	203	14	,	,	PUNCT
iajs-3367	203	15	m.s	m.s	PROPN
iajs-3367	203	16	.	.	PROPN
iajs-3367	203	17	possible	possible	ADJ
iajs-3367	203	18	etiological	etiological	ADJ
iajs-3367	203	19	role	role	NOUN
iajs-3367	203	20	of	of	ADP
iajs-3367	203	21	cd16	cd16	PROPN
iajs-3367	203	22	and	and	CCONJ
iajs-3367	203	23	tgf	tgf	PROPN
iajs-3367	203	24	-	-	PUNCT
iajs-3367	203	25	β1	β1	PROPN
iajs-3367	203	26	in	in	ADP
iajs-3367	203	27	the	the	DET
iajs-3367	203	28	pathogenesis	pathogenesis	NOUN
iajs-3367	203	29	of	of	ADP
iajs-3367	203	30	osteoarthritis	osteoarthritis	ADJ
iajs-3367	203	31	iraqi	iraqi	ADJ
iajs-3367	203	32	patients	patient	NOUN
iajs-3367	203	33	.	.	PUNCT
iajs-3367	204	1	biochem	biochem	PROPN
iajs-3367	204	2	.	.	PUNCT
iajs-3367	205	1	cell	cell	NOUN
iajs-3367	205	2	.	.	PUNCT
iajs-3367	206	1	arch	arch	ADJ
iajs-3367	206	2	,	,	PUNCT
iajs-3367	206	3	2022	2022	NUM
iajs-3367	206	4	,	,	PUNCT
iajs-3367	206	5	22	22	NUM
iajs-3367	206	6	,	,	PUNCT
iajs-3367	206	7	2351	2351	NUM
iajs-3367	206	8	-	-	SYM
iajs-3367	206	9	2356	2356	NUM
iajs-3367	206	10	.	.	PUNCT
iajs-3367	207	1	21	21	NUM
iajs-3367	207	2	.	.	PUNCT
iajs-3367	208	1	kadri	kadri	PROPN
iajs-3367	208	2	,	,	PUNCT
iajs-3367	208	3	z.h.m	z.h.m	PROPN
iajs-3367	208	4	.	.	PUNCT
iajs-3367	208	5	effect	effect	NOUN
iajs-3367	208	6	of	of	ADP
iajs-3367	208	7	cigarette	cigarette	NOUN
iajs-3367	208	8	and	and	CCONJ
iajs-3367	208	9	water	water	NOUN
iajs-3367	208	10	-	-	PUNCT
iajs-3367	208	11	pipe	pipe	NOUN
iajs-3367	208	12	smoking	smoking	NOUN
iajs-3367	208	13	on	on	ADP
iajs-3367	208	14	osteocalcin	osteocalcin	PROPN
iajs-3367	209	1	and	and	CCONJ
iajs-3367	209	2	rankl	rankl	VERB
iajs-3367	209	3	serum	serum	NOUN
iajs-3367	209	4	levels	level	NOUN
iajs-3367	209	5	among	among	ADP
iajs-3367	209	6	iraqi	iraqi	ADJ
iajs-3367	209	7	university	university	NOUN
iajs-3367	209	8	students	student	NOUN
iajs-3367	209	9	.	.	PUNCT
iajs-3367	210	1	eurasian	eurasian	PROPN
iajs-3367	210	2	j.	j.	PROPN
iajs-3367	210	3	biosci	biosci	PROPN
iajs-3367	210	4	.	.	PROPN
iajs-3367	210	5	,	,	PUNCT
iajs-3367	210	6	2020,14	2020,14	NUM
iajs-3367	210	7	,	,	PUNCT
iajs-3367	210	8	3025	3025	NUM
iajs-3367	210	9	-	-	SYM
iajs-3367	210	10	3030	3030	NUM
iajs-3367	210	11	.	.	PUNCT
iajs-3367	211	1	22	22	NUM
iajs-3367	211	2	.	.	PUNCT
iajs-3367	211	3	ramesh	ramesh	PROPN
iajs-3367	211	4	,	,	PUNCT
iajs-3367	211	5	p.	p.	PROPN
iajs-3367	211	6	;	;	PUNCT
iajs-3367	211	7	jagadeesan	jagadeesan	PROPN
iajs-3367	211	8	,	,	PUNCT
iajs-3367	211	9	r.	r.	PROPN
iajs-3367	211	10	;	;	PUNCT
iajs-3367	211	11	sekaran	sekaran	NOUN
iajs-3367	211	12	,	,	PUNCT
iajs-3367	211	13	s.	s.	PROPN
iajs-3367	211	14	;	;	PUNCT
iajs-3367	211	15	dhanasekaran	dhanasekaran	PROPN
iajs-3367	211	16	,	,	PUNCT
iajs-3367	211	17	a.	a.	NOUN
iajs-3367	211	18	;	;	PUNCT
iajs-3367	211	19	vimalraj	vimalraj	PROPN
iajs-3367	211	20	,	,	PUNCT
iajs-3367	211	21	s.	s.	PROPN
iajs-3367	211	22	flavonoids	flavonoid	NOUN
iajs-3367	211	23	:	:	PUNCT
iajs-3367	212	1	classification	classification	NOUN
iajs-3367	212	2	,	,	PUNCT
iajs-3367	212	3	function	function	NOUN
iajs-3367	212	4	,	,	PUNCT
iajs-3367	212	5	and	and	CCONJ
iajs-3367	212	6	molecular	molecular	ADJ
iajs-3367	212	7	mechanisms	mechanism	NOUN
iajs-3367	212	8	involved	involve	VERB
iajs-3367	212	9	in	in	ADP
iajs-3367	212	10	bone	bone	NOUN
iajs-3367	212	11	remodelling	remodelling	NOUN
iajs-3367	212	12	.	.	PUNCT
iajs-3367	213	1	front	front	ADJ
iajs-3367	213	2	.	.	PUNCT
iajs-3367	213	3	endocrinol	endocrinol	NOUN
iajs-3367	213	4	.	.	PROPN
iajs-3367	213	5	,	,	PUNCT
iajs-3367	213	6	2021	2021	NUM
iajs-3367	213	7	,	,	PUNCT
iajs-3367	213	8	12	12	NUM
iajs-3367	213	9	.	.	NOUN
iajs-3367	214	1	23	23	NUM
iajs-3367	214	2	.	.	PUNCT
iajs-3367	215	1	kong	kong	PROPN
iajs-3367	215	2	,	,	PUNCT
iajs-3367	215	3	y.y	y.y	PROPN
iajs-3367	215	4	.	.	PROPN
iajs-3367	215	5	;	;	PUNCT
iajs-3367	215	6	yoshida	yoshida	PROPN
iajs-3367	215	7	,	,	PUNCT
iajs-3367	215	8	h.	h.	PROPN
iajs-3367	215	9	;	;	PUNCT
iajs-3367	215	10	sarosi	sarosi	PROPN
iajs-3367	215	11	,	,	PUNCT
iajs-3367	215	12	i.	i.	PROPN
iajs-3367	215	13	;	;	PUNCT
iajs-3367	215	14	tan	tan	PROPN
iajs-3367	215	15	,	,	PUNCT
iajs-3367	215	16	h.l	h.l	PROPN
iajs-3367	215	17	.	.	PROPN
iajs-3367	215	18	;	;	PUNCT
iajs-3367	215	19	timms	timms	PROPN
iajs-3367	215	20	,	,	PUNCT
iajs-3367	215	21	e.	e.	PROPN
iajs-3367	215	22	;	;	PUNCT
iajs-3367	215	23	capparelli	capparelli	PROPN
iajs-3367	215	24	,	,	PUNCT
iajs-3367	215	25	c.	c.	PROPN
iajs-3367	215	26	;	;	PUNCT
iajs-3367	215	27	morony	morony	PROPN
iajs-3367	215	28	,	,	PUNCT
iajs-3367	215	29	s.	s.	PROPN
iajs-3367	215	30	;	;	PUNCT
iajs-3367	215	31	oliveira	oliveira	PROPN
iajs-3367	215	32	-	-	PUNCT
iajs-3367	215	33	dos	dos	PROPN
iajs-3367	215	34	-	-	PUNCT
iajs-3367	215	35	santos	santo	NOUN
iajs-3367	215	36	,	,	PUNCT
iajs-3367	215	37	a.j	a.j	PROPN
iajs-3367	215	38	.	.	PROPN
iajs-3367	215	39	;	;	PUNCT
iajs-3367	215	40	van	van	PROPN
iajs-3367	215	41	,	,	PUNCT
iajs-3367	215	42	g.	g.	PROPN
iajs-3367	215	43	;	;	PUNCT
iajs-3367	215	44	itie	itie	NOUN
iajs-3367	215	45	,	,	PUNCT
iajs-3367	215	46	a.	a.	NOUN
iajs-3367	215	47	;	;	PUNCT
iajs-3367	215	48	khoo	khoo	PROPN
iajs-3367	215	49	,	,	PUNCT
iajs-3367	215	50	w.	w.	PROPN
iajs-3367	215	51	opgl	opgl	PROPN
iajs-3367	215	52	is	be	AUX
iajs-3367	215	53	a	a	DET
iajs-3367	215	54	key	key	ADJ
iajs-3367	215	55	regulator	regulator	NOUN
iajs-3367	215	56	of	of	ADP
iajs-3367	215	57	osteoclastogenesis	osteoclastogenesis	NOUN
iajs-3367	215	58	,	,	PUNCT
iajs-3367	215	59	lymphocyte	lymphocyte	ADJ
iajs-3367	215	60	development	development	NOUN
iajs-3367	215	61	and	and	CCONJ
iajs-3367	215	62	lymph	lymph	NOUN
iajs-3367	215	63	-	-	PUNCT
iajs-3367	215	64	node	node	ADJ
iajs-3367	215	65	organogenesis	organogenesis	NOUN
iajs-3367	215	66	.	.	PUNCT
iajs-3367	216	1	nature	nature	NOUN
iajs-3367	216	2	,	,	PUNCT
iajs-3367	216	3	1999	1999	NUM
iajs-3367	216	4	,	,	PUNCT
iajs-3367	216	5	397	397	NUM
iajs-3367	216	6	,	,	PUNCT
iajs-3367	216	7	315	315	NUM
iajs-3367	216	8	-	-	SYM
iajs-3367	216	9	323	323	NUM
iajs-3367	216	10	.	.	PUNCT
iajs-3367	216	11	24	24	NUM
iajs-3367	216	12	.	.	PUNCT
iajs-3367	217	1	holliday	holliday	PROPN
iajs-3367	217	2	,	,	PUNCT
iajs-3367	217	3	l.s	l.s	PROPN
iajs-3367	217	4	.	.	PROPN
iajs-3367	217	5	;	;	PUNCT
iajs-3367	217	6	patel	patel	PROPN
iajs-3367	217	7	,	,	PUNCT
iajs-3367	217	8	s.s	s.s	PROPN
iajs-3367	217	9	.	.	PROPN
iajs-3367	217	10	;	;	PUNCT
iajs-3367	217	11	rody	rody	PROPN
iajs-3367	217	12	jr	jr	PROPN
iajs-3367	217	13	,	,	PUNCT
iajs-3367	217	14	w.j	w.j	PROPN
iajs-3367	217	15	.	.	PROPN
iajs-3367	217	16	rankl	rankl	VERB
iajs-3367	217	17	and	and	CCONJ
iajs-3367	217	18	rank	rank	VERB
iajs-3367	217	19	in	in	ADP
iajs-3367	217	20	extracellular	extracellular	ADJ
iajs-3367	217	21	vesicles	vesicle	NOUN
iajs-3367	217	22	:	:	PUNCT
iajs-3367	217	23	surprising	surprising	ADJ
iajs-3367	217	24	new	new	ADJ
iajs-3367	217	25	players	player	NOUN
iajs-3367	217	26	in	in	ADP
iajs-3367	217	27	bone	bone	NOUN
iajs-3367	217	28	remodeling	remodeling	NOUN
iajs-3367	217	29	.	.	PUNCT
iajs-3367	218	1	extracell	extracell	VERB
iajs-3367	218	2	.	.	PUNCT
iajs-3367	219	1	vesicles	vesicle	NOUN
iajs-3367	219	2	circ	circ	NOUN
iajs-3367	219	3	.	.	PUNCT
iajs-3367	220	1	nucleic	nucleic	ADJ
iajs-3367	220	2	acids	acid	NOUN
iajs-3367	220	3	,	,	PUNCT
iajs-3367	220	4	2021	2021	NUM
iajs-3367	220	5	,	,	PUNCT
iajs-3367	220	6	2	2	NUM
iajs-3367	220	7	,	,	PUNCT
iajs-3367	220	8	18	18	NUM
iajs-3367	220	9	.	.	PUNCT
iajs-3367	220	10	ihjpas	ihjpas	PROPN
iajs-3367	220	11	.	.	PUNCT
iajs-3367	221	1	37	37	NUM
iajs-3367	221	2	(	(	PUNCT
iajs-3367	221	3	1	1	NUM
iajs-3367	221	4	)	)	PUNCT
iajs-3367	221	5	2024	2024	NUM
iajs-3367	221	6	16	16	NUM
iajs-3367	221	7	25	25	NUM
iajs-3367	221	8	.	.	PUNCT
iajs-3367	221	9	amarasekara	amarasekara	PROPN
iajs-3367	221	10	,	,	PUNCT
iajs-3367	221	11	d.s.;yu	d.s.;yu	PROPN
iajs-3367	221	12	,	,	PUNCT
iajs-3367	221	13	j.	j.	PROPN
iajs-3367	221	14	;	;	PUNCT
iajs-3367	221	15	rho	rho	PROPN
iajs-3367	221	16	,	,	PUNCT
iajs-3367	221	17	j.	j.	PROPN
iajs-3367	221	18	bone	bone	NOUN
iajs-3367	221	19	loss	loss	NOUN
iajs-3367	221	20	triggered	trigger	VERB
iajs-3367	221	21	by	by	ADP
iajs-3367	221	22	the	the	DET
iajs-3367	221	23	cytokine	cytokine	ADJ
iajs-3367	221	24	network	network	NOUN
iajs-3367	221	25	in	in	ADP
iajs-3367	221	26	inflammatory	inflammatory	ADJ
iajs-3367	221	27	autoimmune	autoimmune	ADJ
iajs-3367	221	28	diseases	disease	NOUN
iajs-3367	221	29	.	.	PUNCT
iajs-3367	222	1	j.	j.	PROPN
iajs-3367	222	2	immunol	immunol	PROPN
iajs-3367	222	3	.	.	PUNCT
iajs-3367	223	1	res	re	NOUN
iajs-3367	223	2	,	,	PUNCT
iajs-3367	223	3	2015	2015	NUM
iajs-3367	223	4	,	,	PUNCT
iajs-3367	223	5	2015	2015	NUM
iajs-3367	223	6	,	,	PUNCT
iajs-3367	223	7	12	12	NUM
iajs-3367	223	8	.	.	NOUN
iajs-3367	223	9	26	26	NUM
iajs-3367	223	10	.	.	X
iajs-3367	224	1	bultink	bultink	NOUN
iajs-3367	224	2	,	,	PUNCT
iajs-3367	224	3	i.e.	i.e.	X
iajs-3367	224	4	bone	bone	NOUN
iajs-3367	224	5	disease	disease	NOUN
iajs-3367	224	6	in	in	ADP
iajs-3367	224	7	connective	connective	ADJ
iajs-3367	224	8	tissue	tissue	NOUN
iajs-3367	224	9	disease	disease	NOUN
iajs-3367	224	10	/	/	SYM
iajs-3367	224	11	systemic	systemic	ADJ
iajs-3367	224	12	lupus	lupus	PROPN
iajs-3367	224	13	erythematosus	erythematosus	PROPN
iajs-3367	224	14	.	.	PUNCT
iajs-3367	225	1	calcif	calcif	PROPN
iajs-3367	225	2	.	.	PUNCT
iajs-3367	226	1	tissue	tissue	NOUN
iajs-3367	226	2	int	int	NOUN
iajs-3367	226	3	.	.	PUNCT
iajs-3367	226	4	,	,	PUNCT
iajs-3367	226	5	2018	2018	NUM
iajs-3367	226	6	,	,	PUNCT
iajs-3367	226	7	102	102	NUM
iajs-3367	226	8	,	,	PUNCT
iajs-3367	226	9	575	575	NUM
iajs-3367	226	10	-	-	SYM
iajs-3367	226	11	591	591	NUM
iajs-3367	226	12	.	.	PUNCT
iajs-3367	227	1	27	27	NUM
iajs-3367	227	2	.	.	PUNCT
iajs-3367	228	1	moester	moester	PROPN
iajs-3367	228	2	m.j	m.j	PROPN
iajs-3367	228	3	.	.	PROPN
iajs-3367	228	4	;	;	PUNCT
iajs-3367	228	5	papapoulos	papapoulos	PROPN
iajs-3367	228	6	s.e	s.e	PROPN
iajs-3367	228	7	.	.	PROPN
iajs-3367	228	8	;	;	PUNCT
iajs-3367	228	9	lowik	lowik	PROPN
iajs-3367	228	10	c.w	c.w	PROPN
iajs-3367	228	11	.	.	PROPN
iajs-3367	228	12	;	;	PUNCT
iajs-3367	228	13	van	van	PROPN
iajs-3367	228	14	bezooijen	bezooijen	PROPN
iajs-3367	228	15	r.l	r.l	PROPN
iajs-3367	228	16	.	.	PROPN
iajs-3367	228	17	sclerostin	sclerostin	PROPN
iajs-3367	228	18	:	:	PUNCT
iajs-3367	228	19	current	current	ADJ
iajs-3367	228	20	knowledge	knowledge	NOUN
iajs-3367	228	21	and	and	CCONJ
iajs-3367	228	22	future	future	ADJ
iajs-3367	228	23	perspectives	perspective	NOUN
iajs-3367	228	24	.	.	PUNCT
iajs-3367	229	1	calcif	calcif	PROPN
iajs-3367	229	2	.	.	PUNCT
iajs-3367	230	1	tissue	tissue	NOUN
iajs-3367	230	2	int	int	NOUN
iajs-3367	230	3	.	.	PUNCT
iajs-3367	230	4	,	,	PUNCT
iajs-3367	230	5	2010	2010	NUM
iajs-3367	230	6	,	,	PUNCT
iajs-3367	230	7	87	87	NUM
iajs-3367	230	8	,	,	PUNCT
iajs-3367	230	9	99–107	99–107	PROPN
iajs-3367	230	10	.	.	PUNCT
iajs-3367	230	11	28	28	NUM
iajs-3367	230	12	.	.	PUNCT
iajs-3367	231	1	balemans	baleman	NOUN
iajs-3367	231	2	,	,	PUNCT
iajs-3367	231	3	w.	w.	PROPN
iajs-3367	231	4	;	;	PUNCT
iajs-3367	231	5	ebeling	ebeling	ADJ
iajs-3367	231	6	,	,	PUNCT
iajs-3367	231	7	m.	m.	NOUN
iajs-3367	231	8	;	;	PUNCT
iajs-3367	231	9	patel	patel	PROPN
iajs-3367	231	10	,	,	PUNCT
iajs-3367	231	11	n.	n.	PROPN
iajs-3367	231	12	;	;	PUNCT
iajs-3367	231	13	van	van	PROPN
iajs-3367	231	14	hul	hul	PROPN
iajs-3367	231	15	,	,	PUNCT
iajs-3367	231	16	e.	e.	PROPN
iajs-3367	231	17	;	;	PUNCT
iajs-3367	231	18	olson	olson	PROPN
iajs-3367	231	19	,	,	PUNCT
iajs-3367	231	20	p.	p.	PROPN
iajs-3367	231	21	;	;	PUNCT
iajs-3367	231	22	dioszegi	dioszegi	NOUN
iajs-3367	231	23	,	,	PUNCT
iajs-3367	231	24	m.	m.	NOUN
iajs-3367	231	25	;	;	PUNCT
iajs-3367	231	26	lacza	lacza	PROPN
iajs-3367	231	27	,	,	PUNCT
iajs-3367	231	28	c.	c.	PROPN
iajs-3367	231	29	;	;	PUNCT
iajs-3367	231	30	wuyts	wuyts	PROPN
iajs-3367	231	31	,	,	PUNCT
iajs-3367	231	32	w.	w.	PROPN
iajs-3367	231	33	;	;	PUNCT
iajs-3367	231	34	van	van	PROPN
iajs-3367	231	35	den	den	PROPN
iajs-3367	231	36	ende	ende	PROPN
iajs-3367	231	37	,	,	PUNCT
iajs-3367	231	38	j.	j.	PROPN
iajs-3367	231	39	;	;	PUNCT
iajs-3367	231	40	willems	willem	NOUN
iajs-3367	231	41	,	,	PUNCT
iajs-3367	231	42	p.	p.	NOUN
iajs-3367	231	43	;	;	PUNCT
iajs-3367	231	44	paes	paes	PROPN
iajs-3367	231	45	-	-	PUNCT
iajs-3367	231	46	alves	alves	PROPN
iajs-3367	231	47	,	,	PUNCT
iajs-3367	231	48	a.fincreased	a.fincrease	VERB
iajs-3367	231	49	bone	bone	NOUN
iajs-3367	231	50	density	density	NOUN
iajs-3367	231	51	in	in	ADP
iajs-3367	231	52	sclerosteosis	sclerosteosis	NOUN
iajs-3367	231	53	is	be	AUX
iajs-3367	231	54	due	due	ADJ
iajs-3367	231	55	to	to	ADP
iajs-3367	231	56	the	the	DET
iajs-3367	231	57	deficiency	deficiency	NOUN
iajs-3367	231	58	of	of	ADP
iajs-3367	231	59	a	a	DET
iajs-3367	231	60	novel	novel	NOUN
iajs-3367	231	61	secreted	secrete	VERB
iajs-3367	231	62	protein	protein	NOUN
iajs-3367	231	63	(	(	PUNCT
iajs-3367	231	64	sost	sost	NOUN
iajs-3367	231	65	)	)	PUNCT
iajs-3367	231	66	.	.	PUNCT
iajs-3367	232	1	hum	hum	PROPN
iajs-3367	232	2	.	.	PUNCT
iajs-3367	233	1	mol	mol	PROPN
iajs-3367	233	2	.	.	PUNCT
iajs-3367	233	3	genet	genet	PROPN
iajs-3367	233	4	.	.	PUNCT
iajs-3367	233	5	,	,	PUNCT
iajs-3367	233	6	2001	2001	NUM
iajs-3367	233	7	,	,	PUNCT
iajs-3367	233	8	10	10	NUM
iajs-3367	233	9	,	,	PUNCT
iajs-3367	233	10	537544	537544	NUM
iajs-3367	233	11	.	.	PUNCT
iajs-3367	234	1	29	29	NUM
iajs-3367	234	2	.	.	PUNCT
iajs-3367	235	1	fayed	fayed	PROPN
iajs-3367	235	2	,	,	PUNCT
iajs-3367	235	3	a.	a.	PROPN
iajs-3367	235	4	;	;	PUNCT
iajs-3367	235	5	soliman	soliman	NOUN
iajs-3367	235	6	,	,	PUNCT
iajs-3367	235	7	a.	a.	NOUN
iajs-3367	235	8	;	;	PUNCT
iajs-3367	235	9	elgohary	elgohary	ADV
iajs-3367	235	10	,	,	PUNCT
iajs-3367	235	11	r.	r.	NOUN
iajs-3367	235	12	measuring	measure	VERB
iajs-3367	235	13	serum	serum	NOUN
iajs-3367	235	14	sclerostin	sclerostin	ADJ
iajs-3367	235	15	in	in	ADP
iajs-3367	235	16	egyptian	egyptian	ADJ
iajs-3367	235	17	patients	patient	NOUN
iajs-3367	235	18	with	with	ADP
iajs-3367	235	19	systemic	systemic	ADJ
iajs-3367	235	20	lupus	lupus	NOUN
iajs-3367	235	21	erythematosus	erythematosus	NOUN
iajs-3367	235	22	and	and	CCONJ
iajs-3367	235	23	evaluating	evaluate	VERB
iajs-3367	235	24	its	its	PRON
iajs-3367	235	25	effect	effect	NOUN
iajs-3367	235	26	on	on	ADP
iajs-3367	235	27	disease	disease	NOUN
iajs-3367	235	28	activity	activity	NOUN
iajs-3367	235	29	:	:	PUNCT
iajs-3367	235	30	a	a	DET
iajs-3367	235	31	case	case	NOUN
iajs-3367	235	32	-	-	PUNCT
iajs-3367	235	33	control	control	NOUN
iajs-3367	235	34	study	study	NOUN
iajs-3367	235	35	.	.	PUNCT
iajs-3367	236	1	jcr	jcr	PROPN
iajs-3367	236	2	:	:	PUNCT
iajs-3367	236	3	j	j	PROPN
iajs-3367	236	4	clin	clin	PROPN
iajs-3367	236	5	rheumatol	rheumatol	NOUN
iajs-3367	236	6	.	.	PUNCT
iajs-3367	236	7	,	,	PUNCT
iajs-3367	236	8	2021	2021	NUM
iajs-3367	236	9	,	,	PUNCT
iajs-3367	236	10	27	27	NUM
iajs-3367	236	11	,	,	PUNCT
iajs-3367	236	12	161	161	NUM
iajs-3367	236	13	-	-	SYM
iajs-3367	236	14	167	167	NUM
iajs-3367	236	15	.	.	PUNCT
iajs-3367	237	1	30	30	NUM
iajs-3367	237	2	.	.	PUNCT
iajs-3367	238	1	hochberg	hochberg	PROPN
iajs-3367	238	2	m.c	m.c	PROPN
iajs-3367	238	3	.	.	PROPN
iajs-3367	238	4	updating	update	VERB
iajs-3367	238	5	the	the	DET
iajs-3367	238	6	american	american	PROPN
iajs-3367	238	7	college	college	PROPN
iajs-3367	238	8	of	of	ADP
iajs-3367	238	9	rheumatology	rheumatology	NOUN
iajs-3367	238	10	revised	revise	VERB
iajs-3367	238	11	criteria	criterion	NOUN
iajs-3367	238	12	for	for	ADP
iajs-3367	238	13	the	the	DET
iajs-3367	238	14	classification	classification	NOUN
iajs-3367	238	15	of	of	ADP
iajs-3367	238	16	systemic	systemic	ADJ
iajs-3367	238	17	lupus	lupus	PROPN
iajs-3367	238	18	erythematosus	erythematosus	PROPN
iajs-3367	238	19	.	.	PUNCT
iajs-3367	239	1	arthritis	arthritis	NOUN
iajs-3367	239	2	rheum	rheum	PROPN
iajs-3367	239	3	.	.	PUNCT
iajs-3367	239	4	,	,	PUNCT
iajs-3367	239	5	1997	1997	NUM
iajs-3367	239	6	,	,	PUNCT
iajs-3367	239	7	40	40	NUM
iajs-3367	239	8	,	,	PUNCT
iajs-3367	239	9	1725	1725	NUM
iajs-3367	239	10	-	-	SYM
iajs-3367	239	11	1725	1725	NUM
iajs-3367	239	12	.	.	PUNCT
iajs-3367	240	1	31	31	NUM
iajs-3367	240	2	.	.	PUNCT
iajs-3367	241	1	ibrahim	ibrahim	PROPN
iajs-3367	241	2	,	,	PUNCT
iajs-3367	241	3	w.s	w.s	PROPN
iajs-3367	241	4	.	.	PROPN
iajs-3367	241	5	;	;	PUNCT
iajs-3367	241	6	abdelghani	abdelghani	PROPN
iajs-3367	241	7	,	,	PUNCT
iajs-3367	241	8	s.e	s.e	PROPN
iajs-3367	241	9	.	.	PROPN
iajs-3367	241	10	programmed	program	VERB
iajs-3367	241	11	cell	cell	NOUN
iajs-3367	241	12	death	death	NOUN
iajs-3367	241	13	1	1	NUM
iajs-3367	241	14	gene	gene	NOUN
iajs-3367	241	15	polymorphism	polymorphism	NOUN
iajs-3367	241	16	association	association	NOUN
iajs-3367	241	17	with	with	ADP
iajs-3367	241	18	activity	activity	NOUN
iajs-3367	241	19	and	and	CCONJ
iajs-3367	241	20	severity	severity	NOUN
iajs-3367	241	21	of	of	ADP
iajs-3367	241	22	systemic	systemic	ADJ
iajs-3367	241	23	lupus	lupus	NOUN
iajs-3367	241	24	erythematosus	erythematosus	NOUN
iajs-3367	241	25	and	and	CCONJ
iajs-3367	241	26	rheumatoid	rheumatoid	VERB
iajs-3367	241	27	arthritis	arthritis	NOUN
iajs-3367	241	28	in	in	ADP
iajs-3367	241	29	egyptian	egyptian	ADJ
iajs-3367	241	30	patients	patient	NOUN
iajs-3367	241	31	.	.	PUNCT
iajs-3367	242	1	tanta	tanta	PROPN
iajs-3367	242	2	med	med	PROPN
iajs-3367	242	3	.	.	PUNCT
iajs-3367	243	1	j.	j.	PROPN
iajs-3367	243	2	,	,	PUNCT
iajs-3367	243	3	2018	2018	NUM
iajs-3367	243	4	,	,	PUNCT
iajs-3367	243	5	46	46	NUM
iajs-3367	243	6	,	,	PUNCT
iajs-3367	243	7	225	225	NUM
iajs-3367	243	8	.	.	X
iajs-3367	243	9	32	32	NUM
iajs-3367	243	10	.	.	PUNCT
iajs-3367	244	1	stefanski	stefanski	PROPN
iajs-3367	244	2	,	,	PUNCT
iajs-3367	244	3	a.l	a.l	PROPN
iajs-3367	244	4	.	.	PROPN
iajs-3367	244	5	;	;	PUNCT
iajs-3367	244	6	wiedemann	wiedemann	PROPN
iajs-3367	244	7	,	,	PUNCT
iajs-3367	244	8	a.	a.	NOUN
iajs-3367	244	9	;	;	PUNCT
iajs-3367	244	10	reiter	reiter	PROPN
iajs-3367	244	11	,	,	PUNCT
iajs-3367	244	12	k.	k.	PROPN
iajs-3367	244	13	;	;	PUNCT
iajs-3367	244	14	hiepe	hiepe	PROPN
iajs-3367	244	15	,	,	PUNCT
iajs-3367	244	16	f.	f.	PROPN
iajs-3367	244	17	;	;	PUNCT
iajs-3367	244	18	lino	lino	PROPN
iajs-3367	244	19	,	,	PUNCT
iajs-3367	244	20	a.c	a.c	PROPN
iajs-3367	244	21	.	.	PROPN
iajs-3367	244	22	;	;	PUNCT
iajs-3367	244	23	dörner	dörner	NOUN
iajs-3367	244	24	,	,	PUNCT
iajs-3367	244	25	t.	t.	PROPN
iajs-3367	244	26	enhanced	enhance	VERB
iajs-3367	244	27	programmed	program	VERB
iajs-3367	244	28	death	death	NOUN
iajs-3367	244	29	1	1	NUM
iajs-3367	244	30	and	and	CCONJ
iajs-3367	244	31	diminished	diminish	VERB
iajs-3367	244	32	programmed	program	VERB
iajs-3367	244	33	death	death	NOUN
iajs-3367	244	34	ligand	ligand	NOUN
iajs-3367	244	35	1	1	NUM
iajs-3367	244	36	up‐regulation	up‐regulation	NOUN
iajs-3367	244	37	capacity	capacity	NOUN
iajs-3367	244	38	of	of	ADP
iajs-3367	244	39	post‐activated	post‐activate	VERB
iajs-3367	244	40	lupus	lupus	NOUN
iajs-3367	244	41	b	b	NOUN
iajs-3367	244	42	cells	cell	NOUN
iajs-3367	244	43	.	.	PUNCT
iajs-3367	245	1	arthritis	arthritis	NOUN
iajs-3367	245	2	rheumatol	rheumatol	NOUN
iajs-3367	245	3	.	.	PUNCT
iajs-3367	245	4	,	,	PUNCT
iajs-3367	245	5	2019	2019	NUM
iajs-3367	245	6	,	,	PUNCT
iajs-3367	245	7	71	71	NUM
iajs-3367	245	8	,	,	PUNCT
iajs-3367	245	9	1539	1539	NUM
iajs-3367	245	10	-	-	SYM
iajs-3367	245	11	1544	1544	NUM
iajs-3367	245	12	.	.	PUNCT
iajs-3367	246	1	33	33	NUM
iajs-3367	246	2	.	.	PUNCT
iajs-3367	247	1	luo	luo	PROPN
iajs-3367	247	2	,	,	PUNCT
iajs-3367	247	3	q	q	X
iajs-3367	247	4	;	;	PUNCT
iajs-3367	247	5	kong	kong	PROPN
iajs-3367	247	6	,	,	PUNCT
iajs-3367	247	7	y	y	PROPN
iajs-3367	247	8	;	;	PUNCT
iajs-3367	247	9	fu	fu	PROPN
iajs-3367	247	10	,	,	PUNCT
iajs-3367	247	11	b	b	NOUN
iajs-3367	247	12	;	;	PUNCT
iajs-3367	247	13	li	li	PROPN
iajs-3367	247	14	,	,	PUNCT
iajs-3367	247	15	x	x	X
iajs-3367	247	16	;	;	PUNCT
iajs-3367	247	17	huang	huang	PROPN
iajs-3367	247	18	,	,	PUNCT
iajs-3367	247	19	q	q	X
iajs-3367	247	20	;	;	PUNCT
iajs-3367	247	21	huang	huang	PROPN
iajs-3367	247	22	,	,	PUNCT
iajs-3367	247	23	z.	z.	PROPN
iajs-3367	247	24	;	;	PUNCT
iajs-3367	247	25	li	li	PROPN
iajs-3367	247	26	,	,	PUNCT
iajs-3367	247	27	j.	j.	PROPN
iajs-3367	247	28	increased	increase	VERB
iajs-3367	247	29	tim-3	tim-3	ADV
iajs-3367	247	30	+	+	ADJ
iajs-3367	247	31	pd-1	pd-1	PART
iajs-3367	247	32	+	+	ADJ
iajs-3367	247	33	nk	nk	PROPN
iajs-3367	247	34	cells	cell	NOUN
iajs-3367	247	35	are	be	AUX
iajs-3367	247	36	associated	associate	VERB
iajs-3367	247	37	with	with	ADP
iajs-3367	247	38	the	the	DET
iajs-3367	247	39	disease	disease	NOUN
iajs-3367	247	40	activity	activity	NOUN
iajs-3367	247	41	and	and	CCONJ
iajs-3367	247	42	severity	severity	NOUN
iajs-3367	247	43	of	of	ADP
iajs-3367	247	44	systemic	systemic	ADJ
iajs-3367	247	45	lupus	lupus	PROPN
iajs-3367	247	46	erythematosus	erythematosus	PROPN
iajs-3367	247	47	.	.	PUNCT
iajs-3367	248	1	clin	clin	PROPN
iajs-3367	248	2	.	.	PUNCT
iajs-3367	249	1	exp	exp	PROPN
iajs-3367	249	2	.	.	PROPN
iajs-3367	249	3	med	med	PROPN
iajs-3367	249	4	.	.	PROPN
iajs-3367	249	5	,	,	PUNCT
iajs-3367	249	6	2022	2022	NUM
iajs-3367	249	7	,	,	PUNCT
iajs-3367	249	8	22	22	NUM
iajs-3367	249	9	,	,	PUNCT
iajs-3367	249	10	47	47	NUM
iajs-3367	249	11	-	-	SYM
iajs-3367	249	12	56	56	NUM
iajs-3367	249	13	.	.	PUNCT
iajs-3367	250	1	34	34	NUM
iajs-3367	250	2	.	.	PUNCT
iajs-3367	250	3	bassiouni	bassiouni	PROPN
iajs-3367	250	4	,	,	PUNCT
iajs-3367	250	5	s.a	s.a	PROPN
iajs-3367	250	6	.	.	PROPN
iajs-3367	250	7	;	;	PUNCT
iajs-3367	250	8	abdeen	abdeen	PROPN
iajs-3367	250	9	,	,	PUNCT
iajs-3367	250	10	h.m	h.m	PROPN
iajs-3367	250	11	.	.	PROPN
iajs-3367	250	12	,	,	PUNCT
iajs-3367	250	13	morsi	morsi	PROPN
iajs-3367	250	14	,	,	PUNCT
iajs-3367	250	15	h.k	h.k	PROPN
iajs-3367	250	16	.	.	PROPN
iajs-3367	250	17	;	;	PUNCT
iajs-3367	250	18	zaki	zaki	PROPN
iajs-3367	250	19	,	,	PUNCT
iajs-3367	250	20	m.e	m.e	PROPN
iajs-3367	250	21	.	.	PROPN
iajs-3367	250	22	;	;	PUNCT
iajs-3367	250	23	abdelsalam	abdelsalam	PROPN
iajs-3367	250	24	,	,	PUNCT
iajs-3367	250	25	m.	m.	NOUN
iajs-3367	250	26	;	;	PUNCT
iajs-3367	250	27	gharbia	gharbia	NOUN
iajs-3367	250	28	,	,	PUNCT
iajs-3367	250	29	o.m	o.m	PROPN
iajs-3367	250	30	.	.	PROPN
iajs-3367	250	31	programmed	program	VERB
iajs-3367	250	32	death	death	NOUN
iajs-3367	250	33	1	1	NUM
iajs-3367	250	34	(	(	PUNCT
iajs-3367	250	35	pd-1	pd-1	X
iajs-3367	250	36	)	)	PUNCT
iajs-3367	250	37	serum	serum	NOUN
iajs-3367	250	38	level	level	NOUN
iajs-3367	250	39	and	and	CCONJ
iajs-3367	250	40	gene	gene	NOUN
iajs-3367	250	41	expression	expression	NOUN
iajs-3367	250	42	in	in	ADP
iajs-3367	250	43	recent	recent	ADJ
iajs-3367	250	44	onset	onset	NOUN
iajs-3367	250	45	systemic	systemic	ADJ
iajs-3367	250	46	lupus	lupus	PROPN
iajs-3367	250	47	erythematosus	erythematosus	PROPN
iajs-3367	250	48	patients	patient	NOUN
iajs-3367	250	49	.	.	PUNCT
iajs-3367	251	1	egypt	egypt	PROPN
iajs-3367	251	2	.	.	PUNCT
iajs-3367	252	1	rheumatol	rheumatol	PROPN
iajs-3367	252	2	.	.	PUNCT
iajs-3367	253	1	2021	2021	NUM
iajs-3367	253	2	,	,	PUNCT
iajs-3367	253	3	43	43	NUM
iajs-3367	253	4	,	,	PUNCT
iajs-3367	253	5	213	213	NUM
iajs-3367	253	6	-	-	SYM
iajs-3367	253	7	218	218	NUM
iajs-3367	253	8	.	.	PUNCT
iajs-3367	254	1	35	35	NUM
iajs-3367	254	2	.	.	PUNCT
iajs-3367	255	1	her	she	PRON
iajs-3367	255	2	,	,	PUNCT
iajs-3367	255	3	m.	m.	NOUN
iajs-3367	255	4	;	;	PUNCT
iajs-3367	255	5	kim	kim	PROPN
iajs-3367	255	6	,	,	PUNCT
iajs-3367	255	7	d.	d.	PROPN
iajs-3367	255	8	;	;	PUNCT
iajs-3367	255	9	oh	oh	INTJ
iajs-3367	255	10	,	,	PUNCT
iajs-3367	255	11	m.	m.	NOUN
iajs-3367	255	12	;	;	PUNCT
iajs-3367	255	13	jeong	jeong	PROPN
iajs-3367	255	14	,	,	PUNCT
iajs-3367	255	15	h.	h.	PROPN
iajs-3367	255	16	;	;	PUNCT
iajs-3367	255	17	choi	choi	NOUN
iajs-3367	255	18	,	,	PUNCT
iajs-3367	255	19	i.	i.	NOUN
iajs-3367	255	20	increased	increase	VERB
iajs-3367	255	21	expression	expression	NOUN
iajs-3367	255	22	of	of	ADP
iajs-3367	255	23	soluble	soluble	ADJ
iajs-3367	255	24	inducible	inducible	ADJ
iajs-3367	255	25	costimulator	costimulator	NOUN
iajs-3367	255	26	ligand	ligand	NOUN
iajs-3367	255	27	(	(	PUNCT
iajs-3367	255	28	icosl	icosl	NOUN
iajs-3367	255	29	)	)	PUNCT
iajs-3367	255	30	in	in	ADP
iajs-3367	255	31	patients	patient	NOUN
iajs-3367	255	32	with	with	ADP
iajs-3367	255	33	systemic	systemic	ADJ
iajs-3367	255	34	lupus	lupus	PROPN
iajs-3367	255	35	erythematosus	erythematosus	NOUN
iajs-3367	255	36	.	.	PUNCT
iajs-3367	256	1	lupus	lupus	NOUN
iajs-3367	256	2	,	,	PUNCT
iajs-3367	256	3	2009	2009	NUM
iajs-3367	256	4	,	,	PUNCT
iajs-3367	256	5	18	18	NUM
iajs-3367	256	6	,	,	PUNCT
iajs-3367	256	7	501	501	NUM
iajs-3367	256	8	-	-	SYM
iajs-3367	256	9	507	507	NUM
iajs-3367	256	10	.	.	NUM
iajs-3367	256	11	36	36	NUM
iajs-3367	256	12	.	.	PUNCT
iajs-3367	257	1	shoenfeld	shoenfeld	VERB
iajs-3367	257	2	,	,	PUNCT
iajs-3367	257	3	y.	y.	PROPN
iajs-3367	257	4	;	;	PUNCT
iajs-3367	257	5	giacomelli	giacomelli	PROPN
iajs-3367	257	6	,	,	PUNCT
iajs-3367	257	7	r.	r.	PROPN
iajs-3367	257	8	;	;	PUNCT
iajs-3367	257	9	azrielant	azrielant	ADJ
iajs-3367	257	10	,	,	PUNCT
iajs-3367	257	11	s.	s.	PROPN
iajs-3367	257	12	;	;	PUNCT
iajs-3367	257	13	berardicurti	berardicurti	PROPN
iajs-3367	257	14	,	,	PUNCT
iajs-3367	257	15	o.	o.	PROPN
iajs-3367	257	16	;	;	PUNCT
iajs-3367	257	17	reynolds	reynolds	PROPN
iajs-3367	257	18	,	,	PUNCT
iajs-3367	257	19	j.a	j.a	PROPN
iajs-3367	257	20	.	.	PROPN
iajs-3367	257	21	;	;	PUNCT
iajs-3367	257	22	bruce	bruce	PROPN
iajs-3367	257	23	,	,	PUNCT
iajs-3367	257	24	i.n	i.n	PROPN
iajs-3367	257	25	.	.	PROPN
iajs-3367	257	26	vitamin	vitamin	NOUN
iajs-3367	257	27	d	d	NOUN
iajs-3367	257	28	and	and	CCONJ
iajs-3367	257	29	systemic	systemic	ADJ
iajs-3367	257	30	lupus	lupus	NOUN
iajs-3367	257	31	erythematosus	erythematosus	NOUN
iajs-3367	257	32	-	-	PUNCT
iajs-3367	257	33	the	the	DET
iajs-3367	257	34	hype	hype	NOUN
iajs-3367	257	35	and	and	CCONJ
iajs-3367	257	36	the	the	DET
iajs-3367	257	37	hope	hope	NOUN
iajs-3367	257	38	.	.	PUNCT
iajs-3367	258	1	autoimmun	autoimmun	PROPN
iajs-3367	258	2	.	.	PUNCT
iajs-3367	259	1	rev	rev	PROPN
iajs-3367	259	2	.	.	PROPN
iajs-3367	259	3	,	,	PUNCT
iajs-3367	259	4	2018	2018	NUM
iajs-3367	259	5	,	,	PUNCT
iajs-3367	259	6	17	17	NUM
iajs-3367	259	7	,	,	PUNCT
iajs-3367	259	8	19	19	NUM
iajs-3367	259	9	-	-	SYM
iajs-3367	259	10	23	23	NUM
iajs-3367	259	11	.	.	PUNCT
iajs-3367	260	1	37	37	NUM
iajs-3367	260	2	.	.	PUNCT
iajs-3367	261	1	khairallah	khairallah	PROPN
iajs-3367	261	2	,	,	PUNCT
iajs-3367	261	3	m.k	m.k	PROPN
iajs-3367	261	4	.	.	PUNCT
iajs-3367	261	5	;	;	PUNCT
iajs-3367	261	6	makarem	makarem	VERB
iajs-3367	261	7	,	,	PUNCT
iajs-3367	261	8	y.s	y.s	PROPN
iajs-3367	261	9	.	.	PROPN
iajs-3367	261	10	;	;	PUNCT
iajs-3367	261	11	dahpy	dahpy	VERB
iajs-3367	261	12	,	,	PUNCT
iajs-3367	261	13	m.a	m.a	PROPN
iajs-3367	261	14	.	.	PROPN
iajs-3367	261	15	vitamin	vitamin	NOUN
iajs-3367	261	16	d	d	NOUN
iajs-3367	261	17	in	in	ADP
iajs-3367	261	18	active	active	ADJ
iajs-3367	261	19	systemic	systemic	ADJ
iajs-3367	261	20	lupus	lupus	NOUN
iajs-3367	261	21	erythematosus	erythematosus	NOUN
iajs-3367	261	22	and	and	CCONJ
iajs-3367	261	23	lupus	lupus	ADJ
iajs-3367	261	24	nephritis	nephritis	NOUN
iajs-3367	261	25	:	:	PUNCT
iajs-3367	261	26	a	a	DET
iajs-3367	261	27	forgotten	forget	VERB
iajs-3367	261	28	player	player	NOUN
iajs-3367	261	29	.	.	PUNCT
iajs-3367	262	1	egypt	egypt	PROPN
iajs-3367	262	2	.	.	PUNCT
iajs-3367	263	1	j.	j.	PROPN
iajs-3367	263	2	intern	intern	PROPN
iajs-3367	263	3	.	.	PUNCT
iajs-3367	263	4	med	med	PROPN
iajs-3367	263	5	.	.	PROPN
iajs-3367	263	6	,	,	PUNCT
iajs-3367	263	7	2020	2020	NUM
iajs-3367	263	8	,	,	PUNCT
iajs-3367	263	9	32	32	NUM
iajs-3367	263	10	,	,	PUNCT
iajs-3367	263	11	1	1	NUM
iajs-3367	263	12	-	-	SYM
iajs-3367	263	13	9	9	NUM
iajs-3367	263	14	.	.	NOUN
iajs-3367	263	15	38	38	NUM
iajs-3367	263	16	.	.	PUNCT
iajs-3367	264	1	shoenfeld	shoenfeld	VERB
iajs-3367	264	2	,	,	PUNCT
iajs-3367	264	3	n.	n.	NOUN
iajs-3367	264	4	;	;	PUNCT
iajs-3367	264	5	amital	amital	PROPN
iajs-3367	264	6	,	,	PUNCT
iajs-3367	264	7	h.	h.	PROPN
iajs-3367	264	8	;	;	PUNCT
iajs-3367	264	9	shoenfeld	shoenfeld	VERB
iajs-3367	264	10	,	,	PUNCT
iajs-3367	264	11	y.	y.	NOUN
iajs-3367	264	12	the	the	DET
iajs-3367	264	13	effect	effect	NOUN
iajs-3367	264	14	of	of	ADP
iajs-3367	264	15	melanism	melanism	NOUN
iajs-3367	264	16	and	and	CCONJ
iajs-3367	264	17	vitamin	vitamin	NOUN
iajs-3367	264	18	d	d	NOUN
iajs-3367	264	19	synthesis	synthesis	NOUN
iajs-3367	264	20	on	on	ADP
iajs-3367	264	21	the	the	DET
iajs-3367	264	22	incidence	incidence	NOUN
iajs-3367	264	23	of	of	ADP
iajs-3367	264	24	autoimmune	autoimmune	ADJ
iajs-3367	264	25	disease	disease	NOUN
iajs-3367	264	26	.	.	PUNCT
iajs-3367	265	1	nat	nat	PROPN
iajs-3367	265	2	.	.	PUNCT
iajs-3367	266	1	clin	clin	PROPN
iajs-3367	266	2	.	.	PUNCT
iajs-3367	267	1	pract	pract	PROPN
iajs-3367	267	2	.	.	PUNCT
iajs-3367	268	1	rheumatol	rheumatol	NOUN
iajs-3367	268	2	.	.	PUNCT
iajs-3367	269	1	,	,	PUNCT
iajs-3367	270	1	2009	2009	NUM
iajs-3367	270	2	,	,	PUNCT
iajs-3367	270	3	5	5	NUM
iajs-3367	270	4	,	,	PUNCT
iajs-3367	270	5	99	99	NUM
iajs-3367	270	6	-	-	SYM
iajs-3367	270	7	105	105	NUM
iajs-3367	270	8	.	.	NOUN
iajs-3367	270	9	39	39	NUM
iajs-3367	270	10	.	.	PUNCT
iajs-3367	271	1	holick	holick	NOUN
iajs-3367	271	2	,	,	PUNCT
iajs-3367	271	3	m.f	m.f	PROPN
iajs-3367	271	4	.	.	PUNCT
iajs-3367	271	5	vitamin	vitamin	NOUN
iajs-3367	271	6	d	d	NOUN
iajs-3367	271	7	deficiency	deficiency	NOUN
iajs-3367	271	8	.	.	PUNCT
iajs-3367	272	1	n.	n.	PROPN
iajs-3367	272	2	engl	engl	PROPN
iajs-3367	272	3	.	.	PUNCT
iajs-3367	273	1	j.	j.	PROPN
iajs-3367	273	2	med	med	PROPN
iajs-3367	273	3	.	.	PROPN
iajs-3367	273	4	,	,	PUNCT
iajs-3367	273	5	2007	2007	NUM
iajs-3367	273	6	,	,	PUNCT
iajs-3367	273	7	357	357	NUM
iajs-3367	273	8	,	,	PUNCT
iajs-3367	273	9	266	266	NUM
iajs-3367	273	10	-	-	SYM
iajs-3367	273	11	281	281	NUM
iajs-3367	273	12	.	.	NUM
iajs-3367	274	1	40	40	NUM
iajs-3367	274	2	.	.	PUNCT
iajs-3367	275	1	zargar	zargar	NOUN
iajs-3367	275	2	,	,	PUNCT
iajs-3367	275	3	a.h	a.h	PROPN
iajs-3367	275	4	.	.	PROPN
iajs-3367	275	5	;	;	PUNCT
iajs-3367	275	6	ahmad	ahmad	PROPN
iajs-3367	275	7	,	,	PUNCT
iajs-3367	275	8	s.	s.	PROPN
iajs-3367	275	9	;	;	PUNCT
iajs-3367	275	10	masoodi	masoodi	PROPN
iajs-3367	275	11	,	,	PUNCT
iajs-3367	275	12	s.r	s.r	PROPN
iajs-3367	275	13	.	.	PROPN
iajs-3367	275	14	;	;	PUNCT
iajs-3367	275	15	wani	wani	PROPN
iajs-3367	275	16	,	,	PUNCT
iajs-3367	275	17	a.i	a.i	PROPN
iajs-3367	275	18	.	.	PROPN
iajs-3367	275	19	;	;	PUNCT
iajs-3367	275	20	bashir	bashir	PROPN
iajs-3367	275	21	,	,	PUNCT
iajs-3367	275	22	m.i	m.i	PROPN
iajs-3367	275	23	.	.	PROPN
iajs-3367	275	24	;	;	PUNCT
iajs-3367	275	25	laway	laway	PROPN
iajs-3367	275	26	,	,	PUNCT
iajs-3367	275	27	b.a	b.a	PROPN
iajs-3367	275	28	.	.	PROPN
iajs-3367	275	29	;	;	PUNCT
iajs-3367	275	30	shah	shah	PROPN
iajs-3367	275	31	,	,	PUNCT
iajs-3367	275	32	z.a	z.a	PROPN
iajs-3367	275	33	.	.	PROPN
iajs-3367	275	34	vitamin	vitamin	PROPN
iajs-3367	275	35	d	d	PROPN
iajs-3367	275	36	status	status	NOUN
iajs-3367	275	37	in	in	ADP
iajs-3367	275	38	apparently	apparently	ADV
iajs-3367	275	39	healthy	healthy	ADJ
iajs-3367	275	40	adults	adult	NOUN
iajs-3367	275	41	in	in	ADP
iajs-3367	275	42	kashmir	kashmir	PROPN
iajs-3367	275	43	valley	valley	PROPN
iajs-3367	275	44	of	of	ADP
iajs-3367	275	45	indian	indian	PROPN
iajs-3367	275	46	subcontinent	subcontinent	PROPN
iajs-3367	275	47	.	.	PUNCT
iajs-3367	276	1	postgrad	postgrad	PROPN
iajs-3367	276	2	.	.	PUNCT
iajs-3367	277	1	med	med	PROPN
iajs-3367	277	2	.	.	PUNCT
iajs-3367	278	1	j.	j.	PROPN
iajs-3367	278	2	,	,	PUNCT
iajs-3367	278	3	2007	2007	NUM
iajs-3367	278	4	,	,	PUNCT
iajs-3367	278	5	83	83	NUM
iajs-3367	278	6	,	,	PUNCT
iajs-3367	278	7	713	713	NUM
iajs-3367	278	8	-	-	SYM
iajs-3367	278	9	716	716	NUM
iajs-3367	278	10	.	.	NOUN
iajs-3367	278	11	41	41	NUM
iajs-3367	278	12	.	.	PUNCT
iajs-3367	279	1	hussain	hussain	PROPN
iajs-3367	279	2	,	,	PUNCT
iajs-3367	279	3	a.n	a.n	PROPN
iajs-3367	279	4	.	.	PROPN
iajs-3367	279	5	;	;	PUNCT
iajs-3367	279	6	alkhenizan	alkhenizan	NOUN
iajs-3367	279	7	,	,	PUNCT
iajs-3367	279	8	a.h	a.h	PROPN
iajs-3367	279	9	.	.	PROPN
iajs-3367	279	10	;	;	PUNCT
iajs-3367	279	11	el	el	PROPN
iajs-3367	279	12	shaker	shaker	PROPN
iajs-3367	279	13	,	,	PUNCT
iajs-3367	279	14	m.	m.	NOUN
iajs-3367	279	15	;	;	PUNCT
iajs-3367	279	16	raef	raef	PROPN
iajs-3367	279	17	,	,	PUNCT
iajs-3367	279	18	h.	h.	PROPN
iajs-3367	279	19	;	;	PUNCT
iajs-3367	279	20	gabr	gabr	NOUN
iajs-3367	279	21	,	,	PUNCT
iajs-3367	279	22	a.	a.	NOUN
iajs-3367	279	23	increasing	increase	VERB
iajs-3367	279	24	trends	trend	NOUN
iajs-3367	279	25	and	and	CCONJ
iajs-3367	279	26	significance	significance	NOUN
iajs-3367	279	27	of	of	ADP
iajs-3367	279	28	hypovitaminosis	hypovitaminosis	NOUN
iajs-3367	280	1	d	d	NOUN
iajs-3367	280	2	:	:	PUNCT
iajs-3367	280	3	a	a	DET
iajs-3367	280	4	population	population	NOUN
iajs-3367	280	5	-	-	PUNCT
iajs-3367	280	6	based	base	VERB
iajs-3367	280	7	study	study	NOUN
iajs-3367	280	8	in	in	ADP
iajs-3367	280	9	the	the	DET
iajs-3367	280	10	kingdom	kingdom	NOUN
iajs-3367	280	11	of	of	ADP
iajs-3367	280	12	saudi	saudi	PROPN
iajs-3367	280	13	arabia	arabia	PROPN
iajs-3367	280	14	.	.	PUNCT
iajs-3367	281	1	arch	arch	PROPN
iajs-3367	281	2	.	.	PUNCT
iajs-3367	282	1	osteoporos	osteoporo	NOUN
iajs-3367	282	2	.	.	PUNCT
iajs-3367	282	3	,	,	PUNCT
iajs-3367	282	4	2014	2014	NUM
iajs-3367	282	5	,	,	PUNCT
iajs-3367	282	6	9	9	NUM
iajs-3367	282	7	,	,	PUNCT
iajs-3367	282	8	1	1	NUM
iajs-3367	282	9	-	-	SYM
iajs-3367	282	10	5	5	NUM
iajs-3367	282	11	.	.	PUNCT
iajs-3367	282	12	ihjpas	ihjpas	PROPN
iajs-3367	282	13	.	.	PUNCT
iajs-3367	283	1	37	37	NUM
iajs-3367	283	2	(	(	PUNCT
iajs-3367	283	3	1	1	NUM
iajs-3367	283	4	)	)	PUNCT
iajs-3367	283	5	2024	2024	NUM
iajs-3367	283	6	17	17	NUM
iajs-3367	283	7	42	42	NUM
iajs-3367	283	8	.	.	PUNCT
iajs-3367	284	1	islam	islam	PROPN
iajs-3367	284	2	,	,	PUNCT
iajs-3367	284	3	m.a	m.a	PROPN
iajs-3367	284	4	.	.	PROPN
iajs-3367	284	5	;	;	PUNCT
iajs-3367	284	6	khandker	khandker	NOUN
iajs-3367	284	7	,	,	PUNCT
iajs-3367	284	8	s.s	s.s	PROPN
iajs-3367	284	9	.	.	PROPN
iajs-3367	284	10	;	;	PUNCT
iajs-3367	284	11	alam	alam	PROPN
iajs-3367	284	12	,	,	PUNCT
iajs-3367	284	13	s.s	s.s	PROPN
iajs-3367	284	14	.	.	PROPN
iajs-3367	284	15	;	;	PUNCT
iajs-3367	284	16	kotyla	kotyla	PROPN
iajs-3367	284	17	,	,	PUNCT
iajs-3367	284	18	p.	p.	PROPN
iajs-3367	284	19	;	;	PUNCT
iajs-3367	284	20	hassan	hassan	PROPN
iajs-3367	284	21	,	,	PUNCT
iajs-3367	284	22	r.	r.	PROPN
iajs-3367	284	23	vitamin	vitamin	PROPN
iajs-3367	284	24	d	d	PROPN
iajs-3367	284	25	status	status	NOUN
iajs-3367	284	26	in	in	ADP
iajs-3367	284	27	patients	patient	NOUN
iajs-3367	284	28	with	with	ADP
iajs-3367	284	29	systemic	systemic	ADJ
iajs-3367	284	30	lupus	lupus	NOUN
iajs-3367	284	31	erythematosus	erythematosus	NOUN
iajs-3367	284	32	(	(	PUNCT
iajs-3367	284	33	sle	sle	PROPN
iajs-3367	284	34	):	):	PUNCT
iajs-3367	284	35	a	a	DET
iajs-3367	284	36	systematic	systematic	ADJ
iajs-3367	284	37	review	review	NOUN
iajs-3367	284	38	and	and	CCONJ
iajs-3367	284	39	metaanalysis	metaanalysis	NOUN
iajs-3367	284	40	.	.	PUNCT
iajs-3367	285	1	autoimmun	autoimmun	PROPN
iajs-3367	285	2	.	.	PUNCT
iajs-3367	286	1	rev	rev	PROPN
iajs-3367	286	2	.	.	PROPN
iajs-3367	286	3	,	,	PUNCT
iajs-3367	286	4	2019	2019	NUM
iajs-3367	286	5	,	,	PUNCT
iajs-3367	286	6	18	18	NUM
iajs-3367	286	7	,	,	PUNCT
iajs-3367	286	8	102392	102392	NUM
iajs-3367	286	9	.	.	PUNCT
iajs-3367	287	1	43	43	NUM
iajs-3367	287	2	.	.	PUNCT
iajs-3367	288	1	attar	attar	PROPN
iajs-3367	288	2	,	,	PUNCT
iajs-3367	288	3	s.m	s.m	PROPN
iajs-3367	288	4	.	.	PROPN
iajs-3367	288	5	and	and	CCONJ
iajs-3367	288	6	siddiqui	siddiqui	NOUN
iajs-3367	288	7	,	,	PUNCT
iajs-3367	288	8	a.m.	a.m.	ADV
iajs-3367	288	9	vitamin	vitamin	NOUN
iajs-3367	288	10	d	d	NOUN
iajs-3367	288	11	deficiency	deficiency	NOUN
iajs-3367	288	12	in	in	ADP
iajs-3367	288	13	patients	patient	NOUN
iajs-3367	288	14	with	with	ADP
iajs-3367	288	15	systemic	systemic	ADJ
iajs-3367	288	16	lupus	lupus	PROPN
iajs-3367	288	17	erythematosus	erythematosus	PROPN
iajs-3367	288	18	.	.	PUNCT
iajs-3367	289	1	oman	oman	PROPN
iajs-3367	289	2	med	med	PROPN
iajs-3367	289	3	.	.	PUNCT
iajs-3367	290	1	j.	j.	PROPN
iajs-3367	290	2	,	,	PUNCT
iajs-3367	290	3	2013	2013	NUM
iajs-3367	290	4	,	,	PUNCT
iajs-3367	290	5	28	28	NUM
iajs-3367	290	6	,	,	PUNCT
iajs-3367	290	7	42	42	NUM
iajs-3367	290	8	.	.	PUNCT
iajs-3367	290	9	44	44	NUM
iajs-3367	290	10	.	.	PUNCT
iajs-3367	291	1	stockton	stockton	PROPN
iajs-3367	291	2	,	,	PUNCT
iajs-3367	291	3	k.a	k.a	PROPN
iajs-3367	291	4	.	.	PROPN
iajs-3367	291	5	;	;	PUNCT
iajs-3367	291	6	kandiah	kandiah	PROPN
iajs-3367	291	7	,	,	PUNCT
iajs-3367	291	8	d.a	d.a	PROPN
iajs-3367	291	9	.	.	PROPN
iajs-3367	291	10	;	;	PUNCT
iajs-3367	291	11	paratz	paratz	NOUN
iajs-3367	291	12	,	,	PUNCT
iajs-3367	291	13	j.d	j.d	PROPN
iajs-3367	291	14	.	.	PROPN
iajs-3367	291	15	;	;	PUNCT
iajs-3367	291	16	bennell	bennell	PROPN
iajs-3367	291	17	,	,	PUNCT
iajs-3367	291	18	k.l	k.l	PROPN
iajs-3367	291	19	.	.	PROPN
iajs-3367	291	20	fatigue	fatigue	NOUN
iajs-3367	291	21	,	,	PUNCT
iajs-3367	291	22	muscle	muscle	NOUN
iajs-3367	291	23	strength	strength	NOUN
iajs-3367	291	24	and	and	CCONJ
iajs-3367	291	25	vitamin	vitamin	NOUN
iajs-3367	291	26	d	d	NOUN
iajs-3367	291	27	status	status	NOUN
iajs-3367	291	28	in	in	ADP
iajs-3367	291	29	women	woman	NOUN
iajs-3367	291	30	with	with	ADP
iajs-3367	291	31	systemic	systemic	ADJ
iajs-3367	291	32	lupus	lupus	NOUN
iajs-3367	291	33	erythematosus	erythematosus	NOUN
iajs-3367	291	34	compared	compare	VERB
iajs-3367	291	35	with	with	ADP
iajs-3367	291	36	healthy	healthy	ADJ
iajs-3367	291	37	controls	control	NOUN
iajs-3367	291	38	.	.	PUNCT
iajs-3367	292	1	lupus	lupus	NOUN
iajs-3367	292	2	,	,	PUNCT
iajs-3367	292	3	2012	2012	NUM
iajs-3367	292	4	,	,	PUNCT
iajs-3367	292	5	21	21	NUM
iajs-3367	292	6	,	,	PUNCT
iajs-3367	292	7	271	271	NUM
iajs-3367	292	8	-	-	SYM
iajs-3367	292	9	278	278	NUM
iajs-3367	292	10	.	.	PUNCT
iajs-3367	293	1	45	45	NUM
iajs-3367	293	2	.	.	PUNCT
iajs-3367	293	3	kavadichanda	kavadichanda	PROPN
iajs-3367	293	4	,	,	PUNCT
iajs-3367	293	5	c.	c.	PROPN
iajs-3367	293	6	;	;	PUNCT
iajs-3367	293	7	singh	singh	PROPN
iajs-3367	293	8	,	,	PUNCT
iajs-3367	293	9	p.	p.	PROPN
iajs-3367	293	10	;	;	PUNCT
iajs-3367	293	11	maurya	maurya	PROPN
iajs-3367	293	12	,	,	PUNCT
iajs-3367	293	13	s.	s.	PROPN
iajs-3367	293	14	;	;	PUNCT
iajs-3367	293	15	tota	tota	PROPN
iajs-3367	293	16	,	,	PUNCT
iajs-3367	293	17	s.	s.	PROPN
iajs-3367	293	18	;	;	PUNCT
iajs-3367	293	19	kiroubagarin	kiroubagarin	PROPN
iajs-3367	293	20	,	,	PUNCT
iajs-3367	293	21	a.	a.	NOUN
iajs-3367	293	22	;	;	PUNCT
iajs-3367	293	23	kounassegarane	kounassegarane	PROPN
iajs-3367	293	24	,	,	PUNCT
iajs-3367	293	25	d.	d.	PROPN
iajs-3367	293	26	;	;	PUNCT
iajs-3367	293	27	anand	anand	PROPN
iajs-3367	293	28	,	,	PUNCT
iajs-3367	293	29	s.	s.	PROPN
iajs-3367	293	30	;	;	PUNCT
iajs-3367	293	31	negi	negi	PROPN
iajs-3367	293	32	,	,	PUNCT
iajs-3367	293	33	v.s.	v.s.	ADJ
iajs-3367	293	34	;	;	PUNCT
iajs-3367	293	35	aggarwal	aggarwal	NOUN
iajs-3367	293	36	,	,	PUNCT
iajs-3367	293	37	a.	a.	NOUN
iajs-3367	293	38	clinical	clinical	ADJ
iajs-3367	293	39	and	and	CCONJ
iajs-3367	293	40	serological	serological	ADJ
iajs-3367	293	41	association	association	NOUN
iajs-3367	293	42	of	of	ADP
iajs-3367	293	43	plasma	plasma	PROPN
iajs-3367	294	1	25hydroxyvitamin	25hydroxyvitamin	PROPN
iajs-3367	294	2	d	d	NOUN
iajs-3367	294	3	(	(	PUNCT
iajs-3367	294	4	25	25	NUM
iajs-3367	294	5	(	(	PUNCT
iajs-3367	294	6	oh	oh	INTJ
iajs-3367	294	7	)	)	PUNCT
iajs-3367	294	8	d	d	NOUN
iajs-3367	294	9	)	)	PUNCT
iajs-3367	294	10	levels	level	NOUN
iajs-3367	294	11	in	in	ADP
iajs-3367	294	12	lupus	lupus	NOUN
iajs-3367	294	13	and	and	CCONJ
iajs-3367	294	14	the	the	DET
iajs-3367	294	15	short	short	ADJ
iajs-3367	294	16	-	-	PUNCT
iajs-3367	294	17	term	term	NOUN
iajs-3367	294	18	effects	effect	NOUN
iajs-3367	294	19	of	of	ADP
iajs-3367	294	20	oral	oral	ADJ
iajs-3367	294	21	vitamin	vitamin	NOUN
iajs-3367	294	22	d	d	NOUN
iajs-3367	294	23	supplementation	supplementation	NOUN
iajs-3367	294	24	.	.	PUNCT
iajs-3367	295	1	arthritis	arthritis	NOUN
iajs-3367	295	2	res	re	NOUN
iajs-3367	295	3	.	.	PUNCT
iajs-3367	296	1	ther	ther	PROPN
iajs-3367	296	2	.	.	PUNCT
iajs-3367	296	3	,	,	PUNCT
iajs-3367	296	4	2023	2023	NUM
iajs-3367	296	5	,	,	PUNCT
iajs-3367	296	6	25	25	NUM
iajs-3367	296	7	,	,	PUNCT
iajs-3367	296	8	1	1	NUM
iajs-3367	296	9	-	-	SYM
iajs-3367	296	10	10	10	NUM
iajs-3367	296	11	.	.	PUNCT
iajs-3367	297	1	46	46	NUM
iajs-3367	297	2	.	.	PUNCT
iajs-3367	298	1	nerviani	nerviani	PROPN
iajs-3367	298	2	,	,	PUNCT
iajs-3367	298	3	a.	a.	PROPN
iajs-3367	298	4	;	;	PUNCT
iajs-3367	298	5	mauro	mauro	PROPN
iajs-3367	298	6	,	,	PUNCT
iajs-3367	298	7	d.	d.	PROPN
iajs-3367	298	8	;	;	PUNCT
iajs-3367	298	9	gilio	gilio	PROPN
iajs-3367	298	10	,	,	PUNCT
iajs-3367	298	11	m.	m.	NOUN
iajs-3367	298	12	;	;	PUNCT
iajs-3367	298	13	grembiale	grembiale	NOUN
iajs-3367	298	14	,	,	PUNCT
iajs-3367	298	15	r.d	r.d	PROPN
iajs-3367	298	16	.	.	PROPN
iajs-3367	298	17	;	;	PUNCT
iajs-3367	298	18	lewis	lewis	PROPN
iajs-3367	298	19	,	,	PUNCT
iajs-3367	298	20	m.j	m.j	PROPN
iajs-3367	298	21	.	.	PROPN
iajs-3367	298	22	to	to	PART
iajs-3367	298	23	supplement	supplement	VERB
iajs-3367	298	24	or	or	CCONJ
iajs-3367	298	25	not	not	PART
iajs-3367	298	26	to	to	PART
iajs-3367	298	27	supplement	supplement	VERB
iajs-3367	298	28	?	?	PUNCT
iajs-3367	299	1	the	the	DET
iajs-3367	299	2	rationale	rationale	NOUN
iajs-3367	299	3	of	of	ADP
iajs-3367	299	4	vitamin	vitamin	NOUN
iajs-3367	299	5	d	d	NOUN
iajs-3367	299	6	supplementation	supplementation	NOUN
iajs-3367	299	7	in	in	ADP
iajs-3367	299	8	systemic	systemic	ADJ
iajs-3367	299	9	lupus	lupus	PROPN
iajs-3367	299	10	erythematosus	erythematosus	PROPN
iajs-3367	299	11	.	.	PUNCT
iajs-3367	300	1	open	open	ADJ
iajs-3367	300	2	rheumatol	rheumatol	NOUN
iajs-3367	300	3	.	.	PUNCT
iajs-3367	301	1	j.	j.	PROPN
iajs-3367	301	2	,	,	PUNCT
iajs-3367	301	3	2018	2018	NUM
iajs-3367	301	4	,	,	PUNCT
iajs-3367	301	5	12	12	NUM
iajs-3367	301	6	,	,	PUNCT
iajs-3367	301	7	226	226	NUM
iajs-3367	301	8	-	-	SYM
iajs-3367	301	9	247	247	NUM
iajs-3367	301	10	.	.	PUNCT
iajs-3367	301	11	47	47	NUM
iajs-3367	301	12	.	.	PUNCT
iajs-3367	302	1	anastasilakis	anastasilakis	PROPN
iajs-3367	302	2	,	,	PUNCT
iajs-3367	302	3	a.d	a.d	PROPN
iajs-3367	302	4	.	.	PROPN
iajs-3367	302	5	;	;	PUNCT
iajs-3367	302	6	goulis	goulis	PROPN
iajs-3367	302	7	,	,	PUNCT
iajs-3367	302	8	d.g	d.g	PROPN
iajs-3367	302	9	.	.	PROPN
iajs-3367	302	10	;	;	PUNCT
iajs-3367	302	11	polyzos	polyzos	PROPN
iajs-3367	302	12	,	,	PUNCT
iajs-3367	302	13	s.a	s.a	PROPN
iajs-3367	302	14	.	.	PROPN
iajs-3367	302	15	;	;	PUNCT
iajs-3367	302	16	gerou	gerou	PROPN
iajs-3367	302	17	,	,	PUNCT
iajs-3367	302	18	s.	s.	PROPN
iajs-3367	302	19	;	;	PUNCT
iajs-3367	302	20	pavlidou	pavlidou	NOUN
iajs-3367	302	21	,	,	PUNCT
iajs-3367	302	22	v.	v.	PROPN
iajs-3367	302	23	;	;	PUNCT
iajs-3367	302	24	koukoulis	koukoulis	PROPN
iajs-3367	302	25	,	,	PUNCT
iajs-3367	302	26	g.	g.	PROPN
iajs-3367	302	27	;	;	PUNCT
iajs-3367	302	28	avramidis	avramidis	PROPN
iajs-3367	302	29	,	,	PUNCT
iajs-3367	302	30	a.	a.	NOUN
iajs-3367	302	31	acute	acute	NOUN
iajs-3367	302	32	changes	change	NOUN
iajs-3367	302	33	in	in	ADP
iajs-3367	302	34	serum	serum	NOUN
iajs-3367	302	35	osteoprotegerin	osteoprotegerin	NOUN
iajs-3367	302	36	and	and	CCONJ
iajs-3367	302	37	receptor	receptor	NOUN
iajs-3367	302	38	activator	activator	NOUN
iajs-3367	302	39	for	for	ADP
iajs-3367	302	40	nuclear	nuclear	ADJ
iajs-3367	302	41	factor	factor	NOUN
iajs-3367	302	42	-	-	PUNCT
iajs-3367	302	43	κb	κb	PROPN
iajs-3367	302	44	ligand	ligand	NOUN
iajs-3367	302	45	levels	level	NOUN
iajs-3367	302	46	in	in	ADP
iajs-3367	302	47	women	woman	NOUN
iajs-3367	302	48	with	with	ADP
iajs-3367	302	49	established	establish	VERB
iajs-3367	302	50	osteoporosis	osteoporosis	NOUN
iajs-3367	302	51	treated	treat	VERB
iajs-3367	302	52	with	with	ADP
iajs-3367	302	53	teriparatide	teriparatide	NOUN
iajs-3367	302	54	.	.	PUNCT
iajs-3367	303	1	eur	eur	PROPN
iajs-3367	303	2	.	.	PUNCT
iajs-3367	304	1	j.	j.	PROPN
iajs-3367	304	2	endocrinol	endocrinol	PROPN
iajs-3367	304	3	.	.	PROPN
iajs-3367	304	4	,	,	PUNCT
iajs-3367	304	5	2008	2008	NUM
iajs-3367	304	6	,	,	PUNCT
iajs-3367	304	7	158	158	NUM
iajs-3367	304	8	,	,	PUNCT
iajs-3367	304	9	411	411	NUM
iajs-3367	304	10	-	-	SYM
iajs-3367	304	11	415	415	NUM
iajs-3367	304	12	.	.	PUNCT
iajs-3367	305	1	48	48	NUM
iajs-3367	305	2	.	.	X
iajs-3367	305	3	carmona	carmona	PROPN
iajs-3367	305	4	-	-	PUNCT
iajs-3367	305	5	fernandes	fernandes	PROPN
iajs-3367	305	6	,	,	PUNCT
iajs-3367	305	7	d.	d.	PROPN
iajs-3367	305	8	;	;	PUNCT
iajs-3367	305	9	santos	santos	PROPN
iajs-3367	305	10	,	,	PUNCT
iajs-3367	305	11	m.j	m.j	PROPN
iajs-3367	305	12	.	.	PROPN
iajs-3367	305	13	;	;	PUNCT
iajs-3367	305	14	perpétuo	perpétuo	NOUN
iajs-3367	305	15	,	,	PUNCT
iajs-3367	305	16	i.p	i.p	PROPN
iajs-3367	305	17	.	.	PROPN
iajs-3367	305	18	;	;	PUNCT
iajs-3367	305	19	fonseca	fonseca	PROPN
iajs-3367	305	20	,	,	PUNCT
iajs-3367	305	21	j.e	j.e	PROPN
iajs-3367	305	22	.	.	PROPN
iajs-3367	305	23	;	;	PUNCT
iajs-3367	305	24	canhão	canhão	PROPN
iajs-3367	305	25	,	,	PUNCT
iajs-3367	305	26	h.	h.	PROPN
iajs-3367	305	27	soluble	soluble	ADJ
iajs-3367	305	28	receptor	receptor	NOUN
iajs-3367	305	29	activator	activator	NOUN
iajs-3367	305	30	of	of	ADP
iajs-3367	305	31	nuclear	nuclear	ADJ
iajs-3367	305	32	factor	factor	NOUN
iajs-3367	305	33	κb	κb	PROPN
iajs-3367	305	34	ligand	ligand	PROPN
iajs-3367	305	35	/	/	SYM
iajs-3367	305	36	osteoprotegerin	osteoprotegerin	NOUN
iajs-3367	305	37	ratio	ratio	NOUN
iajs-3367	305	38	is	be	AUX
iajs-3367	305	39	increased	increase	VERB
iajs-3367	305	40	in	in	ADP
iajs-3367	305	41	systemic	systemic	ADJ
iajs-3367	305	42	lupus	lupus	NOUN
iajs-3367	305	43	erythematosus	erythematosus	PROPN
iajs-3367	305	44	patients	patient	NOUN
iajs-3367	305	45	.	.	PUNCT
iajs-3367	306	1	arthritis	arthritis	NOUN
iajs-3367	306	2	res	re	NOUN
iajs-3367	306	3	.	.	PUNCT
iajs-3367	307	1	ther	ther	PROPN
iajs-3367	307	2	.	.	PUNCT
iajs-3367	307	3	,	,	PUNCT
iajs-3367	307	4	2011	2011	NUM
iajs-3367	307	5	,	,	PUNCT
iajs-3367	307	6	13	13	NUM
iajs-3367	307	7	,	,	PUNCT
iajs-3367	307	8	1	1	NUM
iajs-3367	307	9	-	-	SYM
iajs-3367	307	10	6	6	NUM
iajs-3367	307	11	.	.	NOUN
iajs-3367	307	12	49	49	NUM
iajs-3367	307	13	.	.	PUNCT
iajs-3367	308	1	eghbali	eghbali	PROPN
iajs-3367	308	2	-	-	NOUN
iajs-3367	308	3	fatourechi	fatourechi	PROPN
iajs-3367	308	4	,	,	PUNCT
iajs-3367	308	5	g.	g.	PROPN
iajs-3367	308	6	;	;	PUNCT
iajs-3367	308	7	khosla	khosla	PROPN
iajs-3367	308	8	,	,	PUNCT
iajs-3367	308	9	s.	s.	PROPN
iajs-3367	308	10	;	;	PUNCT
iajs-3367	308	11	sanyal	sanyal	PROPN
iajs-3367	308	12	,	,	PUNCT
iajs-3367	308	13	a.	a.	NOUN
iajs-3367	308	14	;	;	PUNCT
iajs-3367	308	15	boyle	boyle	PROPN
iajs-3367	308	16	,	,	PUNCT
iajs-3367	308	17	w.j	w.j	PROPN
iajs-3367	308	18	.	.	PROPN
iajs-3367	308	19	;	;	PUNCT
iajs-3367	308	20	lacey	lacey	PROPN
iajs-3367	308	21	,	,	PUNCT
iajs-3367	308	22	d.l	d.l	PROPN
iajs-3367	308	23	.	.	PROPN
iajs-3367	308	24	;	;	PUNCT
iajs-3367	308	25	riggs	riggs	PROPN
iajs-3367	308	26	,	,	PUNCT
iajs-3367	308	27	b.l	b.l	PROPN
iajs-3367	308	28	.	.	PROPN
iajs-3367	308	29	role	role	NOUN
iajs-3367	308	30	of	of	ADP
iajs-3367	308	31	rank	rank	NOUN
iajs-3367	308	32	ligand	ligand	NOUN
iajs-3367	308	33	in	in	ADP
iajs-3367	308	34	mediating	mediate	VERB
iajs-3367	308	35	increased	increase	VERB
iajs-3367	308	36	bone	bone	NOUN
iajs-3367	308	37	resorption	resorption	NOUN
iajs-3367	308	38	in	in	ADP
iajs-3367	308	39	early	early	ADJ
iajs-3367	308	40	postmenopausal	postmenopausal	ADJ
iajs-3367	308	41	women	woman	NOUN
iajs-3367	308	42	.	.	PUNCT
iajs-3367	309	1	j.	j.	PROPN
iajs-3367	309	2	clin	clin	PROPN
iajs-3367	309	3	.	.	PUNCT
iajs-3367	310	1	investig	investig	PROPN
iajs-3367	310	2	.	.	PROPN
iajs-3367	310	3	,	,	PUNCT
iajs-3367	310	4	2003	2003	NUM
iajs-3367	310	5	,	,	PUNCT
iajs-3367	310	6	111	111	NUM
iajs-3367	310	7	,	,	PUNCT
iajs-3367	310	8	1221	1221	NUM
iajs-3367	310	9	-	-	SYM
iajs-3367	310	10	1230	1230	NUM
iajs-3367	310	11	.	.	PUNCT
iajs-3367	311	1	50	50	NUM
iajs-3367	311	2	.	.	PUNCT
iajs-3367	311	3	rogers	roger	NOUN
iajs-3367	311	4	,	,	PUNCT
iajs-3367	311	5	a.	a.	NOUN
iajs-3367	311	6	;	;	PUNCT
iajs-3367	311	7	eastell	eastell	PROPN
iajs-3367	311	8	,	,	PUNCT
iajs-3367	311	9	r.	r.	PROPN
iajs-3367	311	10	circulating	circulate	VERB
iajs-3367	311	11	osteoprotegerin	osteoprotegerin	NOUN
iajs-3367	311	12	and	and	CCONJ
iajs-3367	311	13	receptor	receptor	NOUN
iajs-3367	311	14	activator	activator	NOUN
iajs-3367	311	15	for	for	ADP
iajs-3367	311	16	nuclear	nuclear	ADJ
iajs-3367	311	17	factor	factor	NOUN
iajs-3367	311	18	κb	κb	PROPN
iajs-3367	311	19	ligand	ligand	PROPN
iajs-3367	311	20	:	:	PUNCT
iajs-3367	311	21	clinical	clinical	ADJ
iajs-3367	311	22	utility	utility	NOUN
iajs-3367	311	23	in	in	ADP
iajs-3367	311	24	metabolic	metabolic	NOUN
iajs-3367	311	25	bone	bone	NOUN
iajs-3367	311	26	disease	disease	NOUN
iajs-3367	311	27	assessment	assessment	NOUN
iajs-3367	311	28	.	.	PUNCT
iajs-3367	312	1	j.	j.	PROPN
iajs-3367	312	2	clin	clin	PROPN
iajs-3367	312	3	.	.	PUNCT
iajs-3367	313	1	endocrinol	endocrinol	NOUN
iajs-3367	313	2	.	.	PUNCT
iajs-3367	314	1	metab	metab	PROPN
iajs-3367	314	2	.	.	PUNCT
iajs-3367	314	3	,	,	PUNCT
iajs-3367	314	4	2005	2005	NUM
iajs-3367	314	5	,	,	PUNCT
iajs-3367	314	6	90	90	NUM
iajs-3367	314	7	,	,	PUNCT
iajs-3367	314	8	6323	6323	NUM
iajs-3367	314	9	-	-	SYM
iajs-3367	314	10	6331	6331	NUM
iajs-3367	314	11	.	.	PUNCT
iajs-3367	315	1	51	51	NUM
iajs-3367	315	2	.	.	PUNCT
iajs-3367	316	1	hao	hao	PROPN
iajs-3367	316	2	,	,	PUNCT
iajs-3367	316	3	s.	s.	PROPN
iajs-3367	316	4	;	;	PUNCT
iajs-3367	316	5	zhang	zhang	PROPN
iajs-3367	316	6	,	,	PUNCT
iajs-3367	316	7	j.	j.	PROPN
iajs-3367	316	8	;	;	PUNCT
iajs-3367	316	9	huang	huang	PROPN
iajs-3367	316	10	,	,	PUNCT
iajs-3367	316	11	b.	b.	PROPN
iajs-3367	316	12	;	;	PUNCT
iajs-3367	316	13	feng	feng	PROPN
iajs-3367	316	14	,	,	PUNCT
iajs-3367	316	15	d.	d.	PROPN
iajs-3367	316	16	;	;	PUNCT
iajs-3367	316	17	niu	niu	PROPN
iajs-3367	316	18	,	,	PUNCT
iajs-3367	316	19	x.	x.	PROPN
iajs-3367	316	20	;	;	PUNCT
iajs-3367	316	21	huang	huang	PROPN
iajs-3367	316	22	,	,	PUNCT
iajs-3367	316	23	w.	w.	PROPN
iajs-3367	316	24	bone	bone	NOUN
iajs-3367	316	25	remodeling	remodeling	NOUN
iajs-3367	316	26	serum	serum	NOUN
iajs-3367	316	27	markers	marker	NOUN
iajs-3367	316	28	in	in	ADP
iajs-3367	316	29	children	child	NOUN
iajs-3367	316	30	with	with	ADP
iajs-3367	316	31	systemic	systemic	ADJ
iajs-3367	316	32	lupus	lupus	PROPN
iajs-3367	316	33	erythematosus	erythematosus	NOUN
iajs-3367	316	34	.	.	PUNCT
iajs-3367	317	1	pediatr	pediatr	ADJ
iajs-3367	317	2	.	.	PUNCT
iajs-3367	317	3	rheumatol	rheumatol	PROPN
iajs-3367	317	4	.	.	PUNCT
iajs-3367	317	5	,	,	PUNCT
iajs-3367	317	6	2022	2022	NUM
iajs-3367	317	7	,	,	PUNCT
iajs-3367	317	8	20	20	NUM
iajs-3367	317	9	,	,	PUNCT
iajs-3367	317	10	1	1	NUM
iajs-3367	317	11	-	-	SYM
iajs-3367	317	12	6	6	NUM
iajs-3367	317	13	.	.	NOUN
iajs-3367	317	14	52	52	NUM
iajs-3367	317	15	.	.	X
iajs-3367	317	16	ali	ali	PROPN
iajs-3367	317	17	,	,	PUNCT
iajs-3367	317	18	r.	r.	PROPN
iajs-3367	317	19	;	;	PUNCT
iajs-3367	318	1	hammad	hammad	PROPN
iajs-3367	318	2	,	,	PUNCT
iajs-3367	318	3	a.	a.	PROPN
iajs-3367	318	4	;	;	PUNCT
iajs-3367	318	5	el	el	PROPN
iajs-3367	318	6	-	-	PUNCT
iajs-3367	318	7	nahrery	nahrery	NOUN
iajs-3367	318	8	,	,	PUNCT
iajs-3367	318	9	e.	e.	PROPN
iajs-3367	318	10	;	;	PUNCT
iajs-3367	318	11	hamdy	hamdy	PROPN
iajs-3367	318	12	,	,	PUNCT
iajs-3367	318	13	n.	n.	PROPN
iajs-3367	318	14	;	;	PUNCT
iajs-3367	318	15	elhawary	elhawary	ADJ
iajs-3367	318	16	,	,	PUNCT
iajs-3367	318	17	a.k	a.k	PROPN
iajs-3367	318	18	.	.	PROPN
iajs-3367	318	19	;	;	PUNCT
iajs-3367	318	20	eid	eid	PROPN
iajs-3367	318	21	,	,	PUNCT
iajs-3367	318	22	r.	r.	PROPN
iajs-3367	318	23	serum	serum	PROPN
iajs-3367	318	24	rankl	rankl	PROPN
iajs-3367	318	25	,	,	PUNCT
iajs-3367	318	26	osteoprotegerin	osteoprotegerin	NOUN
iajs-3367	318	27	(	(	PUNCT
iajs-3367	318	28	opg	opg	PROPN
iajs-3367	318	29	)	)	PUNCT
iajs-3367	318	30	and	and	CCONJ
iajs-3367	318	31	rankl	rankl	VERB
iajs-3367	318	32	/	/	SYM
iajs-3367	318	33	opg	opg	PROPN
iajs-3367	318	34	ratio	ratio	NOUN
iajs-3367	318	35	in	in	ADP
iajs-3367	318	36	children	child	NOUN
iajs-3367	318	37	with	with	ADP
iajs-3367	318	38	systemic	systemic	ADJ
iajs-3367	318	39	lupus	lupus	PROPN
iajs-3367	318	40	erythematosus	erythematosus	NOUN
iajs-3367	318	41	.	.	PUNCT
iajs-3367	319	1	lupus	lupus	NOUN
iajs-3367	319	2	,	,	PUNCT
iajs-3367	319	3	2019	2019	NUM
iajs-3367	319	4	,	,	PUNCT
iajs-3367	319	5	28	28	NUM
iajs-3367	319	6	,	,	PUNCT
iajs-3367	319	7	1233	1233	NUM
iajs-3367	319	8	-	-	SYM
iajs-3367	319	9	1242	1242	NUM
iajs-3367	319	10	.	.	PUNCT
iajs-3367	320	1	53	53	NUM
iajs-3367	320	2	.	.	PUNCT
iajs-3367	321	1	sandal	sandal	NOUN
iajs-3367	321	2	,	,	PUNCT
iajs-3367	321	3	s.	s.	PROPN
iajs-3367	321	4	;	;	PUNCT
iajs-3367	321	5	rawat	rawat	PROPN
iajs-3367	321	6	,	,	PUNCT
iajs-3367	321	7	a.	a.	NOUN
iajs-3367	321	8	;	;	PUNCT
iajs-3367	321	9	gupta	gupta	PROPN
iajs-3367	321	10	,	,	PUNCT
iajs-3367	321	11	a.	a.	NOUN
iajs-3367	321	12	;	;	PUNCT
iajs-3367	321	13	singh	singh	PROPN
iajs-3367	321	14	,	,	PUNCT
iajs-3367	321	15	s.	s.	PROPN
iajs-3367	321	16	141	141	NUM
iajs-3367	321	17	soluble	soluble	ADJ
iajs-3367	321	18	receptor	receptor	NOUN
iajs-3367	321	19	activator	activator	NOUN
iajs-3367	321	20	of	of	ADP
iajs-3367	321	21	nuclear	nuclear	ADJ
iajs-3367	321	22	factor	factor	NOUN
iajs-3367	321	23	κ	κ	PROPN
iajs-3367	321	24	b	b	PROPN
iajs-3367	321	25	ligand	ligand	PROPN
iajs-3367	321	26	(	(	PUNCT
iajs-3367	321	27	s	s	VERB
iajs-3367	321	28	rank	rank	NOUN
iajs-3367	321	29	-	-	PUNCT
iajs-3367	321	30	l	l	NOUN
iajs-3367	321	31	)	)	PUNCT
iajs-3367	321	32	levels	level	NOUN
iajs-3367	321	33	in	in	ADP
iajs-3367	321	34	paediatric	paediatric	ADJ
iajs-3367	321	35	onset	onset	VERB
iajs-3367	321	36	sle	sle	PROPN
iajs-3367	321	37	.	.	PUNCT
iajs-3367	322	1	lupus	lupus	PROPN
iajs-3367	322	2	sci	sci	PROPN
iajs-3367	322	3	.	.	PROPN
iajs-3367	322	4	med	med	PROPN
iajs-3367	322	5	.	.	PROPN
iajs-3367	322	6	,	,	PUNCT
iajs-3367	322	7	2017,4	2017,4	PROPN
iajs-3367	322	8	,	,	PUNCT
iajs-3367	322	9	a64	a64	NOUN
iajs-3367	322	10	.	.	PUNCT
iajs-3367	323	1	54	54	NUM
iajs-3367	323	2	.	.	PUNCT
iajs-3367	324	1	fernández	fernández	PROPN
iajs-3367	324	2	-	-	PUNCT
iajs-3367	324	3	roldán	roldán	PROPN
iajs-3367	324	4	,	,	PUNCT
iajs-3367	324	5	c.	c.	NOUN
iajs-3367	324	6	;	;	PUNCT
iajs-3367	324	7	genre	genre	NOUN
iajs-3367	324	8	,	,	PUNCT
iajs-3367	324	9	f.	f.	PROPN
iajs-3367	324	10	;	;	PUNCT
iajs-3367	324	11	lópez	lópez	NOUN
iajs-3367	324	12	-	-	PUNCT
iajs-3367	324	13	mejías	mejías	NOUN
iajs-3367	324	14	,	,	PUNCT
iajs-3367	324	15	r.	r.	PROPN
iajs-3367	324	16	;	;	PUNCT
iajs-3367	324	17	ubilla	ubilla	PROPN
iajs-3367	324	18	,	,	PUNCT
iajs-3367	324	19	b.	b.	PROPN
iajs-3367	324	20	;	;	PUNCT
iajs-3367	324	21	mijares	mijares	PROPN
iajs-3367	324	22	,	,	PUNCT
iajs-3367	324	23	v.	v.	PROPN
iajs-3367	324	24	;	;	PUNCT
iajs-3367	324	25	cano	cano	PROPN
iajs-3367	324	26	,	,	PUNCT
iajs-3367	324	27	d.s	d.s	PROPN
iajs-3367	324	28	.	.	PROPN
iajs-3367	324	29	;	;	PUNCT
iajs-3367	324	30	robles	robles	PROPN
iajs-3367	324	31	,	,	PUNCT
iajs-3367	324	32	c.l	c.l	PROPN
iajs-3367	324	33	.	.	PROPN
iajs-3367	324	34	;	;	PUNCT
iajs-3367	324	35	callejas	callejas	NOUN
iajs-3367	324	36	-	-	PUNCT
iajs-3367	324	37	rubio	rubio	PROPN
iajs-3367	324	38	,	,	PUNCT
iajs-3367	324	39	j.l	j.l	PROPN
iajs-3367	324	40	.	.	PROPN
iajs-3367	324	41	;	;	PUNCT
iajs-3367	324	42	fernández	fernández	PROPN
iajs-3367	324	43	,	,	PUNCT
iajs-3367	324	44	r.r	r.r	PROPN
iajs-3367	324	45	.	.	PROPN
iajs-3367	324	46	;	;	PUNCT
iajs-3367	324	47	ruiz	ruiz	PROPN
iajs-3367	324	48	,	,	PUNCT
iajs-3367	324	49	m.e	m.e	PROPN
iajs-3367	324	50	.	.	PROPN
iajs-3367	324	51	;	;	PUNCT
iajs-3367	324	52	gonzález	gonzález	PROPN
iajs-3367	324	53	-	-	PUNCT
iajs-3367	324	54	gay	gay	PROPN
iajs-3367	324	55	,	,	PUNCT
iajs-3367	324	56	m.á	m.á	PROPN
iajs-3367	324	57	.	.	PROPN
iajs-3367	324	58	sclerostin	sclerostin	PROPN
iajs-3367	324	59	serum	serum	NOUN
iajs-3367	324	60	levels	level	NOUN
iajs-3367	324	61	in	in	ADP
iajs-3367	324	62	patients	patient	NOUN
iajs-3367	324	63	with	with	ADP
iajs-3367	324	64	systemic	systemic	ADJ
iajs-3367	324	65	autoimmune	autoimmune	ADJ
iajs-3367	324	66	diseases	disease	NOUN
iajs-3367	324	67	.	.	PUNCT
iajs-3367	325	1	bonekey	bonekey	PROPN
iajs-3367	325	2	rep	rep	PROPN
iajs-3367	325	3	.	.	PROPN
iajs-3367	325	4	,	,	PUNCT
iajs-3367	325	5	2016	2016	NUM
iajs-3367	325	6	,	,	PUNCT
iajs-3367	325	7	5	5	NUM
iajs-3367	325	8	.	.	NOUN
iajs-3367	325	9	55	55	NUM
iajs-3367	325	10	.	.	PUNCT
iajs-3367	326	1	vargas	vargas	NOUN
iajs-3367	326	2	-	-	PUNCT
iajs-3367	326	3	muñoz	muñoz	PROPN
iajs-3367	326	4	,	,	PUNCT
iajs-3367	326	5	v.m	v.m	PROPN
iajs-3367	326	6	.	.	PUNCT
iajs-3367	326	7	;	;	PUNCT
iajs-3367	326	8	jimenez	jimenez	PROPN
iajs-3367	326	9	-	-	PUNCT
iajs-3367	326	10	andrade	andrade	PROPN
iajs-3367	326	11	,	,	PUNCT
iajs-3367	326	12	m.c	m.c	PROPN
iajs-3367	326	13	.	.	PROPN
iajs-3367	326	14	;	;	PUNCT
iajs-3367	326	15	villarreal	villarreal	ADJ
iajs-3367	326	16	-	-	PUNCT
iajs-3367	326	17	salcido	salcido	ADJ
iajs-3367	326	18	,	,	PUNCT
iajs-3367	326	19	j.c	j.c	PROPN
iajs-3367	326	20	.	.	PROPN
iajs-3367	326	21	;	;	PUNCT
iajs-3367	326	22	martinez	martinez	PROPN
iajs-3367	326	23	-	-	PUNCT
iajs-3367	326	24	martinez	martinez	PROPN
iajs-3367	326	25	,	,	PUNCT
iajs-3367	326	26	a.	a.	NOUN
iajs-3367	326	27	;	;	PUNCT
iajs-3367	326	28	acosta	acosta	PROPN
iajs-3367	326	29	-	-	PUNCT
iajs-3367	326	30	gonzalez	gonzalez	PROPN
iajs-3367	326	31	,	,	PUNCT
iajs-3367	326	32	r.i	r.i	PROPN
iajs-3367	326	33	.	.	PROPN
iajs-3367	326	34	;	;	PUNCT
iajs-3367	326	35	lugo	lugo	PROPN
iajs-3367	326	36	-	-	PUNCT
iajs-3367	326	37	zamudio	zamudio	NOUN
iajs-3367	326	38	,	,	PUNCT
iajs-3367	326	39	g.e	g.e	PROPN
iajs-3367	326	40	.	.	PROPN
iajs-3367	326	41	;	;	PUNCT
iajs-3367	326	42	conde	conde	PROPN
iajs-3367	326	43	-	-	PUNCT
iajs-3367	326	44	mercado	mercado	NOUN
iajs-3367	326	45	,	,	PUNCT
iajs-3367	326	46	j.m	j.m	PROPN
iajs-3367	326	47	.	.	PROPN
iajs-3367	326	48	;	;	PUNCT
iajs-3367	326	49	barbosa	barbosa	PROPN
iajs-3367	326	50	-	-	PUNCT
iajs-3367	326	51	cobos	cobos	PROPN
iajs-3367	326	52	,	,	PUNCT
iajs-3367	326	53	r.e	r.e	PROPN
iajs-3367	326	54	.	.	PROPN
iajs-3367	326	55	;	;	PUNCT
iajs-3367	326	56	matias	matias	PROPN
iajs-3367	326	57	-	-	PUNCT
iajs-3367	326	58	morales	morale	NOUN
iajs-3367	326	59	,	,	PUNCT
iajs-3367	326	60	f.a	f.a	PROPN
iajs-3367	326	61	.	.	PROPN
iajs-3367	326	62	;	;	PUNCT
iajs-3367	326	63	ramirez	ramirez	PROPN
iajs-3367	326	64	-	-	PUNCT
iajs-3367	326	65	rosas	rosas	PROPN
iajs-3367	326	66	,	,	PUNCT
iajs-3367	326	67	m.b	m.b	PROPN
iajs-3367	326	68	.	.	PROPN
iajs-3367	326	69	;	;	PUNCT
iajs-3367	326	70	jimenez	jimenez	PROPN
iajs-3367	326	71	-	-	PUNCT
iajs-3367	326	72	andrade	andrade	PROPN
iajs-3367	326	73	,	,	PUNCT
iajs-3367	326	74	j.m	j.m	PROPN
iajs-3367	326	75	.	.	PROPN
iajs-3367	326	76	association	association	NOUN
iajs-3367	326	77	between	between	ADP
iajs-3367	326	78	sclerostin	sclerostin	ADJ
iajs-3367	326	79	and	and	CCONJ
iajs-3367	326	80	bone	bone	NOUN
iajs-3367	326	81	mineral	mineral	NOUN
iajs-3367	326	82	density	density	NOUN
iajs-3367	326	83	in	in	ADP
iajs-3367	326	84	a	a	DET
iajs-3367	326	85	mexican	mexican	ADJ
iajs-3367	326	86	sample	sample	NOUN
iajs-3367	326	87	of	of	ADP
iajs-3367	326	88	women	woman	NOUN
iajs-3367	326	89	with	with	ADP
iajs-3367	326	90	rheumatoid	rheumatoid	NOUN
iajs-3367	326	91	arthritis	arthritis	NOUN
iajs-3367	326	92	:	:	PUNCT
iajs-3367	326	93	a	a	DET
iajs-3367	326	94	pilot	pilot	NOUN
iajs-3367	326	95	study	study	NOUN
iajs-3367	326	96	.	.	PUNCT
iajs-3367	327	1	j.	j.	PROPN
iajs-3367	327	2	arthritis	arthritis	PROPN
iajs-3367	327	3	,	,	PUNCT
iajs-3367	327	4	2015,1	2015,1	NUM
iajs-3367	327	5	-	-	SYM
iajs-3367	327	6	6	6	NUM
iajs-3367	327	7	.	.	PUNCT
iajs-3367	327	8	ihjpas	ihjpas	PROPN
iajs-3367	327	9	.	.	PUNCT
iajs-3367	328	1	37	37	NUM
iajs-3367	328	2	(	(	PUNCT
iajs-3367	328	3	1	1	NUM
iajs-3367	328	4	)	)	PUNCT
iajs-3367	328	5	2024	2024	NUM
iajs-3367	328	6	18	18	NUM
iajs-3367	328	7	56	56	NUM
iajs-3367	328	8	.	.	PUNCT
iajs-3367	329	1	fayed	fayed	PROPN
iajs-3367	329	2	,	,	PUNCT
iajs-3367	329	3	a.	a.	NOUN
iajs-3367	329	4	;	;	PUNCT
iajs-3367	329	5	elgohary	elgohary	ADV
iajs-3367	329	6	,	,	PUNCT
iajs-3367	329	7	r.	r.	PROPN
iajs-3367	329	8	;	;	PUNCT
iajs-3367	329	9	fawzy	fawzy	PROPN
iajs-3367	329	10	,	,	PUNCT
iajs-3367	329	11	m.	m.	NOUN
iajs-3367	329	12	evaluating	evaluate	VERB
iajs-3367	329	13	the	the	DET
iajs-3367	329	14	role	role	NOUN
iajs-3367	329	15	of	of	ADP
iajs-3367	329	16	serum	serum	NOUN
iajs-3367	329	17	sclerostin	sclerostin	NOUN
iajs-3367	329	18	as	as	ADP
iajs-3367	329	19	an	an	DET
iajs-3367	329	20	indicator	indicator	NOUN
iajs-3367	329	21	of	of	ADP
iajs-3367	329	22	activity	activity	NOUN
iajs-3367	329	23	and	and	CCONJ
iajs-3367	329	24	damage	damage	NOUN
iajs-3367	329	25	in	in	ADP
iajs-3367	329	26	egyptian	egyptian	ADJ
iajs-3367	329	27	patients	patient	NOUN
iajs-3367	329	28	with	with	ADP
iajs-3367	329	29	rheumatoid	rheumatoid	NOUN
iajs-3367	329	30	arthritis	arthritis	NOUN
iajs-3367	329	31	:	:	PUNCT
iajs-3367	329	32	university	university	NOUN
iajs-3367	329	33	hospital	hospital	NOUN
iajs-3367	329	34	experience	experience	NOUN
iajs-3367	329	35	.	.	PUNCT
iajs-3367	330	1	clin	clin	PROPN
iajs-3367	330	2	.	.	PUNCT
iajs-3367	331	1	rheumatol	rheumatol	PROPN
iajs-3367	331	2	.	.	PUNCT
iajs-3367	331	3	,	,	PUNCT
iajs-3367	331	4	2020	2020	NUM
iajs-3367	331	5	,	,	PUNCT
iajs-3367	331	6	39	39	NUM
iajs-3367	331	7	,	,	PUNCT
iajs-3367	331	8	1121	1121	NUM
iajs-3367	331	9	-	-	SYM
iajs-3367	331	10	1130	1130	NUM
iajs-3367	331	11	.	.	PUNCT
iajs-3367	332	1	57	57	NUM
iajs-3367	332	2	.	.	PUNCT
iajs-3367	332	3	fernandez	fernandez	PROPN
iajs-3367	332	4	-	-	PUNCT
iajs-3367	332	5	roldan	roldan	PROPN
iajs-3367	332	6	,	,	PUNCT
iajs-3367	332	7	c.	c.	PROPN
iajs-3367	332	8	;	;	PUNCT
iajs-3367	332	9	genre	genre	NOUN
iajs-3367	332	10	,	,	PUNCT
iajs-3367	332	11	f.	f.	PROPN
iajs-3367	332	12	;	;	PUNCT
iajs-3367	332	13	lópez	lópez	NOUN
iajs-3367	332	14	-	-	PUNCT
iajs-3367	332	15	mejías	mejías	NOUN
iajs-3367	332	16	,	,	PUNCT
iajs-3367	332	17	r.	r.	PROPN
iajs-3367	332	18	;	;	PUNCT
iajs-3367	332	19	ubilla	ubilla	PROPN
iajs-3367	332	20	,	,	PUNCT
iajs-3367	332	21	b.	b.	PROPN
iajs-3367	332	22	;	;	PUNCT
iajs-3367	332	23	mijares	mijares	PROPN
iajs-3367	332	24	,	,	PUNCT
iajs-3367	332	25	v.	v.	PROPN
iajs-3367	332	26	;	;	PUNCT
iajs-3367	332	27	cano	cano	PROPN
iajs-3367	332	28	,	,	PUNCT
iajs-3367	332	29	d.s	d.s	PROPN
iajs-3367	332	30	.	.	PROPN
iajs-3367	332	31	;	;	PUNCT
iajs-3367	332	32	robles	robles	PROPN
iajs-3367	332	33	,	,	PUNCT
iajs-3367	332	34	c.l	c.l	PROPN
iajs-3367	332	35	.	.	PROPN
iajs-3367	332	36	;	;	PUNCT
iajs-3367	332	37	callejas	callejas	NOUN
iajs-3367	332	38	-	-	PUNCT
iajs-3367	332	39	rubio	rubio	PROPN
iajs-3367	332	40	,	,	PUNCT
iajs-3367	332	41	j.l	j.l	PROPN
iajs-3367	332	42	.	.	PROPN
iajs-3367	332	43	;	;	PUNCT
iajs-3367	332	44	fernández	fernández	PROPN
iajs-3367	332	45	,	,	PUNCT
iajs-3367	332	46	r.r	r.r	PROPN
iajs-3367	332	47	.	.	PROPN
iajs-3367	332	48	;	;	PUNCT
iajs-3367	332	49	ruiz	ruiz	PROPN
iajs-3367	332	50	,	,	PUNCT
iajs-3367	332	51	m.e	m.e	PROPN
iajs-3367	332	52	.	.	PROPN
iajs-3367	332	53	;	;	PUNCT
iajs-3367	332	54	gonzález	gonzález	PROPN
iajs-3367	332	55	-	-	PUNCT
iajs-3367	332	56	gay	gay	PROPN
iajs-3367	332	57	,	,	PUNCT
iajs-3367	332	58	m.á	m.á	PROPN
iajs-3367	332	59	.	.	PROPN
iajs-3367	332	60	sclerostin	sclerostin	PROPN
iajs-3367	332	61	serum	serum	NOUN
iajs-3367	332	62	levels	level	NOUN
iajs-3367	332	63	in	in	ADP
iajs-3367	332	64	patients	patient	NOUN
iajs-3367	332	65	with	with	ADP
iajs-3367	332	66	systemic	systemic	ADJ
iajs-3367	332	67	autoimmune	autoimmune	ADJ
iajs-3367	332	68	diseases	disease	NOUN
iajs-3367	332	69	.	.	PUNCT
iajs-3367	333	1	bonekey	bonekey	PROPN
iajs-3367	333	2	rep	rep	PROPN
iajs-3367	333	3	.	.	PROPN
iajs-3367	333	4	,	,	PUNCT
iajs-3367	333	5	2016	2016	NUM
iajs-3367	333	6	,	,	PUNCT
iajs-3367	333	7	5	5	NUM
iajs-3367	333	8	.	.	NOUN
iajs-3367	333	9	58	58	NUM
iajs-3367	333	10	.	.	PUNCT
iajs-3367	334	1	durosier	durosier	NOUN
iajs-3367	334	2	,	,	PUNCT
iajs-3367	334	3	c.	c.	PROPN
iajs-3367	334	4	;	;	PUNCT
iajs-3367	334	5	van	van	PROPN
iajs-3367	334	6	lierop	lierop	PROPN
iajs-3367	334	7	,	,	PUNCT
iajs-3367	334	8	a.	a.	NOUN
iajs-3367	334	9	;	;	PUNCT
iajs-3367	334	10	ferrari	ferrari	PROPN
iajs-3367	334	11	,	,	PUNCT
iajs-3367	334	12	s.	s.	PROPN
iajs-3367	334	13	;	;	PUNCT
iajs-3367	334	14	chevalley	chevalley	PROPN
iajs-3367	334	15	,	,	PUNCT
iajs-3367	334	16	t.	t.	PROPN
iajs-3367	334	17	;	;	PUNCT
iajs-3367	334	18	papapoulos	papapoulo	NOUN
iajs-3367	334	19	,	,	PUNCT
iajs-3367	334	20	s.	s.	PROPN
iajs-3367	334	21	;	;	PUNCT
iajs-3367	334	22	rizzoli	rizzoli	NOUN
iajs-3367	334	23	,	,	PUNCT
iajs-3367	334	24	r.	r.	PROPN
iajs-3367	334	25	association	association	PROPN
iajs-3367	334	26	of	of	ADP
iajs-3367	334	27	circulating	circulate	VERB
iajs-3367	334	28	sclerostin	sclerostin	ADJ
iajs-3367	334	29	with	with	ADP
iajs-3367	334	30	bone	bone	NOUN
iajs-3367	334	31	mineral	mineral	NOUN
iajs-3367	334	32	mass	mass	NOUN
iajs-3367	334	33	,	,	PUNCT
iajs-3367	334	34	microstructure	microstructure	NOUN
iajs-3367	334	35	,	,	PUNCT
iajs-3367	334	36	and	and	CCONJ
iajs-3367	334	37	turnover	turnover	NOUN
iajs-3367	334	38	biochemical	biochemical	ADJ
iajs-3367	334	39	markers	marker	NOUN
iajs-3367	334	40	in	in	ADP
iajs-3367	334	41	healthy	healthy	ADJ
iajs-3367	334	42	elderly	elderly	ADJ
iajs-3367	334	43	men	man	NOUN
iajs-3367	334	44	and	and	CCONJ
iajs-3367	334	45	women	woman	NOUN
iajs-3367	334	46	.	.	PUNCT
iajs-3367	335	1	j.	j.	PROPN
iajs-3367	335	2	clin	clin	PROPN
iajs-3367	335	3	.	.	PUNCT
iajs-3367	336	1	endocrinol	endocrinol	NOUN
iajs-3367	336	2	.	.	PUNCT
iajs-3367	337	1	metab	metab	PROPN
iajs-3367	337	2	.	.	PUNCT
iajs-3367	337	3	,	,	PUNCT
iajs-3367	337	4	2013	2013	NUM
iajs-3367	337	5	,	,	PUNCT
iajs-3367	337	6	98,3873	98,3873	NUM
iajs-3367	337	7	-	-	SYM
iajs-3367	337	8	3883	3883	NUM
iajs-3367	337	9	.	.	PUNCT
iajs-3367	338	1	59	59	NUM
iajs-3367	338	2	.	.	PUNCT
iajs-3367	339	1	karataş	karataş	PROPN
iajs-3367	339	2	,	,	PUNCT
iajs-3367	339	3	a.	a.	NOUN
iajs-3367	339	4	;	;	PUNCT
iajs-3367	339	5	ömercikoğlu	ömercikoğlu	PROPN
iajs-3367	339	6	,	,	PUNCT
iajs-3367	339	7	z.	z.	PROPN
iajs-3367	339	8	;	;	PUNCT
iajs-3367	339	9	öz	öz	PROPN
iajs-3367	339	10	,	,	PUNCT
iajs-3367	339	11	b.	b.	PROPN
iajs-3367	339	12	;	;	PUNCT
iajs-3367	339	13	dağli	dağli	PROPN
iajs-3367	339	14	,	,	PUNCT
iajs-3367	339	15	a.f	a.f	PROPN
iajs-3367	339	16	.	.	PROPN
iajs-3367	339	17	;	;	PUNCT
iajs-3367	339	18	catak	catak	PROPN
iajs-3367	339	19	,	,	PUNCT
iajs-3367	339	20	o.	o.	PROPN
iajs-3367	339	21	;	;	PUNCT
iajs-3367	339	22	erman	erman	PROPN
iajs-3367	339	23	,	,	PUNCT
iajs-3367	339	24	f.	f.	PROPN
iajs-3367	339	25	;	;	PUNCT
iajs-3367	339	26	şahi̇n	şahi̇n	PROPN
iajs-3367	339	27	,	,	PUNCT
iajs-3367	339	28	k.	k.	PROPN
iajs-3367	339	29	;	;	PUNCT
iajs-3367	339	30	gözel	gözel	PROPN
iajs-3367	339	31	,	,	PUNCT
iajs-3367	339	32	n.	n.	PROPN
iajs-3367	339	33	;	;	PUNCT
iajs-3367	339	34	koca	koca	PROPN
iajs-3367	339	35	,	,	PUNCT
iajs-3367	339	36	s.s	s.s	PROPN
iajs-3367	339	37	.	.	PROPN
iajs-3367	339	38	wnt	wnt	PROPN
iajs-3367	339	39	signaling	signal	VERB
iajs-3367	339	40	pathway	pathway	NOUN
iajs-3367	339	41	activities	activity	NOUN
iajs-3367	339	42	may	may	AUX
iajs-3367	339	43	be	be	AUX
iajs-3367	339	44	altered	alter	VERB
iajs-3367	339	45	in	in	ADP
iajs-3367	339	46	primary	primary	ADJ
iajs-3367	339	47	sjogren	sjogren	PROPN
iajs-3367	339	48	's	's	PART
iajs-3367	339	49	syndrome	syndrome	NOUN
iajs-3367	339	50	.	.	PUNCT
iajs-3367	340	1	turk	turk	PROPN
iajs-3367	340	2	.	.	PUNCT
iajs-3367	341	1	j.	j.	PROPN
iajs-3367	341	2	med	med	PROPN
iajs-3367	341	3	.	.	PUNCT
iajs-3367	342	1	sci	sci	PROPN
iajs-3367	342	2	.	.	PROPN
iajs-3367	342	3	,	,	PUNCT
iajs-3367	342	4	2021	2021	NUM
iajs-3367	342	5	,	,	PUNCT
iajs-3367	342	6	51	51	NUM
iajs-3367	342	7	,	,	PUNCT
iajs-3367	342	8	2015	2015	NUM
iajs-3367	342	9	-	-	SYM
iajs-3367	342	10	2022	2022	NUM
iajs-3367	342	11	.	.	PUNCT